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Abstract 
Pyrrolizidine Alkaloids (PAs) are known plant toxins which can cause hepatic veno-occlusive 
disease (HVOD) in both humans and livestock when ingested.  Although PAs are primarily 
known for their hepatotoxicity they also induce genotoxicity, carcinogenicity and 
pneumotoxicity.  PAs are consumed through plants as food, for medicinal purposes, or as 
contaminants of agricultural crops.  Aside from ingesting the plants directly PA exposure may 
occur through the consumption of honey produced by bees that visit PA-containing plants or by 
drinking milk produced by animals that have consumed PA-containing plants.  Possible PA 
contamination in our food chain is a potential health risk. 
 
To assess the presence of PAs in the food chain 369 retail honeys from Ireland, 59 honeys from 
Australia, 48 milk samples, 72 cheese samples, 18 herbal teas and 54 Traditional Chinese 
Medicines (TCMs) were analysed using liquid chromatography coupled to mass spectrometry.  
The sample extraction and clean-up protocol was optimised to be robust, sensitive and applicable 
to a range of food matrices providing significant advantages over pre-existing protocols.  LC-MS 
methods were optimised, developed and validated for both ion trap and triple quadrupole mass 
spectrometers whilst utilising software functionalities for data acquisition, integration and 
spectral library matching.  The analytical methods were targeted but the most comprehensive to 
date, including all commercially available PA and PA N-oxide (PANO) reference standards.  
 
The results were utilised in a dietary exposure assessment conducted for the Irish population 
based on the consumption of PAs in honey.  The mean PA concentration in positive honey from 
Irish markets was 81 µg kg-1 (or 20 µg kg-1 for all 369 samples).  The data was positively skewed 
meaning that the majority of results fell to the left of the mean.  The mean results from the 
deterministic approach were exposure values of 0.0016, 0.0024 and 0.0022 µg kg-1 bw day-1 for 
children, teenagers and adults, respectively.  This is based upon the overall mean PA 
concentration (20 µg kg-1) detected and utilising the mean honey consumption data.  The results 
for the probabilistic mean exposure values were 0.0037, 0.0046 and 0.0046 µg kg-1 bw day-1 for 
children, teenagers and adults, respectively.  However, using the 95th percentile exposure 
estimates resulted in values which far exceeded the recommended maximum daily intake of 
0.007 µg kg-1 bw day-1 at 0.0157, 0.0213 and 0.0196 µg kg-1 bw day-1 for children, teenagers and 
adults, respectively.  
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Literature Review 
  
1 
 
1.0 Literature Review 
1.1 Introduction 
1.1.1 Chemistry of PAs 
Some of the first scientific research on PAs dates back to the early 1900’s by Watt (FSANZ, 
2001).  Significant chemical and structural work was carried out by Bull, Culvenor and Dick 
(1968) and Mattocks (1986).  PAs are alkaline compounds, colourless and chemically stable, 
containing two fused five-membered rings, pyrroles, with a common nitrogen heteroatom at 
position 4.  Not all PAs are toxic but those which contain a 1,2-unsaturated necine base are.  
According to Prakash, Pereira, Reilly and Seawright (1999) the requirements for toxicity are; (1) 
one unsaturated pyrrole, (2) hydroxyl groups attached to positions C1 and C7 to facilitate 
esterification, (3) one or preferably two of these hydroxyl groups esterified, and (4) branching of 
the acid moiety.  The PA structure is an ester of an amino-alcohol and termed a necine base to 
which carboxylic acids or necic acids are attached.  There are numerous necic acids but many are 
stereoisomers (Mattocks, 1986).  PAs are classified as monoesters (e.g. lycopsamine), non-cyclic 
(open) diesters (e.g. echimidine) or macrocyclic (closed) diesters (e.g. senecionine) (Bull et al., 
1968). 
 
Figure 1.0 (a) illustrates the 1,2-unsaturated pyrrolizidine nucleus and (b) the necine base and 
necic acid of senecionine.  The majority of naturally occurring toxic PAs are derived from 
retronecine, retronecine N-oxide, heliotridine, and otonecine as per Figure 1.1, whilst the non-
toxic PAs are generally derived from platynecine (Mattocks, 1986).  Platynecine structures have 
a saturated necine base and generally tend to be non-toxic (Lin, Cui and Hawes, 1998), as per 
Figure 1.2.    
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PAs naturally occur as both the tertiary (free base) PA and the N-oxide (PANO).  The PANOs 
are also toxic being reduced to the tertiary or free base form in the gastrointestinal tract and as 
such have a similar toxicity when ingested orally (IPCS, 1988).  To date, it is estimated that 600 
PAs and PANOs are known (EFSA, 2011) with many more still to be identified.  Tertiary PAs 
are soluble in polar solvents, such as methanol, and at low pH the nitrogen heteroatom is 
protonated becoming more water-soluble.  The PANO, a charged molecule, is also soluble in 
methanol or acetonitrile. 
 
 
 
 
 
 
(a) 
 
 
 
 
 
 
(b) 
 
Figure 1.0: (a) 1,2-unsaturated pyrrolizidine nucleus and (b) necine base and necic acid of 
senecionine. 
 
 
 
Figure 1.1: Toxic retronecine, retronecine N-oxide, heliotridine, and otonecine structures. 
 
 
 
 
 
Figure 1.2: Non-toxic platynecine structure. 
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1.1.2 PA-containing Plants 
Pyrrolizidine alkaloids (PAs) are secondary plant metabolites found primarily within the plant 
families Boraginaceae, Compositae (or Asteraceae) and Leguminosae (or Fabaceae).  More than 
95% of PA-containing plants belong to these families (Hartmann, 1999) covering an estimated 
6,000 plant species or 3% of all flowering plants (Smith and Culvenor, 1981).  Thus, PA-
containing plants have widespread distribution making it possible for them to be found in any 
number of environments.  Table 1.0 lists the four PA-containing plant families with 
corresponding genera, species, common name and PA-content.  PAs play an important role in the 
chemical defence mechanism of plants. They have adapted to cope with these toxins by 
sequestering them for their own protection (Hartmann, 1999) against certain insect herbivores, 
such as the cinnabar moth.  
Family Genera Species Common Name PA-content*† Reference 
Boraginaceae Cynoglossum 
Echium 
 
 
Heliotropium 
 
Symphytum 
C. officinale 
E. plantagineum 
 
E. vulgare 
H. europaeum 
H. indicum 
S. asperum 
S. officinale 
S. × uplandicum 
Hound's tongue 
Paterson’s curse or 
Salvation Jane 
Viper’s bugloss 
European heliotrope 
Indian heliotrope 
Rough (prickly) comfrey 
Comfrey (true comfrey) 
Russian comfrey 
1.5-2% 
 
0.95 mg kg-1 
0.2%a 
0.5-2.2% 
0.4% 
0.37% 
0.29% 
0.2% 
Roeder, 2000 
 
Rizk, 1990 
El-Shazly et al., 1996 
O’Dowd & Edgar, 1989 
Roeder, 2000 
Roeder, 1995 
Roeder, 1995 
Roeder, 1995 
Compositae 
(Asteraceae) 
Petasites 
 
Senecio 
 
 
 
Tussilago 
P. hybridus 
P. japonicus 
S. aureus 
S. jacobaea 
S. longilobus 
S. vulgaris 
T. farfara 
Common butterbur 
Giant butterbur 
Golden ragwort 
Ragwort 
Threadleaf groundsel 
Common groundsel 
Coltsfoot 
1.5 mg kg-1b 
N.R. 
0.02% 
0.3% 
3.46% 
0.16%c 
2 mg kg-1 
Aydin et al., 2013 
- 
Dharmananda, 2001 
Roeder, 1995 
Johnson et al., 1985 
Roeder, 1995 
Roeder, 2000 
Leguminosae 
(Fabaceae) 
Crotalaria C. juncea 
C. retusa 
Sunn hemp 
Rattleweed 
0.15% 
6.84% 
Colegate et al., 2012 
Anjos et al., 2010 
* Content given as either percentage (%) of dry weight or as mass (mg kg-1) of PA-content detected. 
† Content based on known PAs and PANOs hence possibly undervalued due to presence of unknown PAs. 
a Content given as % weight in fresh plant material 
b Highest content determined in leaves 
c Content determined in aerial system  
Table 1.0: PA-containing plant families; example genera, species, common name and PA-
content.  
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The biosynthesis of PAs occurs in both the root and shoot of the plant.  Certain plants only 
synthesise PAs in the roots (S. officinale) whereas others exclusively use the shoots (H. indicum) 
(Frölich, Ober and Hartmann, 2007).  PA-plants from the Compositae family begin synthesis of 
PAs in the roots with final modifications to the chemical structures occurring in the leaves and 
inflorescences.  It has been demonstrated that inflorescences exhibit the highest PA content and 
that the concentration can be 5 to 10-fold that of the levels found in leaves or roots (Hartmann 
and Zimmer, 1986).  In the same publication the authors state that the tertiary PA concentration 
remained consistent over the developmental stages of the plant but the PANO concentration 
increased significantly during the flowering stage.  The percentage composition for tertiary PAs 
and PANOs can vary depending upon the species.  Johnson, Molyneux and Merrill (1985) 
determined that the percentage composition for tertiary PAs was higher than the PANO 
percentage in S. jacobaea but the reverse was true for both S. longilobus and S. riddellii.  The PA 
content was determined over a three year period and expressed as percentage of dry weight 
demonstrating that S. riddellii content was 6.40%, S. longilobus 2.19% and S. jacobaea 0.31%.  
In a publication by Roeder (1995), the PA content of certain medicinal plants used in Europe was 
reported and the content given as a percentage of dry weight for Cynoglossum officinale (0.70 to 
1.50%), Symphytum officinale (0.29%), Tussilago farfara (up to 0.02%), Senecio aureus 
(0.02%), S. vulgaris (0.16%) and S. jacobaea (0.30%) with the latter (S. jacobaea) correlating 
with the findings of Johnson et al. (1985).  Further research is needed on the PA-content of plant 
material as it is dependent upon a large number of factors such as species, plant organ, seasonal, 
storage and extraction procedures (EFSA, 2011). 
 
Several PA-containing species, including Symphytum, Petasites and Tussilago, are readily 
consumed as vegetables, used for medicinal purposes or consumed as traditional remedies such 
as ‘bush-teas’ (Wiedenfeld, 2011).  Other species, such as Senecio, Heliotropium and Crotalaria 
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have been accidentally consumed by both humans and animals through contamination of grains 
and cereals.  In the Senecio genera alone one tenth of the species have been associated with PA-
poisonings (Stewart and Steenkamp, 2001). 
 
The initial stages of biosynthesis focus on the decarboxylation of ornithine and arginine which 
results in the formation of putriscine (Hartmann, 1994).  Putriscine and spermidine are then acted 
upon by homospermidine synthase which catalyses the transfer of the aminobutyl group from 
spermidine to putriscine to form homospermidine (Ober and Hartmann, 1999).  The reaction is 
dependent on NAD+ which acts in the first part of the reaction as a hydride donor and a hydride 
acceptor during the second part (Böttcher, Ober and Hartmann, 1994).  Homospermidine is 
converted to a necine base, trachelanthamidine, via 1-(4-aminobutyl)-3,4-dihydro-2H-pyrrolium 
salt (Ober and Kaltenegger, 2009).  The complete biosynthesis process for all PA types and the 
steps involved have yet to be fully elucidated (Frölich et al., 2007).  Esterification of the necine 
base occurs to produce retronecine and heliotridine with further esterification forming a diverse 
range of pyrrolizidine alkaloids (Frölich et al., 2007).  Research on the biosynthesis of the necic 
acids is lacking.  One investigation using labelled precursors in Senecio vulgaris and 
S.pleistocephalus demonstrated that senecic acid formed two equivalents of 2-aminobutyric acid 
(Stirling et al., 1997).  Figure 1.3 illustrates the known stages of the biosynthesis of retronecine 
and helotridine pyrrolizidine alkaloids. 
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Figure 1.3: Stages of the biosynthesis of pyrrolizidine alkaloids (adapted from Ober and 
Hartmann, 1999; Frölich et al., 2007).  
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1.2 Toxicity of PAs 
Toxicity of PA-containing plants to livestock is long recognised with reports of ragwort 
(S.jacobaea) consumption causing deaths in cattle in the U.K. as early as 1787 (Molyneux, 
Gardner, Colegate and Edgar, 2011).  The toxic effect of PAs to humans was first recorded in 
1920 by Wilmot and Robertson.  Since then PAs have been classified primarily as hepatotoxic 
causing veno-occlusive disease (VOD).  In the 1960’s it was discovered that these compounds 
can cause chronic toxicity in the lung (McLean, 1970).  Mattocks (1986) reported that animal 
studies confirmed that several hepatotoxic PAs were also potential carcinogens.  Roeder (1995) 
tested the mutagenic capacity of PAs and summarised 16 common PAs in decreasing mutagenic 
order, noting that senkirkine had the highest mutagenic potential.  Therefore, PAs are not only 
hepatotoxic but also cytotoxic, genotoxic, pneumotoxic and carcinogenic (IPCS, 1988; 
Stegelmeier, Edgar, Colegate, Gardner, Schoch, Coulombe and Molyneux, 1999; Fu, Xia, Lin 
and Chou, 2004).   
 
LD50 values for hepatotoxic PAs according to W.H.O. range from 34 to 547 mg kg-1 (IPCS, 
1988).  These values were determined by using a single intraperitoneal dose on rats.  The acute 
toxicity of PAs can vary widely.  Schoental (1968) summarised that depending on the structure 
toxicity could vary by a factor of 10 or more.  Highly toxic PAs are generally macrocyclic 
diesters of retronecine with LD50 values <100 mg per kg of body weight.  PAs with monoester 
structures are less toxic (Mattocks, 1986).  Table 1.1 lists some of the known LD50 values for 
hepatotoxic PAs.  The extent of toxicity depends not only upon the molecular structure of the 
alkaloid but also upon the mechanism of exposure.  It has been shown that PANOs are as toxic as 
their free bases when given orally but less so when administered intravenously or through 
intraperitoneal doses (Mattocks, 1972).  This was illustrated using retrorsine (LD50 34 mg kg-1) 
and retrorsine N-oxide (LD50 250 mg kg-1).  When retrorsine N-oxide was taken orally its LD50 
8 
 
value was found to be 48 mg kg-1, increasing its toxicity factor 5 times.  In another study it was 
shown that riddelliine N-oxide converted to the tertiary structure riddelliine and thus has the 
potential to be as toxic (Chou, Wang, Yan, Yang, Beger, Williams, Doerge and Fu, 2003).  The 
results from a study by Wang, Yan, Fu and Chou (2005) confirm this finding on riddelliine N-
oxide but also show that this is a general phenomenon in retronecine-based PANOs.  
 
PA LD50  
(mg kg-1) 
Observation 
Time (days) 
Test subject, 
gender and dose 
Reference 
Monocrotaline 109 
230 
4 
4 
rat, male, i.p. 
rat, female, i.p. 
Mattocks, 1972 
Mattocks, 1972 
Echimidine 200 N.R. rat, male, i.p. Culvenor et al., 1969 
Heliotrine 296 
478 
274 
3 
3 
7 
rat, male, i.p. 
rat, female, i.p. 
rat, N.R., i.v. 
Bull et al., 1958 
Bull et al., 1958 
Mattocks, 1986 
Jacobine 138 
77 
3 
7 
rat, female, i.p. 
mouse, N.R., i.v. 
Bull et al., 1958 
Mattocks, 1986 
Lycopsamine 1500 N.R. rat, male, i.p. Cheeke and Shull, 1985 
Retrorsine 34-38 
153 
59 
7 
7 
7 
rat, male, i.p. 
rat, female, i.p. 
mouse, N.R., i.v. 
Mattocks, 1971 
Mattocks, 1972 
Mattocks, 1986 
Retrorsine-N-oxide 250 
834 
7 
7 
rat, male, i.p. 
mouse, N.R., i.v. 
Mattocks, 1971 
Mattocks, 1986 
Senecionine 50 
85 
61 
64 
7 
N.R. 
7 
7 
rat, male, i.p. 
rat, male, i.p. 
hamster, N.R., i.v. 
mouse, N.R., i.v. 
Mattocks, 1972 
Culvenor et al., 1969 
Mattocks, 1986 
Mattocks, 1986 
Seneciphylline 77 
83 
90 
3 
3 
7 
rat, male, i.p. 
rat, female, i.p. 
mouse, N.R., i.v. 
Bull et al., 1968 
Bull et al., 1968 
Mattocks, 1986 
Senkirkine 220 N.R. rat, male, i.p. Hirono et al., 1979 
N.R. = not reported 
 
Table 1.1: LD50 values for PAs and PANOs determined after a single (i) intraperitoneal dose, i.p. 
or (ii) intravenous dose, i.v. 
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On the basis that oral doses of PAs and PANOs could potentially be 5 times more toxic than the 
intraperitoneal dose (Mattocks, 1972), the oral LD50 values of retronecine-type PAs 
(monocrotaline, retrorsine, senecionine and seneciphylline) from Table 1.1 could range from 5 to 
20 mg kg-1.  This value is comparable to the mycotoxin patulin, produced by the fungus 
Penicillium expansum causing apples and pears to rot, with an oral (rat) LD50 of 27 mg kg-1 and 
an EU maximum residue limit (MRL) of 50 µg kg-1 for juices and 10 µg kg-1 for baby and infant 
foods (Shaw, 2013). 
 
 1.2.1 Toxicity studies in animals 
The route of administration, species, sex, age and diet all affect the toxicity exerted by PAs 
(Mattocks, 1986; Stegelmeier et al., 1999).  A similar publication (Mattocks, 1972) found 
Japanese quail to be resistant to PA toxicity from Senecio jacobaea through dietary intake (10% 
of diet consisted of S. jacobaea) but susceptible to acute toxicity when injected with an 
equivalent amount (Buckmaster, Cheeke, Arscott, Dickinson, Pierson and Shull, 1977).  
Different animal species have varying susceptibility to PAs.  Huan, Miranda, Buhler and Cheeke 
(1998) found that there was no strong association between the production of pyrrolic metabolites 
and the vulnerability of animals to PA toxicity among a range of species tested; sheep, cattle, 
gerbils, rabbits, hamsters, Japanese quail, chickens, and rats.  Instead, toxicity was dependent on 
the individual species hepatic microsomal enzyme catalytic capability.  Mori, Sugie, Yoshimi, 
Asada, Furuya and Williams (1985) also found that there was a difference in liver bioactivation 
of PAs among rat, mouse and hamster.  Rats are highly susceptible and develop acute and 
chronic lesions even after a single dose of PAs (Schoental, 1968).  Sheep are up to 10 times more 
resistant than cattle and horses (Hooper, 1978; Elliott, 2005) due to the capacity of their liver 
enzymes or ruminal microbes to detoxify PAs (Cheeke, 1994; Chojkier, 2003) whereas pigs and 
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chickens are the species most at risk.  Thus, toxicity information gained from one species may be 
of little use when predicting toxicity in another species (Stegelmeier et al., 1999).  The difference 
in toxicity resulting from alternative routes of administration, species, sex, age and diet is not 
exclusive to PAs.  Similar findings are evident with mycotoxins.  Deoxynivalenol, a Fusarium 
species which frequently infects corn, wheat, oat, rice and barley in field or during storage, 
differs in toxicity depending upon species, age, gender, route and duration of exposure in animals 
(Sobrova, Adam, Vasatkova, Beklova, Zeman and Kizek, 2010).  Poultry, especially turkeys, are 
extremely sensitive to the toxic and carcinogenic action of aflatoxin B1 (Rawal, Kim and 
Coulombe, 2010).   
 
In a study administering the PA monocrotaline to sheep (Anjos, Nobre, Dantas, Medeiros, 
Oliveira Neto, Molyneux and Riet-Correa, 2010) it was found that single doses of 205 to 274 mg 
per kg of body weight resulted in mortalities for all test subjects (n = 5) from either acute (n = 3) 
or chronic (n = 2) toxicity.  If the dose was decreased to 137 mg per kg of body weight daily for 
70 days the sheep exhibited a resistance to monocrotaline.  In a similar study involving seeds of 
Crotalaria retusa the authors concluded that sheep can be affected by acute monocrotaline 
toxicity when consuming 5 to 40 g per kg of body weight over 5 days (Nobre, Dantas, Riet-
Correa, Barbosa Filho, Tabosa and Vasconcelos, 2005).  Gender and age influence PA 
intoxication with males being more susceptible than females and young more so than adults 
(Stegelmeier et al., 1999).  Maternal ingestion can cause foetal toxicity or PAs and their 
metabolites can be secreted in the milk of lactating animals (Cheeke, 1988).  Diet also affects PA 
intoxication with hepatic bioactivation being promoted or inhibited.  Pre-treatment over three 
days with glycyrrhizin and glycyrrhetinic acid which are active ingredients of liquorice, were 
found to be protective against retrorsine-induced liver damage in rats (Lin, Nnane and Chen, 
1999).   
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The antibacterial agents rifampin and erythromycin were found to be effective against jacobine 
biotransformation (Wachenheim, Blythe and Craig, 1992).  Diets of rats supplemented with 
amino acids or phenobarbital which alters liver microsomal enzyme activity did not alter their 
susceptibility to chronic poisoning by Senecio jacobaea (ragwort).   
 
However, in the same study a combination of butylated hydroxyanisole and cysteine did increase 
the survival time of rats fed ragwort (Garrett and Cheeke, 1984).  It should also be remembered 
that toxicity depends greatly upon the PA ingested.  For example, rats fed groundsel (Senecio 
vulgaris) had a much shorter survival time than those who were fed ragwort (Senecio jacobaea) 
(Buckmaster et al., 1976).  The results from this study are presented in the two graphs below. 
 
 
Figure 1.4: Graphical representation of data to illustrate survival rates for rats fed ragwort and 
groundsel (from results given in Buckmaster et al., 1976). 
 
Common signs of PA toxicosis in livestock are weight loss, jaundice from elevated levels of 
bilirubin in the blood, depression, diarrhoea, abdominal pain, circling and blindness.  Horses are 
particularly sensitive to neurological effects and may walk blind into objects or fences, walk 
aimlessly in circles or straight lines, and/or display head pressing and ataxia (lack of coordination 
and balance).  Death can occur 2 to 3 days after the onset of clinical signs (Elliott, 2005). 
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 1.2.2 Metabolism of PAs 
PAs require hepatic metabolic activation and thus the liver is the main organ of PA metabolism 
(Prakash et al., 1999).  Studies of the metabolism of PAs have shown that three main pathways 
occur; hydrolysis, N-oxidation, and dehydrogenation and these pathways are dependent upon the 
PA structure or type (as per Figure 1.1).  All PA structures can undergo hydrolysis which is an 
important detoxification pathway.  Esterase acts upon the PA molecule causing a cleavage in the 
structure into necine and necic acid fragments.  These are non-toxic water soluble products and 
as no further metabolism occurs they are excreted through the kidneys (Chen et al., 2010).  N-
oxidation, catalysed by microsomal monooxygenases and cytochrome P450, of retronecine and 
heliotridine type PAs can produce highly water soluble N-oxides which can be excreted in urine.  
Although metabolism to the PANO is seen as a detoxification pathway it has also been shown to 
form the corresponding parent PA upon ingestion, thereby producing pyrrolic esters, resulting in 
toxicity.  Otonecine type PAs cannot undergo N-oxidation due to the methylation of the nitrogen 
in their necine base (Jiang, Fu and Lin, 2006).  Figure 1.4 illustrates the metabolic pathways of 
hydrolysis and N-oxidation. 
 
Dehydrogenation, referred to as the activation pathway (COT, 2008), is catalysed by cytochrome 
P450 and results in the formation of toxic pyrrolic derivatives.  Retronecine and heliotridine type 
PAs undergo hydroxylation at C3 and C8 positions on the necine base.  Dehydration follows 
yielding a pyrrolic ester; dehydropyrrolizidine (Fu, Yang, Xia, Chou, Cui and Lin, 2002).  The 
conversion of otonecine type PAs into pyrrolic derivatives occurs following oxidative N-
demethylation and dehydration of the necine base (Jiang et al., 2006).  With appropriate leaving 
groups from positions C7 and C9 of the dehydropyrrolizidine, the pyrrolic esters become strong 
electrophiles and undergo nucleophilic substitution reactions (Stegelmeier et al., 1999).  
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The pyrrolic esters bind to liver macromolecules causing hepatotoxicity and cross-links with 
DNA forming DNA adducts causing tumorigenicity (Chojkier et al., 2003; Jiang et al., 2006).  
 
Pyrrolic esters can also be hydrolysed into secondary metabolites which are less reactive but still 
have mutagenic and carcinogenic effects (Prakash et al., 1999; Chen et al., 2010).  Figure 1.5 
illustrates the oxidative dehydrogenation or activation pathway. 
 
Dehydropyrrolizidine has four further reaction pathways (Stewart and Steenkamp, 2001) which 
are; (i) dehydrogenation to a less toxic pyrrole, (ii) conjugation with glutathione allowing for 
excretion in bile, (iii) alkylation of macromolecules such as proteins or nucleic acids and/or (iv) 
excretion into the circulatory system damaging vascular endothelial cells. 
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Figure 1.5: Hydrolysis and N-oxidation metabolic pathways for PAs (adapted from Fu et al., 
2004; Jiang et al., 2006; Chen et al., 2010). 
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Figure 1.6: Oxidation or dehydrogenation metabolic pathway for PAs (adapted from Fu et al., 
2004; Jiang et al., 2006; Chen et al., 2010). 
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1.2.3 Excretion 
PA metabolites are generally excreted within 24 hours with an estimated 10 to 15% of the total 
dose remaining in urine after 48 hours (Stewart and Steenkamp, 2001).  PAs absorbed into the 
liver or lung tissue can undergo cleavage into the necine and necic acid.  These fragments are 
non-toxic and can be further conjugated to allow excretion via the kidneys (Roeder, 1995; Chen, 
Mei and Fu, 2010).  PAs excreted into urine can be auto-oxidized into the PANO form, an 
occurrence which Stewart and Steenkamp (2001) highlighted as being overlooked, which has 
given rise to misinterpretation in metabolic pathways.  
 
1.2.4 Diagnosis 
Many signs of PA toxicosis do not develop until many weeks or months after the initial exposure.  
As a result, Stegelmeier et al. (1999) state that most diagnoses are made using histological 
changes alone.  Except for PA epidemic situations, which have been seen for both animals and 
humans, chronic toxicity from the ingestion of smaller quantities of PAs can be difficult to 
identify unequivocally (Molyneux et al. 2011; Wiedenfeld 2011). 
 
 1.2.5 Symptoms of Toxicity 
Pyrrolic metabolites are the principal cause of liver toxicity which is characterised by 
megalocytosis (enlargement) of parenchymal cells (hepatocytes), followed by necrosis and 
ultimately cirrhosis (EFSA, 2007).  Acute hepatotoxicity in rodents presents with a loss of central 
venous and sinusoidal endothelial cells, dilated and congested sinusoids with the final stages of 
toxicity resulting in centrilobular parenchymal cell necrosis (Hanumegowda, Copple, Shibuya, 
Malle, Ganey and Roth, 2003).  Chronic intoxications result in megalocytosis of hepatocytes, 
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liver cirrhosis, bile-duct proliferation, fibrosis, vascular damage, loss of metabolic function and 
tumour formation (Mattocks, 1986; IPCS, 1988; EFSA, 2007). 
 
Along with hepatotoxicity, pneumotoxicity and neurotoxicity can ensue.  It has been 
demonstrated that 30 to 60 mg kg-1 of monocrotaline provoked right ventricular hypertrophy in 
rats (Orlinska, Olson, Gebb and Gillespie, 1989) whilst certain PAs can bind to neuroreceptors 
causing interference with signal transduction (Schmeller, El-Shazly and Wink, 1997).  The PAs 
monocrotaline and fulvine (Crotalaria spp.) are most commonly used experimentally to 
demonstrate pulmonary hypertension.  By-products of hepatic metabolism are transported in the 
blood to the lung (Chojkier, 2003).  Renal alteration and teratogenicity have been noted in 
experimental cases of high PA exposure or in fatal acute intoxications (Hooper, 1974; Mattocks, 
1986).  PAs are mutagenic in vivo and in vitro and their mutagenicity appears to be responsible 
for carcinogenesis of PAs (Chen, Mei and Fu, 2010) and has been studied in different biological 
systems, including Drosophila melanogaster, Salmonella typhimurium, and Escherichia coli (Fu, 
Xia, Lin and Chou, 2004).  There are no reports of cancer concerning domestic animals exposed 
to PAs but laboratory studies have been able to produce PA-induced cancer in rodents (Prakash 
et al., 1999).   
 
Individual PAs such as monocrotaline, heliotrine, lasiocarpine, clivorine and riddelline and PA-
containing plants Senecio longilobus and Tussilago farfara L. and their major PA constituents 
have shown to be carcinogenic (Prakash et al., 1999; Harris and Chen, 1970; Hirono, Mori and 
Culvenor, 1976).  Pyrrolic metabolites bind to form DNA-adducts, DNA cross-links and DNA-
protein cross-links giving rise to mutagenicity and carcinogenicity (Prakash et al., 1999).  
Macrocyclic PAs including senecionine, retrorsine and riddelliine are potent DNA cross-links 
leading to cell death, mutations and/or carcinomas (Stewart and Steenkamp, 2001).   
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It has also been shown that damage to DNA from PA pyrrolic metabolites was transmissible to 
the next generation of cells in vitro (Martin, Thorburn, Hutchinson, Bras and Miller, 1972). 
 
Dehydropyrrolizidine alkaloids are the primary metabolites of PAs but due to their instability, 
biological and chemical reactivity it has been impossible to isolate these compounds from 
biological systems (Zhao et al., 2012).  In 2001, a genotoxic mechanism was proposed via (±)-
6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine (DHP)-derived DNA adduct formation 
(Yang et al., 2001).  Structures resulting in adducts were not elucidated until 2012 when Zhao et 
al. (2012) proposed four DNA adduct structures as (i) a pair of epimers of 7-hydroxy-9-
(deoxyguanosin-N2-yl)dehydrosupinidine termed as DHP-dG-3 and DHP-dG-4 and (ii) a pair of 
epimers of 7-hydroxy-9-(deoxyadenosin-N6-yl)dehydrosupinidine termed as DHP-dA-3 and 
DHP-dA-4 adducts.  It has also been shown that the most reactive site for dehydropyrrizidine 
alkaloid metabolites binding with cellular DNA is the C7 position of the necine base (Yang et al., 
2001). 
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1.3 Regulation of PAs 
Currently there are no EU regulatory limits for PAs and their N-oxides.  The European Food 
Safety Authority (EFSA, 2011) has recently conducted a safety assessment of PAs in food and 
feed.  It is recommended not to exceed an intake of 0.007 μg kg-1 body weight (bw) day-1 of 1,2-
unsaturated PAs as doses at this level are unlikely to pose a risk of cancer.  Prior to this 
assessment some countries proposed recommendations and tolerable levels of exposure.   
 
In 1992 the German Federal Health Bureau, Bundesanzeiger, restricted PAs on the basis of their 
potential to be genotoxic and carcinogenic.  The use of herbal medicine containing unsaturated 
PAs and PANOs was controlled.  Regulations limited exposure to a maximum of 1 μg day-1 for a 
total of 6 weeks per year or 0.1 μg day-1 if the exposure was to exceed a 6 week period/duration 
and a zero tolerance for pregnant or lactating women (Bundesanzeiger, 1992).  In Belgium 
medicinal products for internal use containing PAs are prohibited (EMA, 2012) and in Austria it 
has to be proven that the medicinal product which contains PA-containing plants has no PAs or 
PANOs in the final product (Bundesgesetzblatt, 1994).  On the probability of PAs causing 
HVOD the Foods Standards Australia New Zealand (formerly Australia New Zealand Food 
Authority) set an exposure level of 1 μg of PAs kg-1 bw day-1 (FSANZ, 2001).  In the 
Netherlands a recommendation of 0.1 μg of PAs per 100g of food was introduced in 2001 
(Edgar, Colegate, Boppré and Molyneux, 2011).  In 2005 the Dutch National Institute for Public 
Health and the Environment (Rijksinstituut voor Volksgezondheid en Milieu, RIVM) proposed a 
virtual safe dose (VSD) for PAs at a level of 0.43 ng kg-1 bw day-1 (equivalent to 0.00043 µg kg-1 
bw day-1) which signifies a greater risk of developing cancer in at most one person in a million.   
 
The American Herb Products Association (AHPA, 1996) issued a recommendation that all 
products with botanical ingredients containing toxic pyrrolizidine alkaloids carry a cautionary 
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statement on the label “For external use only. Do not apply to broken or abraded skin. Do not 
use when nursing”.  The Consumer Healthcare Products Association established a voluntary 
program for manufacturers with the same recommendation in 2001 (Dharmananda, 2001). 
 
A report from EFSA in 2007 concluded that carry-over of PAs from animal feed into the food 
chain is negligible.  However, they recommended further investigations into honey, milk and 
feed, and quantitative analysis of the same due to the possibility of high risk to infants (EFSA, 
2007).  The U.K. Committee on Toxicology (COT, 2008) issued a statement suggesting that 
levels of 0.007 μg kg-1 bw day-1 were improbable to be a cancer risk.  They determined this from 
long-term experimental feeding studies on rats.  It should be noted this is 16 times greater than 
the VSD advised by RIVM.  
 
Most recently the EFSA Panel on Contaminants in the Food Chain (CONTAM Panel) concluded 
that there is a health concern for children and adults who are high consumers of PA-containing 
honey.  Assessment of the risk was based on three representative age groups and the effects of 
both acute and chronic exposure levels.  The report highlighted the need for on-going analytical 
research into the PA content of food and feed (EFSA, 2007).  To date EFSA (2011), COT (2008), 
and the German Federal Institute of Risk Assessment (Bundesinstitut für Risikobewertung - BfR, 
2011) all recommend not to exceed an intake of 0.007 μg kg-1 bw day-1 of 1,2-unsaturated PAs.  
This level is based upon a BMDL10 (benchmark dose lower confidence limit 10%; an estimate of 
the lowest dose which is 95% certain to cause no more than a 10% cancer incidence in rodents.) 
of 0.073 mg kg-1 bw day-1 derived from the study on lasiocarpine in male rats.  A margin of 
exposure (MOE) of 10,000 and above would thus correspond to doses of up to 0.007 μg kg-1 bw 
day-1 of 1,2-unsaturated PAs and would be unlikely to be of concern.  A summary of the current 
PA regulations are given in Table 1.5.  
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Proposed Regulation Regulatory Authority/Reference 
0.007 µg kg-1 bw day-1 a European Food Safety Authority (EFSA), 2011 
Bundesinstitut für Risikobewertung (BfR), 2011 
Committee on Toxicity (COT), 2008 
 
0.1 µg kg-1 bw day-1 b Rijksinstituut voor Volksgezondheid en Milieu (RIVM), 2007 
 
1.0 µg kg-1 bw day-1 c Food Standards Australia New Zealand (FSANZ), 2001 
 
1.0 µg day-1 d, f 
0.1 µg day-1 e, f 
Bundesanzeiger, 1992 
a Cancer unlikely 
b Non-cancer effects unlikely 
c HVOD unlikely 
d Intake for maximum of 6 weeks per year 
e Intake if exceeding 6 weeks per year 
f Zero exposure for pregnant and lactating women 
 
 
Table 1.2: Current regulations on PAs and PANOs exposure limits (modified from Edgar et al., 
2011). 
  
22 
 
1.4 Human PA Intoxications 
There are many documented cases of human poisoning due to consumption of pyrrolizidine 
alkaloids (PAs), the earliest dating back to 1920.  Wilmot and Robertson (1920) are acclaimed as 
being the first researchers to report that an outbreak of hepatic veno-occlusive disease (HVOD) 
in South Africa was due to the contamination of flour grain with seeds from PA-containing 
plants, those from the Senecio genera.  The term “bread poisoning” originates from around this 
time when bread was prepared from imperfectly winnowed wheat (Selzer, 1951) contaminated 
primarily with Senecio seeds, hence the alternative term “Senecio disease”.  Budd-Chiari 
syndrome, most prevalent in Southern Africa and Asia, has been linked to bread poisoning from 
Senecio (Selzer, 1951).  Budd-Chiari syndrome occurs due to occlusion of the hepatic vein, 
leading to accumulation of fluid in the abdomen (ascites) and scarring of the liver (cirrhosis).  
Both Stein (1957) and Schoental (1968) recognised that the elevated levels of HVOD in South 
Africa at that time were most likely due to "Senecio disease".  Although Budd-Chiari syndrome 
has been compared with HVOD it is wise to note that however similar these conditions are they 
are distinct from each other (Janssen, 2004).   
 
HVOD results from microscopic blockages of veins in the liver leading to an accumulation of 
blood.  This congestion reduces the amount of blood entering the liver and so cells become 
damaged as they do not receive sufficient blood (ischemia).  The congestion causes the liver to 
become enlarged and increases the pressure of the portal vein (portal hypertension).  The 
elevated pressure in the portal vein and the liver congestion leads to fluid accumulating in the 
abdomen which is referred to as ascites.  The spleen may also enlarge.  The skin and whites of 
the eyes can turn yellow.  Bilirubin levels in the blood are elevated.  The damage within the liver 
eventually leads to severe scarring which is referred to as cirrhosis (Culvenor, 1983). 
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1.4.1 Grain 
Human PA poisoning due to contamination of grain has occurred most often in areas that 
experienced drought conditions, poverty or famine, especially Africa, Central and Southern Asia.  
Mass intoxication was observed in these areas due to man’s susceptibility during times of 
deprivation.  PA-containing weeds of the genera Senecio, Heliotropium and Crotalaria can thrive 
during arid periods.  In the 1970's both Afghanistan and India experienced such mass 
intoxications resulting in an estimated 1,667 cases of HVOD, of which there where many 
casualties (Huxtable, 1980).  As with large-scale disasters this figure varies widely and 
symptoms of PA poisoning can take time to present leading to a late diagnosis in patients.  In 
later reports it is stated that the food supply was affected for 35,000 people in Afghanistan alone, 
of which up to 2,000 developed HVOD (Rizk, 1990).  Seeds from Heliotropium popovii were the 
cause of the Afghanistan epidemic (Stickel, Patsenker and Schuppan, 2005).  Mohabbat, 
Srivastava, Younos, Sediq, Menzad and Aram (1976) suggested that 0.03% of the flour grain was 
contaminated and that the alkaloid consumption was 2 mg per person per day with a total 
ingestion of approximately 1.46 g per person.  In India the contamination of millet grain known 
as 'Gondli' with Crotalaria seed was much higher equating to 40 mg per person per day 
(Culvenor, 1983).  It has also been reported that the mean daily intake of PAs would have been 
lower if the level of exposure was estimated (Huxtable, 1989). 
 
Outbreaks of PA poisoning have occurred sporadically in Uzbekistan (formerly part of the Soviet 
Union) from 1935 through to the 1950’s.  One of the first reported incidents involved 
contamination from Heliotropium lasiocarpum seeds with approximately 8.8% of cases resulting 
in fatality within a 2 year period but the rate of alkaloid consumption is unknown (Zheltova, 
1952; Culvenor, 1983).  The second outbreak involved poisoning from Trichodesma seeds in 
food grain which was termed “Trichodesma toxicosis” by the researchers (Shtenberg and Orlova, 
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1955) with the alkaloid content of the T. incanum seed determined as 1.5 to 3.1% dry weight.  At 
the time, this PA poisoning was termed “camel belly” due to the large number of patients 
presenting with ascites.  In 1993 over 3,900 cases of liver toxicity were recorded in Tajikistan 
due to wheat contaminated with Heliotropium lasocarpium (Chauvin, 1994).  In all of the above 
recorded cases the intake of PAs and PANOs far exceed those recommended tolerable intakes 
provided in Table 1.2.  In fact the lowest reported intake of 2 mg of PAs per person would 
exceed the limit of 1 µg kg-1 bw day-1, the least strict limit imposed by FSANZ (2001), by 28 
times. 
 
One would assume that the frequency of PA poisoning due to food grain contamination would 
have decreased in later years, mainly due to increased awareness and better agricultural 
management.  Unfortunately, poisonings have continued to occur.  In Northern Iraq in 1994 
wheat contaminated with seeds from Senecio species affected three families incurring a mortality 
rate of 14% (Altaee and Mahmood, 1998).  Initial reports on the outbreak of PA intoxication in 
the Gulran region of Afghanistan suggest that in excess of 200 people developed HVOD caused 
by wheat contaminated with PAs originating from 'Charmac', a native weed in the Herat Province 
(IRIN, 2010).  The weed was identified as Heliotropium popovii and the major PA constituent 
was heliotrine (Kakar, Akbarian, Leslie, Mustafa, Watson, van Egmond, Omar and Mofleh, 
2010).  The authors examined the Gulran area and conducted an outbreak investigation using a 
case-control design.  The diet of the population consisted mainly of wheat, bread and meat.  It 
was noted by the investigators that during 2007-2008 rain fall levels were normal and there were 
no reports of drought or water shortages.  The investigation included examining clinical history, 
analysing serum and suspected PA-contaminated foods.   
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Figure 1.7: (from left to right) The weed Charmac, which contaminated wheat grain in the 
Gulran district, and the resulting abdominal swelling (ascites) post-consumption (photographs 
from Dr. H. van Egmond). 
 
Samples of flour had a median PA concentration of 4 mg kg-1 (4,000 µg kg-1) with heliotrine, 
heliotrine N-oxide and lasiocarpine detected.  Samples of ‘qurut’ (a cheese produced from goats 
milk) had a median PA concentration of 0.09 mg kg-1 (90 µg kg-1) and also contained heliotrine 
and its N-oxide.  Large amounts of trichodesmine were also found, a PA which is not detected in 
Charmac.  Therefore, it is suspected that the goats had grazed upon the weed/Charmac along with 
another PA-plant containing trichodesmine.  The quantities of PAs detected exceeded by far the 
recommended maximum limit of 0.007 µg kg-1 bw day-1. 
 
The World Health Organisation (W.H.O.) established the Disease Early Warning System 
(DEWS) in Afghanistan in 2006.  The DEWS team responded to the Gulran district due to 
suspected PA-poisoning resulting in 38 cases of massive ascites and 4 deaths (Kakar et al., 2010).  
Ultimately, to negate further re-occurrence in these areas improved food safety and Good 
Agricultural Practices (GAP) must be employed.  Table 1.3 summarises cases of PA poisoning 
caused from contaminated grains.  Wiedenfeld (2011) also summarises PA intoxications linked 
to the consumption of contaminated grains and herbal teas which is comprised of 28 individual 
cases where the source of PA poisoning was explicitly identified.  
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PA Plant PA(s) identified Quantity 
Ingested 
Country of 
incidence 
Reference 
Senecio illiciformis 
Senecio burchelli 
senecionine N.R.  South Africa Wilmot and Robertson (1920) 
Senecio spp. senecionine N.R. South Africa Selzer and Parker (1951) 
Senecio spp.  
(suspected cause) 
N.R. N.R. Iraq Al-Hasany and Mohamed (1970) 
Heliotropium 
popovii 
heliotrine 
 
2 mg person-1 
day-1 
Afghanistan Tandon et al. (1978) ;  
Mohabbat et al. (1976) 
Crotalaria spp. 
Crotalaria nana 
crotananine 
cronaburmine 
monocrotaline 
fulvine 
40 mg person-1 
day-1 
India Tandon et al. (1976) 
Krishnamachari et al. (1977) 
Siddiqui et al. (1978) 
Huxtable (1989) 
Heliotropium 
lasiocarpum 
heliotrine 
lasiocarpine 
N.R. Uzbekistan  
Tajikistan 
Dubrovinskii (1952) 
Zheltova (1952) 
Chauvin et al. (1994) 
Trichodesma 
incanum 
trichodesmine 
incanine 
0.5–3.3  
mg kg-1 bw 
Uzbekistan Shtenberg and Orlova (1955) 
Senecio vulgaris senecionine N.R. Northern Iraq Altaee and Mahmood (1998) 
Heliotropium 
(Charmac) 
Heliotrine 
heliotrine N-oxide 
4 mg kg-1 Afghanistan Kakar et al. (2010) 
N.R. = not reported 
 
Table 1.3: Summary of reported cases of human PA poisoning due to contaminated grains. 
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 1.4.2 Teas and herbal products 
Human intoxications from PAs can also arise from the use of medicinal or herbal products.  A 
substantial amount of countries do not enforce restrictions on herbal preparations, therefore this 
tends to lead to self-medication.  Herbal products are seen by consumers as safe, natural and 
effective despite the lack of quality control and regulations (Stickel, Patsenker and Schuppan, 
2005).  In the U.S. herbal products can be sold without prior demonstration of their safety and 
efficacy as they are defined as dietary supplements (Bent 2008).  The author Bent (2008) 
explains that the Food and Drug Administration (FDA) bears the burden of proving that a dietary 
supplement is unsafe before it can be removed from the market, a direct contrast to 
pharmaceutical products.  Also in the U.S., herbal preparations follow the guidelines of the 
Dietary Supplement and Health Education Act (DSHEA) 1994.  This states that producers of 
herbal products should determine the safety and purity of their goods prior to marketing but there 
is no requirement to register their products prior to distribution.  The European Commission 
introduced the directive 2004/24/EC in 2004 to align the process of licensing a herbal or 
medicinal product (European Commission 2004).  It applies to products with a ‘tradition’ of use 
and that have proven efficacy and safety through scientific publications or ‘well established’ 
records of use.  In herbal usage polls carried out in both Europe and America, Stickel et al. 
(2005) summarised that 21% of patients receiving medical care for liver complaints had taken 
herbal products and 13% had used herbal preparations throughout their treatment. 
 
In the West Indies, predominantly Jamaica, poisoning resulted from regular consumption of 
“bush tea” with many cases resulting in veno-occlusive disease for children (Stuart and Bras, 
1955).  The “bush-tea” was used as a common cold remedy (Fu, Chou, Xia, Yang, Yan, Doerge 
and Chan, 2001).   
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Research has shown this was due to monocrotaline and fulvine from Crotalaria plants but no 
data exists on the quantity consumed by the patients nor the number of HVOD cases as a direct 
consequence of PA intake.  Similar cases have been recorded in Africa and one known case in 
Ecuador due to both Crotalaria and Senecio plants.  Stillman, Huxtable, Consroe, Kohnen and 
Smith (1977) reported on two cases of HVOD in Mexican-American infants, a 6-month-old 
female and a 2-month-old male.  Both had consumed tea prepared from Senecio longilobus 
containing riddelline and retrorsine N-oxide.  Unfortunately, both infants died after intakes of 70 
to 147 mg over 14 days for the female and 66 mg over a period less than 14 days for the male 
(Huxtable, 1980).  There is evidence to show that PA induced tumours occur in rats (Mattocks, 
1986; IPCS, 1988) but no clear evidence that PA induced tumours occur in humans.  However, 
frequent liver tumours present in natives of Central and South Africa who consume bush teas 
with PA plants (Chen et al., 2010).  Three cases of HVOD were reported in India and one in 
Hong Kong from the use of Heliotropium containing tea.  Of these four cases two were fatal from 
daily intakes equivalent to 30 mg of PAs day-1 over a period of 20-50 days (Molyneux and 
James, 1990; Culvenor, 1983).   
 
Despite events of HVOD prior to 1980 it was not until then that the medicinal product commonly 
known as “Comfrey” from Symphytum officinale was investigated for hepatoxicity.  Symphytum 
officinale is more common in Europe whereas S. x uplandicum (Russian Comfrey) is more 
widely used in Australia and America (Culvenor, 1983).  During the 1980’s four individual cases 
were recorded; two in America, one in the U.K. and one in New Zealand, the latter resulting in 
death.  The consumption of comfrey varied from root powder, dietary capsules, tea, and ingestion 
of plant leaves in salad.  Betz, Eppley, Taylor and Andrzejewski (1994) investigated the content 
of hepatotoxic PAs in commercial comfrey products and found that 80% of those tested 
contained 0.1 to 400 mg L-1 PAs, with root products having a higher content than those made 
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from the leaf.  Analysis of commercial comfrey tea products by Oberlies, Kim, Brine, Collins, 
Handy, Sparacino, Wani and Wall (2004) confirmed Betz et al. (1994) previous conclusion in 
that there was a greater content of PAs in root products.  However, Oberlies et al. (2004) 
suggested that the PA content in leaf teas may be significantly undervalued due to the lack of 
consideration for PANOs.  Subsequent to these publications and other scientific literature, the 
American Herb Products Association (AHPA) notified members to the potential toxic effects of 
comfrey, limiting the use of comfrey to external applications only.  In 2001 the American FDA 
investigated at least seven cases of HVOD associated with comfrey and on completion of their 
review advised all dietary supplement manufacturers to remove comfrey products from the 
market, specifically Symphytum officinale (common comfrey), S. asperum (prickley comfrey) 
and S. x uplandicum (Russian comfrey).  In Europe, the Federal Health Department of Germany 
imposed restrictions on PA-containing plants, including comfrey, to a maximum internal intake 
of no more than 1 μg day-1 for a maximum of 6 weeks per year (Bundesanzeiger, 1992). 
 
Senecio tephrosioides known as 'huamanripa' is a Chilean herb used to treat bronchitis and other 
respiratory complaints.  It was reported to have caused HVOD in a Peruvian woman after 
ingestion of herbal tea containing 'huamanripa' (Tomioka, Calvo, Siguas, Sánchez, Nava, García, 
Valdivia and Reátegui, 1995).  Failure to discontinue use of traditional herbal medicines 
containing PAs brought about another 2 cases of HVOD from Tussilago farfara (coltsfoot).  In 
1995 an Austrian child developed HVOD after consumption of coltsfoot tea with an estimated 60 
μg kg-1 bw day-1 being consumed over a 15-month period (Roulet, Laurini, Rivier and Calame, 
1988).  Another incidence of PA poisoning due to coltsfoot was reported by Bach, Thung and 
Schaffner (1989) where a 47 year old woman consuming 10 cups of comfrey tea per day had 
developed HVOD.  Analysis of commercial samples of comfrey tea reported the presence of the 
PA senkirkine at a concentration of 19.5 to 46.6 mg L-1 (Jiang, Liu, Goh, Yu, Li, Ong and Ong, 
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2009) and 2.5 to 11.2 mg L-1 (Lebada, Schreier, Scherz, Resch, Krenn and Kopp, 2000).  
Applying the lower concentration detected of 2.5 mg L-1 and a consumption of 10 cups per day 
(approx. 200 mL per cup) meant this woman was regularly consuming 5 mg of senkirkine. 
 
A Brazilian medicinal tea containing Ageratum conyzoides was found to contain lycopsamine 
and lycopsamine N-oxide (Bosi, Rosa, Grougnet, Lemonakis, Halabalaki, Skaltsounis and 
Biavatti, 2013).  It was noted by the authors that this tea is freely available and popular, enjoying 
frequent consumption.  Likewise a Mexican “miracle tea” was investigated by Fragoso-Serrano, 
Figueroa-González, Castro-Carranza, Hernández-Solis, Linares, Bye and Pereda-Miranda (2012) 
who tested 22 commercial samples which were found to contain senecionine (232 mg kg-1) and 
retrorsine (331 mg kg-1).  Recently the German Federal Institute for Risk Assessment (BfR) 
conducted a study of 221 retail herbal teas determining a PA concentration ranging from 0 to 
3.43 mg kg-1.  The higher PA content was found in teas classified as “Camomile”, “Nettle” and 
“Melissa”.  The BfR stated that although a risk assessment was not practical due to the sample 
size they urged for regular testing of herbal produce for PAs and PANOs.  Their findings would 
suggest that frequent consumers of said herbal teas are at increased risk of impaired health due to 
PA toxins.  Table 1.4 summarises reports of PA poisoning due to herbal preparations and Table 
1.5 illustrates some common PA-containing plants and lists their uses.   
 
There has been a surge in the use of herbal medicines (Pak, Esrason and Wu, 2004) including 
traditional Chinese medicines (TCMs) in the Western world (Stickel et al., 2005).  Senecio 
scandens has been used in TCM for the treatment of various ailments including gastroenteritis, 
conjunctivitis, and respiratory tract infections (Wang, Huang and Chen, 2013).  S. scandens 
contains hepatotoxic PAs.  In two separate reports, the PA content of the dried herb was 
determined to be 109 μg g−1 (Zhang, Wang, Wang, Chen, Ma, Zhang, Zhang, Bligh and Wang, 
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2008) and 10.82 μg g−1 (Li, Lin, Fu, Chan, Li, Jiang and Zhao, 2008).  Li et al. (2008) reported 
that the TCM “Qian Bai Bi Yan Pian” in tablet form is comprised of the herb S. scandens (76%) 
and based on the average daily dosage given by the Chinese Pharmacopoeia would contain an 
intake range of 3.9 to 5.2 μg kg-1 bw day–1 of toxic PAs.  There are only 5 PA species that are 
documented to be officially used as the plant sources for TCM herbs in the Chinese 
Pharmacopoeia; Lithospermum erythrorhizon (Zi Cao), Arnebia euchroma (Ruan Zi Cao), 
Eupatorium fortunei (Pai Lan), Senecio scandens (Qian Li Guang), and Tussilago farfara (Kuan 
Dong Hua).  However, Fu et al. (2002) reported that approximately 44 PA containing plants are 
used in TCMs in different areas in China and are documented in the Traditional Chinese 
Dictionary. 
PA Plant  PAs identified Quantity 
Ingested 
Country Reference 
Crotalaria retusa; 
Crotalaria fulva 
monocrotaline; 
fulvine 
N.R. West Indies Bras et al. (1954) 
Stuart and Bras (1957) 
Crotalaria juncea trichodesmine;  
senecionine; 
riddelliine 
N.R. Ecuador Lyford et al. (1976) 
 
Senecio longilobus riddelline;  
retrorsine N-oxide 
4.7-10.5 mg day-1 
within 14 days 
U.S.A. Stillman et al. (1977) 
Fox et al. (1978) 
Huxtable (1980) 
Heliotropium 
eichwaldi 
heliotrine N-oxide 30 mg day-1 over 
20-50 day period 
India Datta et al. (1978) 
Heliotropium 
lasiocarpum 
heliotrine; 
lasiocarpine 
30 mg person-1 
day-1 
Hong Kong  Kumana et al. (1985) 
Culvenor et al. (1986) 
Symphytum officinale  
S. x uplandicum 
 
symphytine; 
symglandine;  
 
N.R. 
 
 
 
U.S.A. 
Australia 
Europe 
Culvenor et al. (1981) 
Ridker et al. (1985) 
Huxtable et al. (1986) 
Rasenack et al. (2003) 
Senecio tephrosioides N.R. N.R. Peru Tomioka et al. (1995) 
Tussilago farfara senecionine 
senkirkine 
0.06 mg-1 kg bw 
day-1 
Central Europe Roulet et al. (1988) 
Lebada et al. (2000) 
Table 1.4: Summary of reported cases of human PA poisonings due to ingestion of medicinal 
herbs or herbal products. 
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 Borage 
(Borago officinalis) 
Used in salads (flowers) and spice 
(leaves).  In herbal medicine as a 
prophylactic, for the treatment of 
rheumarthritis, cough and throat 
infections.  
 
 
Butterbur 
(Petasites hybridus) 
Used for hayfever, gastrointestinal 
tract, gallbladder and pancreatic 
diseases, for the treatment of 
headaches and to promote sleep. 
 
 
Comfrey 
(Symphytum officinale) 
Used in salads.  As a poultice on 
fractures and contusions, and for 
the treatment of gastrointestinal 
and respiratory tract infections. 
 
 
Russian Comfrey 
(Symphytum × uplandicum) 
Eaten in salads and blended with 
slurry to be used as an organic 
fertiliser. 
 
 
Coltsfoot 
(Tussilago farfara) 
Treatment of coughs, colds, 
influenza, gastroenteritis and 
metabolic stimulation. 
 
Table 1.5: Common PA-containing plants and their medicinal use (photographs display 
individual copyrights).  
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“Gynura segetum” a traditional herbal product used for haemostasis in Chinese herbal medicine 
was tested for PAs and found to contain seneciphylline, senecionine, seneciphylline and 
seneciphylline N-oxide (Qi, Wu, Cheng and Qu, 2009).  While identification was performed by 
the authors no quantification was reported.  “Daun dewa” (Gynura pseudo-china (L.) DC.) is a 
PA containing plant used regularly in Indonesia, India, Thailand and China for treating uterine 
hemorrhages, dysentery, and inflammation of open wounds (Windono, Jenie and Kardono, 
2012).  Another popular TCM “Chuan Zi Wan” from the Ligularia species was shown to contain 
up to 26 hepatotoxic PAs identified by their characteristic mass fragments reported in literature.  
The authors estimated that the TCM preparation contained PAs amounting to 7.92 mg g−1 (Tang, 
Chen and Hattori, 2012).  Herbal retail preparations of “Tusanqi” provided by patients with 
hepatic sinusoidal obstruction syndrome (HSOS) were positive for the PAs senecionine and 
seneciphylline although the authors do not report the quantities detected (Gao, Wang, Zheng and 
Lin, 2012).  Roeder (2000) investigated 38 plants used regularly in Chinese herbal medicine 
which contained approximately 90 PAs.  The listing was in agreement with other Chinese 
publications (Zhao, Chan and Ogle, 1989; Chen and Huo, 2010).  Table 1.6 summarises the most 
commonly used PA-containing plants which are used in TCM.   
 
A detailed discussion on PAs in herbal teas and TCMs is given in Chapter 5 and its related 
publication. 
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PA plant species Principal PA(s) Quantity 
Detected 
Chinese Herb Medicinal use 
Crotalaria assamica 
Benth 
monocrotaline 2.9% in seeds  Zi Xiao Rong  
 
Treatment of cough, 
toothache and swelling  
Crotalaria sessiliflora 
L. 
monocrotaline 
integerrimine 
trichodesmine 
N.R. Ye Bai He 
 
Used to dispel heat, 
promote urination and as 
an anticancer agent  
Cynoglossum 
officinale 
 
heliosupine 
lasiocarpine 
heliotrine 
trachelanthamine 
1.5-2.0% of plant  Radix cynoglossi 
officinalis 
Dispel heat, expectorant, 
relieve cough  
Gynura segetum 
(Lour.) Merr. 
seneciphylline 
senecionine 
integerrimine 
N.R. Jusanqi or 
Radix Gynurae 
Treatment of bleeding, 
relieve pain, cure injury 
Heliotropium indicum 
L. 
heliotrine 
supinine 
lasiocarpine 
0.4 % of plant Da Wei Yao Treatment of ulcers, 
wounds, ringworm, 
rheumatism, common 
colds, tonsillitis, and 
urinary tract stones 
Senecio scandens 
Buch.-Ham. 
seneciphylline 
senecionine 
up to 109 mg kg-1 Qianliguang Treatment of acute 
inflammatory disease 
Tussilago farfara L. senkirkine 
senecionine 
up to 150 mg kg-1 Kuan Dong Hua Cold, asthma, influenza, 
gastroenteritis, blood 
purification and externally 
for wounds 
 
Table 1.6: Summary of the most commonly used PA-containing plants in TCM. 
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1.4.3 PA-poisoning through foodstuffs 
Other foods that are prone to PA-contamination are honey, bee pollen, milk, eggs and meat from 
PA-exposed livestock, and therefore are possible sources of PA-poisoning to humans.  Although 
there are no known reports of these foodstuffs alone causing PA toxicosis in humans there is 
evidence that they could contribute to HVOD.  For example “qurut”, a fermented goats’ milk 
consumed in the Gulran district of Afghanistan, was found to contain PAs where the population 
had induced PA toxicosis from contaminated grain (Kakar et al., 2010).  Rasenack, Müller, 
Kleinschmidt, Rasenack and Wiedenfeld (2003) reported that post-mortem results of a preterm 
neonate confirmed PA poisoning with Symphytum alkaloids, the same which were detected in a 
herbal mixture used in cooking by the family.   
 
Deinzer, Thomson, Burgett and Isaacson (1977) reported on the occurrence of PAs in honey (up 
to 3.9 mg kg-1 PA concentration) collected from Senecio jacobaea L. (tansy ragwort), a weed 
indigenous to Northern America, Europe, South Africa, Australia and New Zealand.  
Examination of honey from Echium plantagineum (Salvation Jane or Paterson’s Curse) for PAs 
showed that the alkaloid concentration was 1.9 mg kg-1 (Culvenor, 1981).  The author reported 
that up to a quarter of the honey produced in Australia is derived from Echium spp. and high 
consumers of “unifloral” honey could possibly intake up to 20 μg of PAs day-1.  Other reports 
have estimated that the daily intake rate is lower but still in excess of recommended tolerable 
intakes as summarised in Table 1.2.  More recent findings of PAs in retail honeys strengthen the 
possibility that PA-poisoning could result from ingestion of honey.  Retail samples, taken at the 
point of consumption, and bulk samples which are blended before being packaged for sale have 
been shown to contain PAs and PANOs up to 2.2 mg kg-1 (bulk) and 2.9 mg kg-1 (retail) (Beales, 
Betteridge, Colegate and Edgar, 2004; Betteridge, Cao and Colegate, 2005).  PA contamination 
of retail honeys is discussed in depth within the publications of Chapter 4.  The use of honey as 
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an ingredient (content range 5 to 37%) in other foods and the potential PA contamination 
downstream has also been investigated (Kempf, Wittig, Reinhard, von der Ohe, Blacquière, 
Raezke, Michel, Schreier and Beuerle, 2011b).  From the samples taken PAs were persistent in 
fennel honey (10 to 130 µg kg-1), mead (10 to 484 µg kg-1) and candy (10 to 40 µg kg-1).  Thus, 
honey coated breakfast cereals, cereal bars and baked goods which have not been analysed to 
date could potentially contain PAs. 
 
Bee pollen products, royal jelly, honeycomb and propolis are marketed as “superfoods” having 
nutritional and therapeutic properties and thus have become a popular food supplement  The 
main constituents of pollen are amino acids, vitamins, minerals, flavonoids and phytoestrogens 
(Silva, Camara, Lins, Barbosafilho, Silva, Freitas and Santos, 2006).  It was noted that the 
concentration of PAs in pollen were significantly higher than that of in honey (Boppré, Colegate 
and Edgar, 2005).  Research on 55 commercial bee pollen products detected PAs in 31% of 
samples ranging from 1.08 to 16.35 mg g-1 (Kempf, Heil, Haßlauer, Schmidt, von der Ohe, 
Reinhard, Schreier and Beuerle, 2010b).  The authors state that given a mean concentration of 
5.17 mg g-1, a 30% probability of occurrence and a daily dose of 10 g (recommended serving) 
would result in an intake of 15 mg day-1.  The concentration was based on retronecine 
equivalents and as such did not account for any possible otonecine-type PAs which could be 
present.  Thus, the intake is significantly above recommended guidelines as stated in Table 1.2. 
 
PA-poisoning in livestock is well-documented and while no record exists of human PA-
poisoning due to consumption of milk (alone) or meat, it is unrealistic to not consider such an 
occurrence.  The first studies on the PA content in milk were through the feeding of Senecio 
jacobaea (tansy ragwort) to cows and goats resulting in levels of 16.7 and 81.0 μg 100 mL-1 of 
milk respectively (Dickinson, Cooke, King and Mohamed, 1976; Deinzer, Arbogast and Buhler, 
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1982).  Through a more defined procedure Candrian, Zweifel, Lüthy and Schlatter (1991) 
determined a maximum alkaloid concentration of 10.2 μg 100 mL-1 of milk.  The PA-content of 
goat’s milk is a higher toxicity risk to humans since they are browsing animals. In contrast, cattle 
are grazing animals and so the toxicity is lessened (Molyneux and James, 1990).  It has been 
proposed that higher PA contaminated milk comes from animals that have a greater resistance to 
PA toxicity such as sheep (Panter and James, 1990).  More recently, Hoogenboom, Mulder, 
Zeilmaker, van den Top, Remmelink, Brandon, Klijnstra, Meijer, Schothorst and van Egmond 
(2011) conducted an investigation into the carryover of PAs in feed to milk in dairy cows.  
Although 80% of the PAs in the feed (contaminated with Senecio jacobaea) were in the N-oxide 
form none were observed in the milk.  The overall carryover was deemed to be 0.1% (4% for the 
PA jacoline).  Even though the percentage carryover was lower than expected, the authors state 
that the possibility of PAs in milk is still “relevant for consumer health considering the genotoxic 
and carcinogenic properties demonstrated for some of these compounds” (Hoogenboom et al., 
2011). 
 
Experimental data available suggests that residues of PAs and their metabolites can be 
transferred into eggs from laying hens feeding on unfettered grain contaminated with 
Heliotropium seeds (Edgar and Smith, 2000; Byron, 1998).  An earlier study on both chickens 
and ducks feeding on commercial poultry grain showed that ascites and liver lesions developed.  
It was the author's opinion that H. europaeum had been harvested within the wheat (Pass, 1979).  
It is evident that animal feed should be screened for PA-contamination, not only for animal safety 
but for the safety of our food chain.  The PA-content in honey, milk and eggs is lower than that 
contained in medicinal, herbal preparations and bee pollen products but the levels are such that 
hepatic disease is a measurable possibility. 
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It has also been reported that leafy PA-containing plants such as Symphytum (comfrey) and 
Borago (borage) are consumed in salads (Edgar et al., 2011).  In 2009 the German Federal 
Institute for Risk Assessment (BfR) detected Senecio vulgaris (common groundsel) in packed 
salads being sold in Germany.  The leaves of S. vulgaris are similar to that of rocket (Figure 1.8) 
and as such misidentification is possible but nevertheless this was a clear indication of poor 
quality control procedures.  The analysis of the contaminated salad found a PA concentration of 
2.6 mg per 45 g of salad (one retail portion as shown in Figure 1.8). 
 
 
Figure 1.8: The salad product on sale in Germany contaminated with Senecio vulgaris and the 
similarity of S. vulgaris to rocket (Eruca sativa) (photographs obtained from Wiedenfeld, 2011). 
 
 
Consumption of just 5 g of this lettuce would result in an adult consuming approximately 280 µg 
of PAs which is four times the limit given by EFSA of 70 µg per day (based on 0.007 µg kg-1 bw 
day-1 for a 70 kg adult, Table 1.2). 
  
S. vulgaris (detected in salad)
Rocket (Eruca sativa)
© Wiedenfeld (2010) © Wiedenfeld (2011)
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1.6 Liquid Chromatography-Mass Spectrometry (LC-MS) 
 
 1.6.1 Introduction to LC-MS 
Liquid chromatography-mass spectrometry (LC-MS) has many analytical applications ranging 
from elemental, pharmaceutical, petrochemical and environmental analysis to food safety, 
biological and clinical analysis.  Researchers from various disciplines depend upon mass 
spectrometric analysis.  In the pharmaceutical industry researchers use LC-MS for drug 
discovery and development, relying upon the specificity, dynamic range and sensitivity of MS to 
differentiate closely related metabolites in a complex matrix.  Biochemists apply LC-MS to 
protein, peptide and oligonucleotide analysis whilst clinical chemists utilize it for drug testing 
and neonatal screening.  Food safety researchers opt for LC-MS to measure trace contaminants 
and residues within the food chain such as pesticides and mycotoxins. 
 
LC-MS has proven beneficial in the analysis of PAs since it simtaneously detects both the 
tertiary (free base) PA and the PANO, thus negating the need for N-oxide reduction which is 
necessary for GC-MS.  It has significant sensitivity advantages over HPLC-UV and GC-FID.  
Also, GC-MS reports retronecine-type equivalents whereas LC-MS identifies and quantifies the 
individual PA/PANO or all four structural PA types as given in Figure 1.1.  Thus, LC-MS was 
the experimental technique of choice for the research presented herein to detect, identify and 
quantify PAs and/or PANOs, trace contaminants, within the food chain.  The technologies 
available and employed were liquid chromatography coupled to (i) an iontrap mass spectrometer 
and (ii) a triple quadrupole mass spectrometer with positive electrospray ionisation used on both.   
 
An overview of the theory of these techniques is given in the following sections of this chapter.  
Other ionisation techniques such as negative mode or Matrix-assisted laser desorption/ionisation 
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(MALDI) for biomolecules are not discussed.  Nor are MS technologies such as single 
quadrupole, high mass accuracy via Time-of-flight (TOF) or Orbitrap, and hybrid instruments 
such as QTOF, QTrap, quadrupole-orbitrap or linear ion trap-orbitrap (LTQ). 
 
1.6.2 Theory of LC-MS 
Separation of test sample components is achieved using high performance liquid chromatography 
(HPLC) where the analytes are differentially partitioned between the mobile phase and the 
stationary phase of the analytical column.  The mechanism of retention and separation will 
depend upon the mode of chromatography used, namely reverse-phase, normal phase, ion-pair or 
ion-exchange chromatography.  The sample is introduced to the HPLC system via injection from 
the autosampler into the mobile phase stream.  Best chromatographic performance is obtained 
when the sample solvent has equal or lower eluotropic strength than the flowing mobile phase.  
Thus, sample preparation in the starting mobile phase composition or in a less organic solvent 
than the mobile phase is preferred.  Once the sample is injected onto the analytical column it will 
partition or distribute between the mobile and stationary phase.  If a compound has greater 
affinity for the stationary phase it will be retained longer on the column, immobilised to the 
surface thus having increased retention (time, tR and retention factor, k).  The degree to which the 
sample analyte will partition between the mobile and stationary phase is governed by its 
distribution co-efficient, demonstrated by the equation; 
Kx = Cstat 
        Cmob 
 
The distribution co-efficient will be constant for an analyte under given chromatographic 
conditions.  When the analyte band elutes from the column a chromatographic peak is formed, of 
which the optimum peak shape is symmetrical.  Elution may be performed using isocratic (good 
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for high throughput) or gradient (necessary for poorly resolved peaks, separation and/or peak 
shape) conditions.  An important consideration is that of solvent miscibility for mobile phases 
and when UV detectors are employed, the UV cut-off point for solvents.  Other considerations 
include the use of mobile phase modifiers, controlling pH, adjusting flow rate, column selection 
and operating temperature, and band broadening. 
 
The Van Deemter equation (HETP = A + B/u + Cu) provides an explanation of the terms or 
factors which contribute to band broadening.  Briefly; (i) Eddy diffusion, the ‘A’ term, relates to 
variations in the mobile phase flow or analyte flow path.  The analyte band can be broadened due 
to variations in the column packing and as a result the analyte has multiple paths.  Variations can 
be minimised by using well packed columns or smaller particle size (but this can increase back 
pressure within the system).  (ii) Longitudinal diffusion, the ‘B’ term, occurs when the HPLC 
system has internal volumes, within the PEEK tubing, which are unnecessarily large.  (iii) Mass 
transfer, the ‘C’ term, relates to the analyte residence time on the porous stationary phase.  Mass 
transfer effects can be minimised with lower linear velocities, i.e. lower flow rates, or higher 
column temperatures. 
 
In MS the analyte(s) of interest is detected based on its mass to charge ratio (m/z).  The analyte 
species are converted into gas phase ions within the ion source of the mass spectrometer.  The 
most common ionisation modes in MS are electrospray ionisation (ESI), atmospheric pressure 
chemical ionisation (APCI) and atmospheric pressure photo-ionisation (APPI).  The processes 
that take place in the source are complex and are sample matrix and mobile phase sensitive, with 
salts and other ionisable compounds competing with the analytes for charge.   
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During the investigations of this research the experimental technique of choice was LC-(+)ESI-
MS.  ESI is explained in section 1.6.3.  Since APCI and APPI were not employed in this research 
they are concisely explained as follows; 
o In APCI the LC eluent is discharged from the capillary as a liquid and surrounded by a flow 
of inert nebulising gas in a heated region.  A Corona electrode pin is placed at the end of the 
heated region with a potential applied that ionises the eluent molecules.  The ionised 
molecules impart a charge to the analyte molecules via a charge transfer or molecular 
associations.   
o APPI is a complementary technique to both ESI and APCI for compounds which are not 
easily ionised such as non-polar polycyclic aromatic hydrocarbons.  Ionisation is by means of 
photo-irradiation.  A molecular radical is produced on absorption of a photon. 
 
1.6.3 Electrospray Ionisation in MS 
Two processes take place in the ion source; ionisation and desolvation.  In an ESI source 
ionisation precedes desolvation whereas in an APCI source desolvation precedes ionisation.  
Ionisation is achieved by the application of high voltage to the source, desolvation by the 
application of gas flow (pneumatic nebulisation) coupled with heating.   In terms of ionisation, 
ESI sources promote a process known as ion evaporation which leverages the innate polarity of 
the analyte and maximises the production of molecular ion species (Johnstone and Rose, 1996).  
Solvent molecules become charged and undergo ion/molecule reactions. 
 
In LC-MS it is necessary to ensure adequate heat and gas flow for nebulisation of the eluent 
stream and the desolvation process.  To prevent condensation from the aqueous content of the 
mobile phase, the source should be operated at temperatures above 100oC.    
43 
 
The electrospray ionisation, a soft ionisation technique, involves the transformation of ions from 
the LC eluent into ions in the gas phase.  Figure 1.09 shows a simplified schematic of an ESI 
interface and Figure 1.10 the ion source housing on the Thermo Scientific TSQ Quantum 
Discovery Max MS. 
 
 
Figure 1.9: schematic of an ESI interface (Cech and Enke, 2001). 
 
The LC eluent enters the ESI capillary which is held at a positive or negative potential 
(depending on the mode required).  In this research project PAs are basic compounds which in 
low pH or acidic mobile phase give the protonated (positive) molecular ion. 
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 Figure 1.10: the ion source housing on the Thermo Scientific TSQ Quantum Discovery Max MS 
(author’s own photograph) and a cross-sectional view of the chamber (Thermo Scientific, 2012). 
 
An electric field is generated between the capillary tip and inlet to the MS.  The LC eluent is 
pumped through the capillary tip, to which a high voltage is applied, and ions of the same 
polarity come to the solution surface forming a “Taylor cone” (Cech and Enke, 2001).  The 
heated auxiliary gas interacts with the primary spray to help to break up the molecules of the 
analyte(s).  The more uniformed the droplet size the more efficient it dries which is optimum for 
the tube lens to focus the droplets into the skimmer (sampling cone).  The skimmer allows the 
correct amount of droplets through to the mass analyser to increase signal to noise (S/N) ratio and 
sensitivity.  Solvent evaporation from the droplets is aided by an increase in the temperature of 
the ambient air within the ionisation housing.  This is supplemented by an inert desolvation gas, 
generally nitrogen.  The temperature and gas flow are optimised based upon the properties of the 
droplet and the eluent flow rate.  Two main theories govern solvent evaporation (i) Dole’s 
“charged-residue” model and (ii) the “ion evaporation” model proposed by Iribarne and 
Thompson in 1979 (Cech and Enke, 2001).   
 
The “charged-residue” theory is that desolvation shrinks the droplet size and increases the charge 
on the droplet.  When the charge reaches a maximum, the Rayleigh limit, Coulomb repulsion 
ensues causing an “explosion” forming smaller, lower charged droplets.  
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The alternative theory of “ion evaporation” is that droplets with a radius < 10 nm can form under 
field desorption and release a gaseous ion.  The evaporation process duration is a few hundred 
microseconds to a few milliseconds.   
 
Figure 1.11: Coulomb explosions producing charged droplets within the spray chamber (adapted 
from de Hoffmann and Stroobant, 2007). 
 
Adhering to a few simple guidelines will improve results obtained by LC-ESI-MS; 
- Minimise salts, e.g. sodium, by eliminating soap and detergent 
- Use ultra/high purity LC-MS grade solvents 
- Eliminate the use of TFA and strong acids 
- A low acid concentration in mobile phase is preferred, depending on the pKa values for the 
target analytes (impacts upon ionisation efficiency) 
- Use a low probe voltage 
- Increase the organic solvent content but always have some water in the mobile phase. 
 
1.6.3.1  Advantages and Disadvantages of ESI 
ESI-MS application areas are diverse ranging from large macromolecules to small organic and 
inorganic molecules.  Modern ion signals from ESI-MS provide “a clear and deep perception 
about the analytes properties far beyond the conventional mass and structural properties of the 
analytes” (Banerjee and Mazumdar, 2010).  There are few disadvantages to ESI-MS.  Those that 
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do exist are more so associated with the sample preparation for ESI.  Table 1.7 provides a list of 
advantages and disadvantages for the use of ESI. 
 
Advantages Disadvantages 
 Mass range up to 70,000 Da 
 Good sensitivity 
 Soft ionisation – capable of producing non-
covalent complexes in a gaseous phase 
 Easily connected to liquid 
chromatography/LC eluent flow 
 Easily connected to a wide range of MS 
technologies 
 Off-axis configuration good for higher flow 
rates and minimising matrix interferences 
 Multiple charging allows for detection of 
high mass ions with relatively low m/z 
range 
 Presence of buffers (phosphate, Na+, K+), 
salts and ion-pairing reagents (TFA) can 
lower vapour pressure, reducing signal and 
thus decreasing sensitivity 
 Complex mixtures can reduce sensitivity 
 Sample purity is important to increase 
sensitivity 
 Simultaneous mixture analysis can be 
difficult, particularly for identical 
transitions 
 Sample carryover (significantly reduced in 
off-axis configurations and software data 
acquisition modes)  
 
Table 1.7: Advantages and disadvantages of electrospray ionisation (ESI). 
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1.6.4 Triple Quadrupole (QqQ) Mass Spectrometry (MS) Technology 
The method of acquiring LC-MS data can be highly sensitive, specific and selective.  It is usually 
used to make quantitative measurements of target materials, or to establish the presence of target 
material at low levels.  In quadrupole devices electric fields are used to separate ions according to 
their m/z as they travel along the central axis of four parallel equidistant rods.  Triple quadrupole 
instruments can perform selected ion monitoring (SIM) in addition to selected reaction 
monitoring (SRM) where specific product ions are derived from selected precursor ions.  The 
first quadrupole is set at the target m/z value and controlled fragmentation is performed in the 
second quadrupole.  A product ion from that process is selected as the target ion for the third 
quadrupole and the ion current resulting from the whole process is recorded.  This has the effect 
of reducing both signal and noise, but noise is reduced to a greater degree, thus increasing the 
signal-to-noise ratio.   
 
Figure 1.12: schematic of a Thermo Scientific TSQ Quantum Discovery Max QqQ MS 
displaying its unique 90 degree geometry collision cell (Thermo Scientific, 2012). 
 
 
The alignment of two mass filters in succession with a collision quadrupole in between allows 
the structure of the ionised sample molecules to be elucidated.  Four main modes can be 
performed (de Hoffmann and Stroobant, 2007); 
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(1) In a Product ion scan (daughter scan) the first quadrupole (Q1) is set to select a parent ion of 
a known m/z to be fragmented in the second quadrupole (q2) by collision-induced 
dissociation (CID).  The third quadrupole (Q3) is set to scan the entire m/z range, giving 
information on the size/abundance of the fragments produced.  From the ion fragmentation 
information, the structure of the original ion can be deduced.  This experiment is commonly 
performed to identify transitions used for quantification by tandem MS. 
(2) In a Precursor ion scan (parent scan) a certain product ion is selected in Q3 and the 
precursor masses are scanned in Q1.  This experiment is selective for ions having a particular 
functional group (e.g. a phenyl group) released by the fragmentation in q2. 
(3) In a Neutral loss scan both Q1 and Q3 are scanned together, but with a constant mass offset.  
This allows the selective recognition of all ions which, by fragmentation in q2, lead to the 
loss of a given neutral fragment (e.g. H2O, NH3, etc.).  Similar to the precursor ion scan, this 
technique is also useful in the selective identification of closely related classes of compounds 
in a mixture. 
(4) In Selected reaction monitoring (SRM) or Multiple reaction monitoring (MRM) both Q1 
and Q3 are set to a selected mass, allowing only a distinct fragment ion from a certain 
precursor ion to be detected.  SRM is a very selective analysis mode, which can increase 
sensitivity.  If Q1 and/or Q3 are set to more than a single mass, this configuration is called 
multiple reaction monitoring. 
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1.6.5 Ion Trap (IT) Mass Spectrometry (MS) Technology 
Ion trap (IT) MS uses an oscillating electric field to store ions.  Ion traps can be 2D - linear ion 
traps (LITs) or 3D - quadrupole ion traps (QITs) preferably termed a “Paul” ion trap (de 
Hoffmann and Stroobant, 2007).  Ion traps are used to perform sequential fragmentation, MS(n), 
by fragmenting ions of interest to derive more structural information on a single analyte. 
 
 
Figure 1.13: schematic of an ion trap MS and the spray chamber of an Agilent 6300 series 
(Agilent Technologies, 2006). 
 
 
Referring to Figure 1.13 above; charged ions produced from ESI within the spray chamber are 
drawn into the capillary into a higher vacuum region.  As the ions exit the capillary tube they are 
accelerated towards skimmer 1.  Skimmer 1 removes neutral excess gas and solvent molecules 
whilst skimmer 2 focuses ions and removes more neutral species before the ions reach the 
octopole.  The octopole homogenises any energy distributions of the ions before they enter the 
quadrupole trap.  The ion trap mass filter accumulates all ions.  The oscillating potential 
difference established between the ring and endcap electrodes form a substantially quadrupolar 
field which can trap ions of a particular mass range.  For efficient trapping and cooling of ions 
generated by the ESI helium gas is introduced.  The helium also serves as a collision gas during 
MS(n) operation.  Mass accumulation times in the trap are generally < 200 ms (milliseconds).  
Ions are ejected from the trap in mass order to a high energy dynode detector which counts the 
50 
 
ions and amplifies the signal.  Once the ions have been counted and amplified, they are recorded 
in the mass spectrum (Agilent Technologies, 2006).   
 
1.6.6 Collision-Induced Dissociation (CID) 
Collision-induced dissociation (CID) is a mechanism by which molecular ions are fragmented in 
the gas phase typically by acceleration of an electrical potential to a high kinetic energy in the 
vacuum region.  This is followed by collision with neutral gas molecules from helium, nitrogen 
or argon.  A portion of the kinetic energy is converted by the collision resulting in chemical 
bonds breaking and the molecular ion being reduced to smaller fragments. 
 
 
Figure 1.14: “Fast” collision-induced dissociation (CID; adapted from de Hoffmann and 
Stroobant, 2007). 
 
 
1.6.7 Advantages and Disadvantages of MS Technologies Employed 
As previously stated IT-MS and QqQ-MS were utilised in this work as these were the MS 
technologies available in the research laboratory.  Therefore, other MS analysers such as single 
quadrupole, Time of Flight (TOF), Orbitrap, and hybrid mass analysers are not discussed.  Both 
IT and QqQ mass analysers exhibit advantages and disadvantages, not only in the physical 
technology/instrumentation but also in their individual software capabilities. 
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1.6.7.1  Ion Trap Mass Spectrometry (IT-MS) 
In IT-MS ions are stored in the trap and manipulated using DC (direct current) and RF (radio 
frequency) electric fields in a series of carefully timed events providing MS/MS capabilities, high 
resolution and high sensitivity.  The main limitation is the timing of the trapping of the ions as 
undesirable effects such as space charge effects and unimolecular decomposition can occur. 
 
Advantages Disadvantages 
 Powerful MS/MS and MSn capabilities for 
ion fragmentation experiments 
 High scan speed 
 Relatively low cost 
 Adaptability - hybrid instruments 
 Advancements in software functionalities 
have increased performance (e.g. Auto-MSn 
and data dependent studies) 
 Limited dynamic range or space charge 
effects (now overcome with larger traps 
and software functionalities) 
 Ion-molecule interactions 
 Relatively low resolution  
 One-third cutoff rule (associated with 
traditional ion trap CID spectra) 
Figure 1.8: Advantages and disadvantages of ion trap mass spectrometry (IT-MS). 
 
 
1.6.7.2  Triple Quadrupole Mass Spectrometry (QqQ-MS) 
A significant advantage of QqQ-MS lies in the fact it can be used over four modes of analysis to 
obtain both structural information and superior quantitation.  
 
Advantages Disadvantages 
 MRM/SRM studies allow increased 
selectivity, lower S/N and LOQ 
 Four analysis modes 
 Quantitative experiments  
 Good reproducility 
 Low energy CID 
 Limited resolution (with some systems) 
 Peaks heights are variable with mass (peak 
height vs. mass response must be tuned) 
 Low energy CID dependent upon energy, 
collision gas and pressure 
Figure 1.9: Advantages and disadvantages of triple quadrupole mass spectrometry (QqQ-MS). 
 
  
52 
 
1.6.8 Role of LC-MS in food safety 
Food safety concerns have risen globally as the number of food contamination incidents and 
product recalls have increased.  As a result, the ‘from farm to fork’ methodology was adopted 
within Europe initiating a science-based approach to food safety testing and the establishment of 
key legislation (Malik, Blasco and Picó, 2010).  Accurate surveillance of contaminant levels in 
food and agricultural produce is vital to ensure the safety of the food chain.  The “basic 
analytical requirements in food analysis are high resolution, high throughput, high sensitivity 
detection and quantification of contaminants at or below the maximum residue limit (MRL) or 
tolerance of the compound in a given food matrix” (Soler, Manes and Picó, 2008).   
 
 
 
Figure 1.15: Notable food safety incidents over the past 2 decades. 
 
Liquid chromatography-mass spectrometry (LC-MS) has been a central technique in food safety 
and quality control.  Its utilisation has increased in food manufacturer’s quality control and R&D 
divisions as a flexible alternative to traditional methods due to its high sensitivity and faster 
throughput (Szpylka, 2013).  The European Commission has incorporated the use of mass 
spectrometry for food safety under decision 2002/657/EC which contains specific legislation on 
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from undercooked 
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Hepatitis A from 
green onions; 
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Sudan I Dye from  
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chilli powder
E.coli in spinach;
205 illnesses, 3 deaths
Melamine in infant formula; 
860 illnesses, 6 deaths
Pork dioxin crisis
E.coli in bean sprouts;  
4000 illnesses, 53 deaths
Undeclared horse meat             
in beef products
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sampling, sample preparation and requirements for methods of analysis to control contaminants 
in foodstuffs.  The main advantage of using LC-MS/MS is the reduced amount of sample clean-
up required because of the mass spectrometer’s high specificity.  LC-MS is particularly suited for 
the analysis of food contaminants as it provides a large amount of information for a complex 
matrix, thus enabling the screening, confirmation and quantification of hundreds of components 
within one analysis, both parent compounds and their metabolites (Malik et al., 2010). 
 
LC-MS is the technique of choice for environmental contaminants, natural and marine toxins, 
veterinary drug residues, pesticides, and contaminants from food processing using two distinct 
approaches; (i) analysis using nominal masses and performing MS/MS (QqQ or QqLIT) and (ii) 
obtaining accurate mass measurements (TOF, QqTOF, Orbitrap).   
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1.7 Previous analysis of PAs  
In analysing PAs both the tertiary PA and its corresponding N-oxide are generally present.  In 
some cases, as discussed in section 1.1.2, the PANO quantity present can exceed that of the PA.  
The following sections give a brief overview of the previous analysis of PAs and in most cases 
there are further discussed in the publications of this research. 
 
1.7.1 Extraction methods 
PAs have been extracted from both fresh and dried plant material.  Methods include steeping 
fresh plant material in methanol or aqueous acids followed by heating or ultrasonic agitation 
(Crews, Berthiller and Krska, 2010).  Fresh plant material has also been air-dried or freeze-dried.  
Traditionally, PAs and their N-oxides are extracted from dried, ground/powdered plant material 
with hot or cold alcohol (methanol).  The alcohol solvent is evaporated and the resulting oily 
residue is dissolved in acidic aqueous solutions to uptake the bases.  Hydrochloric acid is avoided 
due to its reaction with PA epoxide groups making sulphuric acid the popular choice.  The 
waxes, fats and chlorophyll are removed by LLE with petroleum, ether or hexane (Mattocks, 
1986).  The PANOs are reduced to the corresponding basic alkaloid with stirring over zinc dust.  
The solution is made alkaline on the addition of ammonia and the PAs are finally extracted with 
a non-polar organic solvent such as chloroform (IPCS, 1988).  Alternatively, alcohol can be 
continuously circulated through the plant material using Soxhlet extraction or reflux and then 
passed through a cation exchange resin (Mattocks, 1971).   
 
Lebada et al. (2000) compared several solvent compositions for their efficacy in extracting 
senkirkine and senecionine (not their N-oxides) from Tussilago farfara.  The greatest yields were 
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obtained with heating under reflux using 50:50 v/v methanol and aqueous citric acid at pH 2 for 
15 minutes whilst prolonged Soxhlet extraction over 48 hours proved least satisfactory. 
 
To determine the full profile of PAs and their N-oxides two analyses are carried out concurrently; 
the first of the extracted PA free bases alone and the second of the total free bases obtained by 
reduction of the N-oxides (Crews et al., 2010).  The proportion of the N-oxides is determined by 
difference.  In a study conducted by Beales, Colegate and Edgar (2003) the authors found that 
reduction efficiency can vary with the batch of zinc dust being used and with the reaction time.  
Yields were optimised between 30 minutes and 4 hours but found to decrease with reaction 
overnight.  Thus, today it is more practical to avoid reduction and determine both free bases and 
N-oxides by using HPLC (Crews et al., 2010). 
 
When attempting to isolate PAs from animal tissues, it must be considered that the toxic 
alkaloids are often metabolised readily (within a few hours) and that the quantities recoverable 
are small (IPCS, 1988).  Thus, urine and blood samples are taken for detection of metabolites.  
On this analytical scale the most useful technique is LC-MS. 
 
1.7.2  Clean-up procedures 
Clean-up procedures which employ LLE are being used less frequently when analysing PAs due 
to the time consumption and having to deal with large quantities of undesirable solvents such as 
diethyl ether, chloroform and dichloromethane.  To achieve sufficient clean-up of the acidic 
aqueous extract for chromatography the sample must be washed several times.  Thus, solid phase 
extraction (SPE) has become more favoured.  Early SPE methods did not support non-cyclic 
diesters and were replaced with cation-exchange mechanisms.  Mroczek, Glowniak and 
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Wlaszczyk (2002) highlighted that use of C18 sorbent allowed the co-elution of matrix 
interferences for chromatography and that a polymeric strong cation-exchange (SCX) SPE could 
isolate both free bases and N-oxides whilst minimising possible interferences. 
 
1.7.3 Ehrlich Reaction 
This method was developed to be specific for unsaturated pyrrolizidine alkaloids (IPCS, 1988).  
The procedure involves oxidising the PA to its N-oxide using hydrogen peroxide, a step which 
can be omitted if the N-oxides are being estimated alone.  The resulting product reacts with 
acetic anhydride to form a pyrrolic derivative (dehydro-alkaloid) that produces a purple colour 
when reacted with a modified Ehrlich reagent (containing boron trifluoride).  This method was 
successfully applied to tissue samples (Mattocks, 1986).  An improved “field test” version was 
published in 1987 (Mattocks and Jukes) for use with plants or any materials of plant origin, such 
as cereals or herbal teas.  The purple (magenta) colour in the "test" sample compared to the 
"blank" indicates the presence of unsaturated PA(s).  The intensity of colour can give a rough 
indication of the quantity of alkaloids present, and whether further chemical testing is required 
(IPCS, 1988).  This colourimetric technique could be used as an initial qualitative screening 
procedure, particularly for plant materials.  The protocol would allow an estimation of the total 
PA-content of the plant material and may help to overcome instances where the relevant PA 
reference standards are not available.  The test was reported to be linear over a range of 5 to 100 
µg for most retronecine-type PAs (Mattocks and Jukes, 1987). 
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1.7.4  Chromatographic methods 
1.7.4.1  Thin-layer chromatography (TLC) 
TLC using silica plates eluted with chloroform or an aluminium oxide adsorbent have been used 
for detecting PAs.  Many protocols use Ehrlich reagent (4-dimethylaminobenzaldehyde) by 
spraying the plates with a solution of orthochloranil followed by Ehrlich’s and heating after each 
spray (Molyneux and Roitman, 1980).  The pyrrole gives a violet-blue appearance.  The PANOs 
are detected by spraying a solution of acetic anhydride, heating the plate, and then spraying 
Ehrlich’s reagent (IPCS, 1988).  Stelljes, Kelley, Molyneux and Seiber (1991) employed the use 
of TLC to separate PA fractions prior to identification by GC-MS. 
 
1.7.4.2  Gas chromatography (GC) 
Gas chromatography coupled to mass spectrometry (GC-MS) has been frequently used for the 
identification and quantitative determination of PAs but GC-FID has also been reported.  For 
example, PAs were extracted from honey and identified by Deinzer et al. (1977) and Culvenor, 
Edgar and Smith (1981) using GC-MS.  This protocol identifies retronecine-PA equivalents 
rather than individual PA identification.  PANOs generally undergo thermal decomposition when 
analysed by GC and thus they are first reduced to the corresponding tertiary alkaloid.  
Alternatively, PANOs can be derivatised using trimethylsilylation (IPCS, 1988).  However, 
derivatisation seems to cause some alteration or destruction of senecionine and seneciphylline 
(Crews et al., 2010) and thus tends not to be used today.  Soft chemical ionisation techniques are 
advisable to induce the formation of the protonated molecular ion (Bicchi, Caniato, Tabacchi and 
Tsoupras, 1989) and base peak accomplished using methane, isobutene and ammonia.  Electron-
impact ionisation (EI) is used to distinguish between similar PA compounds (Crews et al., 2010). 
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1.7.4.3  High performance liquid chromatography (HPLC) 
Analytical and preparative scale HPLC separation of PAs was first described by Segall (1979a; 
1979b).  HPLC methods are non-destructive and have the benefit of analysing both the tertiary 
PA and its N-oxide simultaneously without the need for PANO reduction.  Many different 
stationary and mobile phases have been employed (see publication in Chapter 4 for tables of 
previous analysis).  With reverse-phase chromatography using an acidic mobile phase the PA 
will elute prior to its N-oxide.  This is reversed with the use of an alkaline mobile phase as the 
PANO becomes more polar eluting earlier (Qi et al., 2009).  Although UV has been employed 
the optimum wavelength is low (220 nm) meaning that typically retronecine PAs are derivatised 
with orthochloranil, followed by boron trifluoride and Erhlich’s reagent.  Thus MS is a more 
popular detector. 
 
1.7.4.4  Liquid Chrmoatography-Mass Spectrometry (LC-MS) 
APCI-MS has been reported (Beales et al., 2004) in the analysis of PAs but ESI is generally more 
suitable for polar compounds.  It has been shown that for the polar PANOs ionisation was 
significantly lower in APCI than in ESI mode to the extent that APCI would not be applicable for 
the trace analysis of some PANOs (Beales et al., 2003; Crews et al., 2010).  Single-stage LC-MS 
can be limited as PAs can share the same molecular mass and empirical formulae, being 
stereoisomers.  Ion traps, TOF and QqQ MS have all been used in the analysis of PAs. 
 
A disadvantage for the quantitative analysis of PAs remains the lack of commercially available 
standards which hinders accurate LC-MS quantification.  A common approach is to estimate the 
PA-concentration by quantifying against a single standard, by retronecine equivalents or for an 
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N-oxide against the tertiary PA.  However, PAs can ionise very differently and thus their 
response factors are not equivalent leading to under- or over-estimation of results.   
 
The mass spectra of retronecine-type PAs and PANOs (including diester, monoester and non-
ester PANOs) display two characteristic fragment ions at m/z 120 and 138.  For the N-oxides of 
diester PAs, including both open chain diesters (such as lasiocarpine N-oxide) and macrocycle 
diesters (e.g. N-oxides of retrorsine, senecionine, seneciphylline and monocrotaline) these exhibit 
two additional characteristic ion clusters at m/z 118–120 and 136–138.  Ruan, Li, Xia, Fu, Peng, 
Ye and Lin (2012) proposed that these characteristic fragment ion clusters were generated 
through three individual fragmentation pathways; 
(1) the cleavage of two ester groups at C-7 and C-9 positions to produce a fragment ion at 
m/z 154, which is fragmented further to give ions at m/z 136 and 137 through the loss of 
H2O and an OH group, respectively. 
(2) involves the simultaneous loss of the said two ester groups and a molecule of water to 
generate the ion at m/z 136 followed by further loss of a molecule of H2O or an OH group 
giving the fragment ions m/z 118 and 119, respectively. 
(3) the loss of the oxygen atom attached to the nitrogen of the necine base to form the 
corresponding PA.   
These pathways are shown in Figure 1.16 (a) to (c).  Ruan et al. (2012) also observed that only 
one ion cluster at m/z 136–138 was observed in monoesters (e.g. heliotrine and lycopsamine N-
oxide) and that the presence or absence of the ion cluster at m/z 118–120 can be used to 
differentiate retronecine-type diester PANOs from non-ester and monoester PANOs with the 
ester substituted at the C-9 position.   
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Note: In this study the retronecine-type PAs (crotaline, echimidine, retrorsine, senecionine, 
seneciphylline and trichodesmine) contained the fragment m/z 120, characteristic of its moiety.  
Lycopsamine displayed the fragment m/z 138 instead of m/z 120, consistent with literature for 
monoester PAs (Ruan et al. 2012).  The retronecine-type PANOs (crotaline N-oxide, retrorsine 
N-oxide, senecionine N-oxide and seneciphylline N-oxide) are all macrocyclic diesters having 
characteristic ion clusters at m/z 118–120 and 136–138.  The otonecine-type PAs (otosenine and 
senkirkine) exhibited characteristic fragments m/z 150 and 168 whilst fragments m/z 138 and m/z 
156 were observed for the heliotridine-type PA (heliotrine). All were in agreement with the 
findings of Ruan et al. (2012). 
(a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b) 
 
(c) 
 
 
 
 
Figure 1.16: Fragmentation pathways as described by Ruan et al. (2012); (a) pathway 1, (b) 
pathway 2 and (c) pathway 3.  
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1.7.5  Use of Enzyme Linked Immunoassays (ELISA) 
Most ELISA techniques for PAs are based on antibodies raised against retrorsine (Crews et al., 
2010).  ELISA tests tend to be highly specific for single targets with some cross reactivity to 
other PAs but only with similar structural analogues rather than multi-target analysis 
(Oplatowska, Elliott, Huet, McCarthy, Mulder, von Holst, Delahaut, van Egmond and Campbell, 
2014).  It has been used to estimate total PA content of plants and feed (Lee, Schoch, 
Stegelmeier, Gardner, Than and Molyneux, 2001) and a sensitive quantitative technique for 
detecting retrorsine and monocrotaline using immunogens based on quaternary pyrrolizidinium 
salts (Roseman, Wu and Kurth, 1996).   
 
Recently a multiplex qualitative screening assay for the detection of a number of pyrrolizidine 
alkaloids in honey and feed was developed and validated by Oplatowska et al. (2014).  The 
detection capability was determined to be 25 μg kg-1 which in light of current LC-MS methods is 
poor but the authors suggest that the detection levels could be lower with a more elaborate 
sample preparation.  However, similar to the Ehrlich’s reaction for PAs, ELIZA is a useful 
screening process.   
 
1.7.6 Other Techniques  
1.7.6.1  Near Infrared and Raman Spectroscopy 
Near Infrared spectroscopy (NIRS) is a fast and non-destructive analytical method.  A study by 
Graham et al. (2012) demonstrated that both NIRS and Raman technology could be applied as 
rapid screening techniques for the detection of oil adulteration in the food and feed industry.  
Carvalho et al. (2013) predicted, with moderate accuracy (63%), pyrrolizidine alkaloids in 
Jacobaea vulgaris, Jacobaea erucifolia and Senecio inaequidens plant material using NIRS.  
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However, work by Moghaddam (2010) concluded that there are many wavelengths related to, 
and affected by, PAs and that most of these wavelengths are also affected by other known 
biochemicals such as nitrogen, proteins and starch.  Selected wavelengths for Jacobaea vulgaris 
were common with Senecio inaequidens.  The author concluded that the accuracy of NIRS was 
weak due to the relatively low concentrations of PAs and the different PA chemotypes present 
(Moghaddam, 2010).  The application of NIRS and Raman spectroscopy for PAs could prove 
very beneficial as a non-destructive, in-process control detection method and therefore warrants 
further investigation. 
 
1.7.6.2  Precursor Ion Scan (PIS) on Mass Spectrometry (MS) 
Utilising the precursor ion scan (PIS) function on a mass spectrometer is another worthwhile 
technique and could possibly overcome the lack of commercially available PA reference 
standards.  The PIS acquisition can be used to detect peaks (or parent masses) from the 
characteristic product ions at m/z 120 and 138 for retronecine-type PAs and ion clusters at m/z 
118-120 for retronecine N-oxides (Figure 1.16).  Ruan et al. (2012) successfully applied this 
technique with a HPLC-QTrap-MS method to analyse two PA-containing plant samples Gynura 
pseudochina and G. Japonica.  A further investigation by this research group (Zhu et al., 2014) 
developed a UHPLC-QTOF-MS method to detect retronecine-type PAs and their N-oxides in 15 
PA-containing plants (members of Senecio, Gynura and Parasenecio genus).  Quantitation was 
carried out using extracted ion chromatograms (EICs) at accurate mass of m/z 120.0813 and m/z 
138.0919 with a 5 ppm window.  This approach has limitations in that it is not as accurate as 
directly quantifying against the corresponding PA/PANO and its application is to retronecine-
type PAs and their N-oxides (excluding other classifications of PAs as per Figure 1.1). 
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1.7.6.3  QuEChERS 
QuEChERS is an acronym for Quick Easy Cheap Effective Rugged Safe. It was originally 
developed for pesticide residue extraction (Anastassiades, Lehotay, Stajnbaher, & Schenck, 
2003).  It is a valuable analytical approach which simplifies the analysis of multiple pesticide 
residues in fruit, vegetables, cereals and processed products.  The QuEChERS protocol entails a 
number of simple steps which are fast and easy to perform, namely salting out extraction induced 
by phase separation of the aqueous and organic solvent followed by dispersive SPE (dSPE) for 
clean-up.  It has been applied to other contaminants and residues such as mycotoxins 
(Yogendrarajah et al., 2013), steroids (Klinsunthorn et al., 2011) and veterinary residues 
(Kinsella et al., 2009; Whelan et al., 2010) in many different matrices.  On conducting a literature 
review, there are only three publications to date on the use of QuEChERS for PAs (Kempf et al., 
2011b; Martinello et al., 2014; Bolechova et al., 2015). 
 
In a recent study on PAs in animal feed a modified QuEChERS procedure was employed for 
sample extraction using acetonitrile and aqueous formic acid with phase separation induced by 
magnesium sulphate and sodium chloride (Bolechova et al., 2015).  The authors did not perform 
a dSPE clean-up on the extracts.  An average recovery of 72 to 94% was obtained at a 5 µg kg-1 
spiking level for five PAs (monocrotaline, retrorsine, seneciphylline, senecionine and 
senkirkine).  Two publications utilised a modified QuEChERS approach for the detection of PAs 
in honeys (Kempf et al., 2011b; Martinello et al., 2014).  The extraction step was similar for both 
using acetonitrile and sodium citrate in water followed by phase separation with magnesium 
sulphate and sodium chloride.  Kempf et al. (2011b) did not perform a dSPE and reported 
recoveries of 97.5 to 104.6% (%RSD ranging from 4.9 to 38.8%).  Martinello et al. (2014) did 
employ dSPE with primary secondary amine (PSA), magnesium sulphate and carbon, reporting 
recoveries of 67 to 122%.  Both of these methods were optimised for the detection of nine PAs.  
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Chapter 2 
Aims & Objectives 
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2.0 Aims and Objectives 
 
The aim of this research was to investigate the presence of, and quantify, pyrrolizidine alkaloids 
(PAs) and pyrrolizidine alkaloid N-oxides (PANOs) in food using liquid chromatography-mass 
spectrometry. 
 
The research objectives of this project were; 
1) To develop and validate an effective methodology for the accurate quantification of 
pyrrolizidine alkaloids (PAs) and pyrrolizidine alkaloid N-oxides (PANOs) using liquid 
chromatography-mass spectrometry (LC-MS) technologies. 
2) To optimise and validate an effective sample extraction and clean-up procedure for the 
analysis of PAs and PANOs in a range of food matrices. 
3) To investigate a range of food produce, including honey, herbal teas, traditional Chinese 
medicines (TCMs), milk and cheese, for PA-contamination. 
4) To conduct a comprehensive survey of honey sold on the Irish market for PA-contamination 
and to determine the risk to the Irish population through an exposure assessment study. 
5) To contribute to the analytical research area of PAs thereby improving food safety. 
6) To become an expert in analytical method development. 
7) To establish scientific collaborations and disseminate research findings on PAs in the food 
chain through international peer-reviewed publications and presentations. 
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Chapter 3 
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3.0 Experimental Methods 
Note: Each analytical chapter (4 to 6 inclusive) of this thesis describes in full the experimental 
approach taken within each study.  Therefore, the purpose of this experimental chapter is to 
provide an overview of how the methods were developed and optimised for their application in 
the analysis of PAs in honeys, herbal products, milk and cheese. 
3.1 Preparation of materials 
3.1.1 Reference Standards 
Reference standards were purchased from the suppliers as listed in Table 3.0 with molecular 
structures presented for all ten PAs and four PANOs in Table 3.1. 
PA/PANO Supplier Purity %Purity 
confirmed by 
Quantity 
obtained 
Crotaline Sigma Aldrich ≥98% TLC and NMR 1.0 g 
Crotaline N-oxide Phytolab GmbH & Co. ≥99% HPLC-MS, IR, TLC 
and NMR 
10.0 mg 
Echimidine Phytolab GmbH & Co. ≥90% HPLC-UV 10.0 mg 
Heliotrine Latoxan ≥98% TLC 50.0 mg 
Lycopsamine Phytolab GmbH & Co. ≥95% HPLC-UV, IR, GC  
and ICP-MS 
10.0 mg 
Otosenine Phytolab GmbH & Co. ≥95% N.R. 10.0 mg 
Retrorsine  Phytolab GmbH & Co. ≥95% N.R. 10.0 mg 
Retrorsine N-oxide Phytolab GmbH & Co. ≥99% HPLC-MS, IR 10.0 mg 
Seneciphylline Phytolab GmbH & Co. ≥99.5% HPLC-UV, IR, GC  
and MS 
10.0 mg 
Seneciphylline  
N-oxide 
Phytolab GmbH & Co. ≥98% HPLC-MS, IR 10.0 mg 
Senecionine Phytolab GmbH & Co. ≥99% GC, ICP-MS, NMR 10.0 mg 
Senecionine N-oxide Phytolab GmbH & Co. ≥95% HPLC-MS, IR 10.0 mg 
Senkirkine Carl Roth  
GmbH & Co. 
≥99.5% GC, TLC, NMR 10.0 mg 
Trichodesmine Latoxan ≥98% TLC 25.0 mg 
 
Table 3.0: Supplier listing, detailing % purity, for reference PA and PANO standards. 
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Table 3.1: Molecular structures for PAs and PANOs included in this study. 
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Both PA and PANO reference standards were prepared in HPLC grade methanol from the 
original supplier vial (of 10 mg) to primary stock standard solutions of 1 mg mL-1 (10 replicates).  
These stock standards were dried under nitrogen and stored at -20oC.  Weekly working standards 
were prepared using serial dilution and stored between 2 to 4oC in solution (methanol).  The 
freeze dried vial was allowed to equilibrate at room temperature before the addition of 1.0 mL of 
HPLC grade methanol and mixed using a vortex for 1 minute.  Working standards were prepared 
by mixing all PAs and PANOs and subjecting this mixture to serial dilution to produce a 7-point 
calibration curve range.  All PAs and PANOs are soluble in methanol whilst some are insoluble 
or produce turbid solutions in water (or solutions composed of a high % of water). 
 
During the course of the optimisation of the method (as per section 3.3) it was noted that 
preparation of standards in methanol afforded better chromatographic peak shape and ionisation 
than those standards prepared in a diluents of the starting mobile phase composition.  This is 
illustrated in Figure 3.0 with the PA lycopsamine. 
 
 
Figure 3.0: Comparison of chromatographic peak obtained for the PA lycopsamine when 
prepared in starting mobile phase composition versus 100% HPLC grade methanol.   
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3.1.2 Controls  
Control samples were prepared by spiking a blank matrix, a sample (honey, herbal teas, TCMs, 
milk and cheese) which was found to have no detectable levels of PAs and PANOs included 
within the analysis, after being subjected to extraction and clean-up as per the experimental 
protocol with a mixture of reference standards at two concentration levels (with the exception of 
the work as presented in Griffin et al. (2013) where one concentration level was employed as 
samples were analysed in duplicate).  Controls were used to determine the intra- and inter-day 
variability and reported in terms of relative standard deviation (%RSD), a measure of a statistical 
estimate's reliability obtained by dividing the standard deviation by the mean and expressed as a 
percentage. 
3.2  Sample preparation procedures 
 3.2.1 SPE: Theory and Protocol 
One of the main objectives of this project was to develop a simple but robust sample extraction 
and clean-up protocol that could be applied to a range of food matrices and suitable for LC-MS 
analysis with minimum ion suppression (or enhancement) effects from the sample matrix.  High 
sensitivity was an essential requirement for the analysis of PAs and PANOs in food produce as 
concentration levels can be low and the food matrices are challenging, particularly for produce 
such as honey.  An assessment of all published methods for the analysis of PAs and PANOs was 
conducted and can be seen in Griffin et al., 2014b (for honeys), Griffin et al., 2014a (for teas and 
TCMs) and in Chapter 6 (for milk).  Liquid-liquid extraction (LLE) is a popular method for 
detecting PAs in plant extracts but the long extraction times (up to 24 hr), use of heat and 
hazardous chemicals (such as dichloromethane, diethyl ether and chloroform) rendered this 
method unsuitable as it did not meet the objectives of this project.  Other literature has shown 
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that SPE is effective at reducing interferences from a complex food matrix such as honey in the 
analysis of insecticides (Blasco, Vazquez-Roig, Onghena, Masia and Picó, 2011) and at reducing 
ion suppression effects for LC-MS analysis (Furey, Moriarty, Bane, Kinsella and Lehane, 2013).  
The use of a polymeric SCX-SPE for PA analysis was recommended by Mroczek et al. (2002).  
Using SCX-SPE allows PAs to interact via a cation exchange mechanism and PANOs by polar 
interactions with the active sites of the sorbent.  Thus, both analytes, PAs and PANOs, are 
isolated simultaneously by SCX and mixed-mode.   
 
The SPE protocol developed and presented herein had significant time, labour and commercial 
cost improvements over previous publications (Betteridge et al., 2005; Boppré et al., 2005; 
Dübecke et al., 2011);  
(i) The SPE cartridge bed size was reduced from 500 mg to 60 mg.  This provides both a 
cost and time saving.  Large bed sizes are more expensive to purchase (approximately 
double the price), take longer to condition and require larger volumes of both solvents 
and sample. 
(ii) Sample size was reduced to the equivalent of 1 g of honey versus previous publications 
having 10 to 20 g.  The supernatant loading of honey samples was therefore reduced by 
approximately 10 times from 25 mL to 2.5 mL.  This introduces less sample matrix 
interferences and also reduces the time spent on loading. 
It should be noted that 1 g of honey was deemed a sufficient sample size in respect of 
sample homogeneity for retail honeys.  On average the maximum contents of a retail 
honey jar is 454 g and as such can be easily homogenised.  However, for bulk honeys (> 1 
kg/container) the sample size would need to be optimised and possibly increased.  For 
larger imports (> 10 kg/container) composite sampling would be necessary. 
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(iii) For a viscous sample matrix, such as honey, it was not necessary to maintain the warming 
of the supernatant prior to loading nor divide the supernatant volume and load to separate 
SPE cartridges, as per a previous publication (Betteridge et al., 2005).   
(iv) The polymeric bed provided superior sample elution with no incidences of cartridge 
blockage.  Filtration to remove particulate matter was performed by Dübecke et al. (2011) 
“overnight”, an excessively labour intensive step which was not required in the protocol 
presented herein. 
Under mildly acidic conditions most PAs are more stable, although epoxide functionalities are 
present in some PAs which are sensitive to halogenic acids.  Halogenated solvents promote 
quaternisation of tertiary PAs to corresponding salts with modified characteristics (EFSA, 2011).  
For this reason sulphuric acid was chosen for the acidic extraction protocol.   
 
The chosen SPE cartridge (Phenomenex Strata-X-CTM 60 mg bed/3 mL volume, as per section 
3.2.2) was conditioned with methanol (2 mL) to remove any random impurities and allow the 
sorbent to be solvated.  Following this the cartridge was equilibrated with water (2 mL) to 
prepare for sample loading.  The sample was loaded onto the cartridge manually, using a 
handheld pipette since the aliquot was relatively small (2.5 mL).  The sample volume was 
matched to the bed size so as to not overload the capacity of the cartridge.  Samples were loaded 
under atmospheric pressure, i.e. no vacuum was applied to the manifold, and allowed to dry for 1 
minute before washing.  Wash solvent strength and volume were optimised to flush as many 
matrix interferences as possible from the cartridge without losing the PA and PANO analytes.  
An aqueous buffer of 0.1% formic acid (2 mL) was used to remove water soluble interferences 
followed by methanol (2 mL) to remove hydrophobic substances without disrupting the PA and 
PANO analytes.  Finally, the elution step consisted of ammoniated methanol (6 mL) which 
removed the analytes of interest, both PAs and PANOs.  The ammoniated methanol solvent 
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strength was increased from 0.1% to 5%.  This was optimised to ensure complete elution of the 
analytes but without disrupting and eluting the more strongly retained interferences from the 
cartridge.  This was verified by post-column infusion studies to investigate matrix interferences. 
The same protocol was applied to honeys (chapter 4), herbal products (chapter 5) and milk and 
cheese (chapter 6) except in the instances where the ratio of sample mass to extraction solvent 
(0.05 M H2SO4) volume was necessarily changed. 
 
 
Figure 3.1: General overview of the SPE protocol (A = analyte, M = matrix components). 
 
 
To ensure the correct SPE sorbent/cartridge was chosen a study of five different SPE cartridges 
was conducted using an extract of honey spiked with a mixture of ten PAs and four PANOs (as 
per the listing provided in Table 3.0 and 3.1) at 3 different concentration levels; low, medium and 
high (7.1, 71.4 and 357.1 ng mL-1).  Selection criteria included analyte selectivity, elimination of 
matrix interfences and analyte recovery.  Recovery studies for individual PAs and PANOs were 
quantified against their corresponding calibration curves followed by an assessment of matrix 
clean-up performance.  Table 3.2 summarises the SPE cartridges selected for this comparison 
study.  
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No. Supplier Brand Sorbent Type Size Moiety Method 
1. Phenomenex Inc. Strata-X-CTM Cation mixed-
mode polymeric 
60 mg bed; 
3 mL volume 
Sulfonic acid-modified  
divinylbenzene polymer  
 
 
 
 
 
 
As per Figure 3.1 
2. Agilent 
Technologies 
Bond Elut 
Plexa PCX 
Cation mixed-
mode polymeric 
30 mg bed; 
3 mL volume 
Functionalised hydrophilic 
styrene divinylbenzene 
 
 
 
 
 
 
Condition: 2 mL methanol 
Equilibrate: 2 mL deionised water 
Load: 2.5 mL aliquot and dry for 1 minute 
Wash (1): 2 mL 0.1% formic acid in water 
Wash (2):2 mL methanol 
Elute: 9 mL 3% ammoniated methanol 
3. Agilent 
Technologies 
SampliQ 
SCX 
Cation mixed-
mode polymeric 
60 mg bed; 
3 mL volume 
Sulfonic acid-modified  
divinylbenzene polymer 
 
As detailed in No.1 above 
 
As detailed in No.2 above 
4. Waters Oasis HLB 
(hydrophobic-
lipophilic-
balanced)  
Polymeric 
reverse phase 
200 mg bed; 
3 mL volume 
Hydrophilic N-vinylpyrrolidone 
and lipophilic divinylbenzene 
 
As detailed in No.2 above 
 
5. Phenomenex Inc. Strata-XTM Polymeric 
reverse phase 
200 mg bed; 
3 mL volume 
Neutral polar functionalized 
styrene-divinylbenzene 
 
Condition: 2 mL methanol 
Equilibrate: 2 mL deionised water 
Load: 2.5 mL aliquot and dry for 1 minute 
Wash (1): 2 mL 90:10v/v 0.1% formic acid 
in water/methanol, Wash (2): 2 mL methanol 
Elute: 9 mL 3% ammoniated methanol 
 
Table 3.2: Summary of SPE cartridges tested during a comparison study for sample clean-up optimisation. 
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3.2.2 Results and Discussion of SPE Comparison 
Mroczek et al. (2002) were the first to report on the use of SCX-SPE (Merck LiChrolut SCX) 
filled with polymeric sorbent to analyse both N-oxides and free bases of PAs.  N-oxides are 
retained on the cation-exchange materials by binding to the active sites of the sorbent rather than 
a cation-exchange process (Crews et al., 2010).  It was determined that SCX was superior to C18 
sorbents which allowed the elution of co-extracted materials (Mroczek et al., 2002).  
 
Polymeric cation-exchange sorbent (such as Strata-X-CTM from Phenomenex Inc. or SampliQ 
from Agilent Technologies) consists of a styrene-divinylbenzene backbone and carries a sulfonic 
acid functionality as well as other polar moieties capable of hydrogen bonding and dipolar 
interactions.  Due to these structural features, these sorbents were expected to furnish cleaner 
extracts from a complex matrix such as honey which is a mixture of neutral, acidic and basic 
components (Blasco et al., 2011).  The mixed-mode cation-exchange resin provides better 
hydrophobic and polar retention characteristics compared to a neutral polymer with the same 
backbone structure, such as the Strata-XTM.  The authors Huq, Dixon, Kelly and Kallury (2005) 
described that the greater hydrophobic retention of the Strata-X-CTM sorbent was due to the 
electron withdrawing nature of the sulfonic acid group, inducing more electron polarisation due 
to the aromatic ring.  
 
All results were obtained using the same LC-MS conditions.  In brief these were; LC-(+)ESI-
QqQ-MS using a Phenomenex Kinetex PFP (150 x 2.1 mm, 2.6 µm) analytical column with a 
gradient mobile phase consisting of (A) 0.05% formic acid in water with 5% acetonitrile and (B) 
100% acetonitrile, at a flow rate of 0.2 mL min-1.  The analytical column was maintained at 35oC 
and the sample injection volume was 10 µL.  All samples were tested in triplicate.   
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Table 3.3 summarises the results obtained for all PA and PANO analytes for the five SPE 
cartridges tested showing the percentage recovery obtained for the triplicate injection of the 
medium concentration level, 71.4 ng mL-1. 
 
Analyte* 
Strata XC Bond Elut SampliQ HLB Strata X 
% SD % SD % SD % SD % SD 
Crotaline 109 20 145 23 90 14 ND ND ND ND 
Crotaline N-oxide 94 8 85 15 ND ND ND ND ND ND 
Echimidine 107 3 101 16 97 19 89 13 101 19 
Heliotrine 101 5 95 19 86 9 90 17 91 6 
Lycopsamine 83 6 107 20 122 25 83 5 76 8 
Otosenine 110 11 93 13 101 6 120 18 127 20 
Retrorsine 100 6 104 23 90 10 ND ND 97 12 
Retrorsine N-oxide 97 16 112 16 ND ND ND ND ND ND 
Senecionine 120 4 122 22 110 13 90 8 98 8 
Senecionine N-oxide 109 18 104 17 ND ND ND ND ND ND 
Seneciphylline 100 5 86 21 110 13 ND ND ND ND 
Seneciphylline N-oxide 94 15 87 20 ND ND ND ND ND ND 
Senkirkine 101 8 93 8 83 9 68 8 104 22 
Trichodesmine 86 5 108 22 115 13 ND ND 131 24 
* note all results obtained under the same LC-MS conditions 
% = % recovery based on triplicate injections 
SD = standard deviation 
ND = not detected 
 
Table 3.3: Summary of results from the SPE comparison study for the analysis of PAs and 
PANOs at the concentration level of 71.4 ng mL-1. 
 
From the results the best performance was obtained on the Phenomenex Strata-X-CTM (mean 
recovery of 101% ±9 SD) and the Agilent Bond Elut Plexa PCX (mean recovery of 103% ±18 
SD).  However, the Strata-X-CTM was chosen as both the percentage recovery and standard 
deviation range were narrower and more consistent.  Figure 3.2 illustrates the TICs for the SPE 
test cartridges obtained at the 71.4 ng mL-1 concentration.  As is clear from the chromatograms 
shown, the Strata-X-CTM provides superior clean-up and recovery over the other test SPE 
cartridges. 
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Figure 3.2: TICs for the SPE test cartridges obtained at the 71.4 ng mL-1 concentration. 
 
 
The final developed and optimised method of acidic extraction for honey samples followed by 
SCX-SPE clean-up using the Phenomenex Strata-X-CTM cartridge is given in Figure 3.3.  The 
estimated time for sample preparation (n = 20) based upon (i) using a 20-sample SPE manifold, 
(ii) optional adjustment to an accurate 10 mL using a volumetric flask, and (iii) centrifuge and 
turbovap of appropriate capacity is 1 hour per 20 samples.  This is a significant time saving over 
previously published methods (Dübecke, Beckh and Lüllmann, 2011; Kempf, Beuerle, 
Bühringer, Denner, Trost, von der Ohe, Bhavanam and Schreier, 2008; Betteridge et al., 2005 
and Beales et al., 2004).  
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Figure 3.3: Flow diagram for the sample preparation of honeys (extraction followed by SCX-
SPE on Strata-X-CTM). 
  
Strata-X-CTM
60 mg/3 mL cartridge
Condition:
2 mL methanol
Load: 
2.5 mL of sample
Wash (1): 
2 mL 0.1% aq. formic acid
Equilibrate:
2 mL deionised water
Wash (2): 
2 mL methanol
Elute: 
9mL 3% ammoniated methanol
Honey homogenised  (40oC)
4.0 g (±0.1 g) honey + 6.0 mL 
0.05M sulphuric acid in 15 mL 
centrifuge tube
Vortex 1 min
Centrifuge 6,000 rpm (3,421 g) 10 min
Transfer 10 mL volumetric flask 
(adjust to mark with 0.05M 
sulphuric acid, if necessary)
Honey Sample Preparation/Extraction
Solid Phase Extraction/Clean-up
Dry under N2 in Turbovap (45oC)
Reconstitute in 1.0 mL methanol and 
syringe filter (0.22 µm) to LC vial 
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 3.2.3 Modified QuEChERS 
Since it was first introduced in 2003 QuEChERS (Quick Easy Cheap Effective Rugged and Safe) 
has grown in popularity and has proven its use in multi-class, multi-residue analysis of pesticides.  
The two step extraction technique is based upon salting out extraction followed by clean-up using 
dispersive SPE (dSPE).  Salting out historically involved sodium chloride (NaCl) but this can 
hinder the recovery of base-sensitive compounds such as PAs.  Therefore, the developed method 
used for the detection of PAs in milk and cheese samples is based upon the AOAC (American 
Association of Analytical Chemists) 2007.01 method which employs an acetic acid/sodium 
acetate buffer instead of NaCl.  After extraction in acetonitrile the extract is cleaned using dSPE 
with primary-secondary amine (PSA) and graphitized carbon (C) to clarify the extract.  
Dispersive SPE aims to retain matrix/undesired components whilst allowing the analyte of 
interest to remain in the liquid phase, an opposite mode of action to SPE. 
 
QuEChERS was applied to milk and cheese extracts for PA analysis as it had been used 
previously by a collaborating laboratory for the testing of anthelmintics in such matrices 
(Kinsella et al., 2009; Whelan et al., 2010).  Prior to extraction the sample should be 
homogenised; milk by manually shaking and cheese by thoroughly mixing with water.  Water is 
a necessary component for partitioning to occur.  Acetonitrile is recommended for use in 
QuEChERS over other solvents, such as acetone and ethyl acetate, due to its high polarity and 
tendency for separation on the addition of salts.  When salts are added it is advisable that the 
extraction tubes are shaken by hand immediately to avoid clumping.  For clean-up of high fat 
matrices, such as cheese, PSA is recommended.  These considerations were undertaken when 
developing a QuEChERS procedure as outlined in Figure 6.1 and discussed for its application in 
Chapter 6.   
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3.3  Method Optimisation 
3.3.1 Liquid Chromatography 
Mobile phase 
The pka range for PAs is approximately 5 to 7 (senkirkine 6.65, senecionine 5.44, seneciphylline 
5.44, and retrorsine 5.37) with protonation occurring at a pH below their pka values.  Therefore, 
an acidic aqueous mobile phase was chosen (pH 3.0).  PAs are basic compounds and as such an 
acidic mobile phase will protonate silanols on the surface of the stationary phase preventing ion-
exchange interactions between the positively charged basic compounds and negatively charged 
silanols.  This should also reduce peak tailing which can occur from ion-exchange interactions.  
The mobile phase generally consisted of (A) 0.05% formic acid in water and (B) 100% 
acetonitrile.  However, in later analysis the composition of mobile phase (A) was changed to 95:5 
v/v 0.05% formic acid in water/acetonitrile to prevent the possibility of microbial growth in the 
aqueous phase.  Formic acid was chosen over (i) trifluoroacetic acid (TFA) as this was shown to 
suppress the signal response and (ii) acetic acid as this led to poor peak shape.  All mobile phases 
were adequately degassed, filtered (0.45 µm) and equilibrated to room temperature before use. 
 
LC Column(s) 
In the early stages of method development it was noted that a selection of C18 and C18 polar 
endcapped analytical columns, similar to those used in previously published articles on PAs (see 
Chapter 4 publications for tables summarising previously used methods) such as Phenomenex 
Aqua C18 and Waters XBridgeTM, afforded poor elution in that the analytes eluted too early, 
eluted together with little resolution or had poor peak shape.  It was therefore decided to trial a 
Thermo Scientific™ Hypersil GOLD™ aQ polar endcapped C18 column which was new to the 
market and promoted as providing excellent peak shape for polar basic compounds, such as PAs, 
81 
 
by controlling secondary interactions and having stability in 100% aqueous mobile phases.  
Figure 3.4 displays a comparison in the chromatography obtained for the PA crotaline (m/z 326, 
71.4 ng mL-1) with a Phenomenex Aqua C18 column versus the Thermo Scientific™ Hypersil 
GOLD™ aQ column under the same LC conditions with the column maintained at 30oC and a 
binary gradient separation performed using a flow rate of 0.2 mL min-1.  The mobile phase 
consisted of 0.05% formic acid in water (A) and 100% acetonitrile (B) with a gradient elution of 
0–2 min 20% B and 2–15 min with a linear increase in B from 20-50%, and the injection volume 
was 10 µL.  
 
 
Figure 3.4: Comparison in the chromatography obtained for the PA crotaline (m/z 326) with a 
Phenomenex Aqua C18 column versus the Thermo Scientific™ Hypersil GOLD™ aQ column 
under the same LC conditions. 
 
The Thermo Scientific™ Hypersil GOLD™ aQ column was selected for the initial investigation 
into PAs in commercial honey with the outcome of this experimental work being published in 
Griffin et al. (2013).  After this publication it was decided to expand the investigation into 
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commercial honey as PA-positive samples had been detected.  It should be noted that initial 
investigation and development work was performed blind, i.e. no PA-positive sample was 
available, rather it was assumed that PA-positive samples existed on the marketplace based upon 
earlier publications (Beales et al., 2004; Betteridge et al., 2005 and Kempf et al., 2008).  In the 
initial investigation of fifty commercial honeys, 16% (n = 8) were positive for the PAs included 
within the study.   
 
Although the Thermo Scientific™ Hypersil GOLD™ aQ column performed well in the study it 
was found to degrade relatively quickly, approximately 300 sample injections (not including 
calibrants, blanks and/or injections in methanol).  The degradation can be seen in Figure 3.5.  
This is in comparison to the Phenomenex Kinetex PFP which performed in excess of 700 
samples injections before seeing equivalent degradation.  Thus in an effort to improve 
chromatographic performance a study of a selection of analytical columns deemed appropriate 
(based on the chemistry of PAs) for the analysis was undertaken.  A list of these columns is 
provided in Table 3.4.  Since core-shell columns were increasing in popularity these were 
included within the study.  All columns were newly purchased and dedicated solely to PA 
research work. 
 
An evolutionary event in HPLC technology was the commercialisation of a new generation 
HPLC column packed with superficially porous particles also known as core–shell (Yang, 
McCabe and Pursch, 2011).  Core-shell columns offer higher efficiency particles allowing 
reduced run times while still maintaining or improving chromatographic resolution.  Core-shell 
particles maximise the performance of the column without generating excessive back pressures.  
They consist of an impermeable inner core surrounded by a layer of fully-porous silica.   
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The superficially porous particles have been reported to offer comparable separation efficiency to 
that of columns packed with sub-2-mm totally porous particles (Yang et al., 2011). 
 
 
Figure 3.5: Column degradation seen in the Thermo Scientific™ Hypersil GOLD™ aQ after 
approximately 300 samples injections (honeys). 
 
Supplier Column Particles Dimensions Part Number 
Phenomenex Inc. Kinetex PFP Core-shell 150 x 2.1 mm, 2.6 µm 00F-4477-AN 
Agilent Technologies Poroshell SB-C18 Poroshell 100 x 2.1 mm, 2.7 µm 685775-902 
Thermo Scientific Accucore PFP Solid core 100 x 2.1 mm, 2.6 µm 17426-102130 
Thermo Scientific Accucore aQ C18 Solid core 150 x 2.1 mm, 2.6 µm 17326-152130 
Supelco Ascentis Express 
F5 
Fused-core 100 x 2.1 mm, 2.7 µm 53569-U 
Advanced Materials  
Tech. Ltd. 
Halo C18 Fused-core 150 x 2.1 mm, 3.0 µm 92812-702 
Advanced Chromatography 
Tech. (ACE) Ltd. 
ACE 3-C18 Inert high 
purity silica 
150 x 2.1 mm, 3.0 µm ACE-111-1502 
GL Sciences InertSustain C18 Evolved 
surface silica 
100 x 2.1 mm, 3.0 µm 5020-07414 
Shodex ODP2* HP-2D Polymer resin 150 x 2.0 mm, 3.0 µm G803031 
* hydrophilic polyhydroxymethacrylate gel of totally porous spherical resin 
 
Table 3.4: List of analytical columns included in the PA column selection study.  
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The benefits of these column particles in reducing the mass transfer term and narrowing the 
particle size distribution have been observed for small molecule separations but have not been as 
successful with larger molecules (Gritti and Guiochon, 2007).  All the selected columns were 
primed for use according to manufacturer’s instructions and equilibrated for 20 void volumes of 
the column with the starting mobile phase before use.  All columns were subjected to similar 
conditions as follows; 
o Instrument: Accela LC system hyphenated to a triple quadrupole (QqQ) TSQ Quantum 
Discovery Max mass spectrometer. 
o LC conditions: Mobile phase composed of (A) 0.05% formic acid in water with 5% 
acetonitrile and (B) 100% acetonitrile, at a flow rate of 0.2 ml min-1 under optimised gradient 
elution.  The column compartment was maintained at 35°C (± 1°C). 
o MS Parameters: The HESI was operated in positive mode with a spray voltage of 3600 V, 
vaporiser temperature of 80°C and an auxiliary gas (nitrogen) flow rate set to 30 arbitrary 
units. A sheath gas of nitrogen was used to dry the excess solvent at 35 arbitrary units.  The 
capillary temperature was maintained at 250°C. Argon was used as the collision gas at 1.5 
mTorr.  Parameters including collision energies and tube lens voltage were optimised for all 
compounds using an automated tuning function and this tune file was saved and applied to 
the method. 
o Data acquisition: This was performed using the “EZ method” in SRM mode. 
o Sample: PA and PANO mixture at 71.4 ng mL-1 prepared in blank honey extract.  A 10 µL 
volume was injected from the autosampler. 
 
Table 3.5 summarises the results obtained from the column study.  The better performing 
columns were core-shell and generally PFP columns, such as the Phenomenex Kinetex, Thermo 
Accucore and Supelco Ascentis Express.  
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Supplier Column Particles Description of results obtained 
Phenomenex Inc. Kinetex PFP Core-shell Sharp peaks for all analytes, low baseline noise 
giving high S/N ratio. 
Agilent Technologies Poroshell 
SB-C18 
Poroshell Poor peak shape for some analytes (heliotrine, 
seneciphylline, senecionine, senkirkine and 
echimidine), broad and unsymmetrical. 
Thermo Scientific Accucore PFP Solid core Good peak shape for all analytes, relatively sharp, 
and high S/N ratio. 
Thermo Scientific Accucore 
aQ C18 
Solid core Peak shape on most analytes good (broad peaks, 
>1min at base, for senecionine, senkirkine and 
echimidine).  S/N is relatively low in comparison to 
PFP columns. 
Supelco Ascentis 
Express F5 
Fused-core Good peak shape for all analytes, relatively sharp, 
and high S/N ratio 
Advanced Materials  
Tech. Ltd. 
Halo C18 Fused-core Poor peak shape on all analytes, broad (>1min at 
base) and unsymmetrical 
Advanced Chromatography 
Tech. (ACE) Ltd. 
ACE 3-C18 Silica Relatively good peak shape but poor S/N ratio in 
comparison to other columns tested 
GL Sciences InertSustain 
C18 
Silica Poor peak shape on the majority of analytes, in 
particular later eluting (seneciphylline, senecionine 
and their N-oxides, senkirkine and echimidine) and 
low S/N ratio 
Shodex ODP2* HP-2D Polymer Broad analyte peaks (>1min at base) and low S/N 
ratio 
* hydrophilic polyhydroxymethacrylate gel of totally porous spherical resin 
 
Table 3.5: Summary of results obtained from the column study for the analysis of PAs. 
 
The PFP column, a pentafluorophenyl stationary phase, contains a stable reversed phase packing 
with electron-deficient phenyl rings due to the presence of electronegative fluorines.  Interactions 
form from pi-pi bonds, mild steric and polar interactions which all provide superior retention for 
PAs (basic polar compounds).  The MS signal for PAs and PANOs was a factor of 7 times 
greater on the PFP phase than on C18 or aQ C18 or polar endcapped phases.  Similar findings have 
been previously reported for tropane alkaloids, in particular benzoylmethylecgonine (cocaine) 
and its metabolites (Needham, Jeanville, Brown and Estape, 2000).  Figure 3.6 displays the TICs 
obtained for the three PFP phase columns included in this study. 
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All three columns, as per Figure 3.6, provided excellent chromatographic results.  The 
Phenomenex Kinetex PFP column was chosen due to higher sensitivity, resolution and signal-to-
noise (S/N) ratio for all PA and PANO analytes.  Although stability/robustness was tested 
(between 50 to 100 injections per test column) it was not done extensively with all columns listed 
in Table 3.5.  However, as previously stated the Phenomenex Kinetex PFP column offered over 
700 sample injections before noticeable column degradation in comparison to 300 sample 
injections with the Thermo ScientificTM Hypersil GOLDTM aQ (as per Figure 3.5).  The C18 
columns did not provide the same chromatographic efficiency as the PFP.  Figure 3.7 (a) 
illustrates the chromatography acquired using the Agilent Poroshell SB-C18 and the broad 
fronting peaks obtained for some PA analytes such as (b) echimidine.   
 
Figure 3.7: (a) TIC obtained for PA analytes such the Agilent Poroshell SB-C18 column and (b) 
the broad fronting chromatographic peak for the PA echimidine (m/z 398) on the same analytical 
column.  
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Also, since the completion of this research work a publication by Mathon et al. (2014) stated that 
the Phenomenex Kinetex PFP column was the only column in their investigation work on PAs to 
give baseline resolution versus C18, polar and phenyl-hexyl stationary phase columns. 
 
3.3.2 Mass Spectrometry 
Data Acquisition 
Data was acquired by the relevant data acquisition software, Xcalibur™ (Thermo Scientific) and 
DataAnalysis™ and LibraryEditor™ software (Bruker Daltonik GmbH).  The features of the 
acquired data are governed by the acquisition parameters and the scan(s) function. Briefly, 
acquisition parameters would deal with the following attributes: the mass-to-charge range 
scanned, scan cycle repetition rate, and the decision whether to acquire pre-processed 
(centroided) data or unprocessed (profile) data.  The unprocessed data acquisition collects a 
signal over several scans and can therefore generate excessively large data files.  Thus, the 
centroid data acquisition is more frequently used.  The scan function defines whether the mass 
spectrometer scans and acquires a range of masses, or monitors one or more masses.  The former 
yields full scan data comprising complete mass spectra, the latter selected or targeted ion data.  
 
Considerations for quantitative measurements  
The processes that take place in a mass spectrometer ion source are complex.  The response to a 
sample at the detector depends on several parameters that need control.  It is often advantageous 
to introduce a similar species, present at a constant (and similar to the target range) concentration 
as an ‘internal standard’ or a stable labelled analogue of the target compound.  Although an 
internal standard and/or deuterated standard were sought none were commercially available. 
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Qualification check  
It is not only scientifically prudent but also necessary to be able to demonstrate that a mass 
spectrometer is qualitatively and quantitatively accurate before producing quality critical data.  
This was achieved by running a control sample before acquiring analytical data.   
 
Instrument calibration  
Calibration was performed on a monthly or bimonthly basis to set the electron multiplier gain (a 
limiting factor for sensitivity as this detects the ion signals from the mass analyser), calibrating 
mass, resolution (in both positive and negative mode) and system tube lenses to achieve optimum 
mass spectral performance.  Calibrations were carried out in accordance with manufacturers’ 
guidelines and using a calibration solution, e.g. polytyrosine. 
 
Sample ionisation, the ion source, tuning and optimisation  
Instrument tuning is a combination of the optimisation of the conversion of the liquid phase 
analyte to its characteristic gas phase ions in the mass spectrometer inlet, the optimisation of ion 
transmission efficiency through the instrument, and the optimisation of peak shape.  
 
3.3.2.1  QqQ MS Tuning (Thermo Scientific TSQ Quantum Discovery Max) 
Firstly, the default parameters for the HESI probe were used as a starting point for tuning the PA 
and PANO analytes.  A mixture of the reference compounds was prepared in methanol.  All 
tuning and optimisation was performed by infusion with a T-junction to the mobile phase flow.  
This set up is explained further in Figure 3.19.   
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Figure 3.8: MS parameters for tuning and optimisation. 
 
 
 
 
Figure 3.9: Optimised source parameters for the QqQ-MS method. 
 
 
Optimised source parameters are displayed in the provided screenshot, Figure 3.9.  Secondly, the 
optics are optimised, this includes the tube lens.  The tube lens restricts the expansion of the ion 
beam as it exits the ion transfer tube.  A graphical view of this optimisation is shown below in 
Figure 3.10 for the PA senecionine (m/z 336). 
  
1.  Source Parameters
• [1] Probe position/housing 
(default setting of 1 µm and 
vertical position ‘C’)
• [2] Capillary temperature 
(ramped from 200 to 350oC)
• [3] Vaporisation temperature 
(ramped from 0 to 150oC)
• [4] Sheath gas flow (ramped 
from 0 to 50 units)
• [5] Auxiliary gas flow (ramped 
from 0 to 50 units)
2.  Ion Optics
• [6] Tube lens Voltages                       
(both optimised through the 
automatic function)
3.  MS2 Parameters
• [7] Collision pressure (set at 
default 1.5 mTorr)
• [8] Collision energy (optimised 
by ramping  20 to 60 V with 8 
increments)
• [9] Resolution (default setting 
of 0.7 FWHM)
• [10] Scan Width (default 
setting of 0.002 m/z)
• [11] Scan Time (optimised 
using EZ method)
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 Figure 3.10: Tube lens optimisation for the PA senecionine (m/z 336). 
 
Lastly, the MS2 parameters for the method were optimised including collision energy.  MS/MS 
spectra that employ CID vary with collision energy, generally expressed in units of eV (or volts).  
A charged ion is accelerated to a kinetic energy by applying a potential difference producing a 
MS/MS spectrum.  For all PAs and PANOs the collision energy was optimised over a range of 20 
to 60 volts, ramping upwards over eight steps with the four most intense product ions being 
recorded.  Figure 3.11 illustrates the plot obtained for the optimisation of collision energy for the 
PA senecionine.  Appendix A displays plots for all PAs and PANOs. 
 
Figure 3.11: Collision energy optimisation for the PA senecionine (m/z 336).  
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Resolution and scan width were then optimised.  The scan width selected should be as small as 
possible.  The QqQ-MS method developed used the Thermo ‘EZ’ method which is favoured for 
SRM analysis.  The scan width is set to a default of 0.002 m/z meaning that the MS will scan 
between M-0.001 and M+0.001 and centred on the mass of interest, thus it is important not to 
enter nominal masses but analyte masses correct to two decimals.  The resolution is also set to a 
default of 0.7 FWHM (full width at half maximum).  In SRM mode the scan time represents the 
time taken for the MS to scan each transition inputted into the method.  The scan time should be 
adjusted so that chromatographic peak will be correctly sampled and have a sufficient number of 
data points across the peak (minimum required; 15).  Background noise and thus signal to noise 
ratio can be improved with an increased scan time however care must be taken to allow the dwell 
time to sufficiently gather enough data points across the chromatographic peak. 
 
In the EZ method a constant cycle time can be chosen to equally space data points across all 
peaks.  The MS adjusts the scan time to be equal to the cycle time and divided by the number of 
SRM transitions inputted into the method.  For example, a MS acquisition time of 12 minutes 
with a total of 45 transitions would equal a cycle time of approximately 0.3 seconds.  Figure 3.12 
displays a screenshot of the EZ method setup.  Retention time windows were used to segment the 
MS acquisition so that SRM scan records for each target analyte within the time zone of known 
retention, thus improving method sensitivity.  To further improve the robustness of the method a 
divert valve was utilised to eliminate unwanted contaminants from entering the MS.  The first 2 
minutes (for gradient elution, or 1 minute for isocratic elution) of the elution and the column 
wash during equilibration was diverted to waste which was particularly useful for complex food 
matrices such as honey, herbal products and dairy samples. 
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Figure 3.12: EZ method for the analysis of PAs and PANOs. 
 
 
3.3.2.2  IT-MS Tuning (Agilent 6300 Ion Trap) 
Similar optimisation was performed for the IT-MS method.  However, the source parameters on 
the Agilent 6300 IT-MS did not require as much tuning as those on the TSQ Quantum.  The 
default parameters used for a flow rate of 0.2 mL min-1 were; positive ESI mode with nebuliser 
pressure at 20 psi and drying gas (nitrogen) at 10 L min-1, and capillary temperature of 350ºC.  
MS conditions were optimised using the SmartFrag collision energy ramping tool which uses 
collision-induced dissociation (CID) voltage ramping over a range of energies (30–200% of the 
amplitude) to ensure the precursor ion receives the necessary energy for maximum fragmentation 
with minimal ion loss from the trap. It eliminates time-consuming manual CID voltage 
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optimisation.  The fragmentation amplitude ranged from 0.5 to 1.2 V (Table 1 in Griffin et al., 
2013).  To ensure a minimum of 15 data points acquired per chromatographic peak and 
reproducible integration for quantitative analysis time segments were used at 6.5 and 11.5 min 
(Figure 3 in Griffin et al., 2013).   
 
Figure 3.13: Illustration of the Agilent IT-MS software interface. 
 
 
 
3.3.3 Matrix Study 
Matrix effects and adduct formation can be a major cause for concern if they comprise or even 
invalidate both qualitative and quantitative results.  Matrix effect is defined as the ion 
suppression or enhancement of the ionisation of analytes, which is evaluated by comparing the 
corresponding peak areas from a spiked extract with that of the standard prepared in solvent.  
Also, the influence of mobile phase composition on ionisation efficiency in MS is recognised and 
mobile phase additives can have an impact on matrix induced ion suppression/enhancement of an 
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analyte (Lambert, 2004).  “If ion suppression is not assessed and corrected in an analytical 
method, the sensitivity of the LC–MS method can be seriously undermined, and it is possible that 
the target analyte may be undetected even when using very sensitive instrumentation” (Furey et 
al., 2013). 
 
Post-column infusion experiments were conducted to determine ion suppression/enhancement 
effects.  This approach is similar to that described by Allis, Dauphard, Hamilton, Ni 
Shuilleabhain, Lehane, James and Furey (2007).  The experimental setup used in these 
experiments involved the infusion of standard mixture into a blank matrix solution.  A T-junction 
was placed between the LC system and the MS source, and the standard mixture was monitored 
by MRM while being introduced at a flow of 10.0 µL min-1 into the LC eluent.  The standard 
mixture (71.4 ng mL-1) was placed in a 1.0 mL glass gastight syringe (Hamilton) and delivered 
with a syringe pump.  A blank matrix sample (subjected to acidic extraction and SPE clean-up) 
was injected (10 µL) via the autosampler into the LC system.  The response of the standard 
mixture was monitored continuously to produce a profile of the matrix effect. This was repeated 
several times (n = 3) to ensure the effect was reproducible.  All blank sample matrices (honey, 
milk, cheese, teas and TCMs) were tested in the same manner.  Figure 3.19 provides an 
illustration of the post-column infusion setup. 
 
Matrix-matched calibration curves were also studied for ion suppression or enhancement effects.  
These experiments were preformed on all food matrices tested and over five concentration levels 
(3.6, 7.1, 35.7, 57.1 and 71.4 ng ml-1) for each PA and PANO.  The possible matrix effects are 
investigated by comparison of the response of peak areas of the individual analytes between the 
blank spiked extract and the reference standard prepared in solvent (such as HPLC grade 
methanol).  Example illustrations of matrix studies for ion suppression/enhancement are given in 
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Chapter 4 (Figure 2 of the article submitted to Food Additives and Contaminants, October 2014), 
Chapter 5 (Griffin et al., 2014a) and Chapter 6 (Figures 6.4, 6.5 and 6.6).   
 
3.3.4 Data Processing 
The identity of the PA and PANO analytes were confirmed when the criteria for ion ratio (±20%) 
and retention time (±0.2 min) were met in comparison to the positive control samples.  Hence, 
for a deviation in the ion ratio the value must be less than 20% and for retention time the value 
should be less than 2.5%.  The ion ratio was calculated as follows: 
Ion ratio (%) = A (lowest intensity ion)   x 100 
                        B (highest intensity ion) 
 
For the Thermo Scientific instruments data is acquired and processed using Xcalibur software.   
 
Figure 3.14: Xcalibur™ Software “Road map” homepage. 
 
In the “Qual Browser” function of Xcalibur™ many tools are available to the user to review 
acquired data, manipulate chromatograms and/or spectra, perform integration, activate library 
searches and produce reports.  Figure 3.15 is a screenshot of Qual Browser with the first data cell 
illustrating a chromatogram for a PA and PANO reference standard mixture and the second cell 
displaying the transitions for the lycopsamine peak at the retention time of 3.15 minutes.  
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Figure 3.15: XcaliburTM Software “Qual Browser”. 
 
Automated processing can be performed using the “Quan Browser” function.  After a trial 
injection a processing method is optimised by selecting the “Processing Setup” icon from the 
“Road map” homepage.  This processing method is selected when setting a new sequence or can 
be retrospectively applied to a previously obtained sequence.  The data files are then viewed 
using this processing method in the “Quan Browser” field.   
 
 
Figure 3.16: a screenshot of the “Quan Browser” function.  
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3.3.5 Spectral Library 
A fully automated processing method was created for analysis performed on the Agilent 6300 
series IT-MS.  In liquid chromatography, absolute retention times or retention times relative to a 
standard can be used to qualify chromatographic peaks for integration and quantification.  To 
further aid identification, a spectral library may be created.  The data system acquires the 
chromatogram and spectral data of the chromatographic peaks in question.  These peaks are 
compared with those stored in a user-created library.  A spectral library was built for all PA and 
PANO analytes included in this research work.  This was performed by acquiring LC-MS data of 
both the solvent (methanol) and matrix prepared analytes over a linear range.   
 
The program lists the match factor, reversed search match factor, probability, and names of the 
compounds in the library most resembling your unknown spectrum.  The number is calculated 
using the dot product mass spectral search NIST algorithm, which is equal to the cosine of the 
angle between the unknown and the library spectral vectors.   Mass peaks are scaled using the 
square root of their abundance.  Scores for Fit (F), Reserve Fit (R), Purity (P) and Match Factor 
(M) are generated.  The fit correlates the number of spectral peaks and intensities between the 
sample and library entry.  The reverse fit demonstrates the uniformity between these peaks, thus 
if the reverse fit score is low it signifies that there are too many interferences in the obtained 
sample spectrum.  The purity score is representative of an amalgamation between fit and reverse 
fit.  Incorporating the user pre-specified parameters allows for the match score to be returned 
giving an overall effective score with a maximum of 1000.  Thus, a positive sample will return a 
match score ideally above 900, with 1000 indicating an exact correlation.  
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 Figure 3.17: Illustration of library matching performed on the Agilent 6300 series IT-MS. 
 
Although the accurate set-up of a spectral library may be initially labour-intensive it can prove 
extremely beneficial in the longterm.  It is particularly useful when processing large sample 
sequences where positives can be identified in a matter of minutes (Gomez-Romero et al., 2011).  
They can become a powerful and valuable tool when used in combination for multi-analyte or 
multi-toxin assays.  For example, animal feed could be screened for mycotoxins, plant toxins 
(including pyrrolizidine alkaloids) and environmental contaminants (including pesticides).   
The application of the spectral library to PA-positive honey samples is discussed in Chapter 4 
and in the associated publication Griffin et al. (2013).   
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3.4  Method Development Considerations 
 
 
Figure 3.18: Considerations for method development. 
  
Analyte & 
Sample
•Understand both analyte and sample of interest
•Knowledge of the matrix: (i) what other compounds are present? (ii) what are the 
potential interferences (iii) conduct matrix matched calibration and post-column 
infusion studies
•Concentration and quantity: (i) concentration range (ii) possibility of finding a positive 
sample (retail) (iii)is there more than one analyte?
•Chemical and physical properties of the analyte (pKa, MW, solubility, etc.)
Aim of 
Method
•Purpose of the analysis: what is the end goal?
•(i) Detect, (ii) Identify (iii) Quantify and (iv) Profile
•Applicable to a range of sample matrices 
•High through-put analysis or robust routine testing
How to 
Achieve
•(i) Suitable detection technique
•(ii) Identification using a targeted approach employing certified reference standards, 
fragmentation patterns and comparison with published literature
•(iii) Quantitation by external calibration, specificity, accuracy and precision
•(iv) Profile using a comprehensive method and development of a spectral library
•Conduct an extensive literature review
Analysis
•LC-MS methods provide advantages over GC-MS for detection of these analytes; no 
derivatisation necessary, all analytes detected simultaneously (PAs and PANOs)
•Systematic screening protocol for selection of method parameters (mobile phase, pH, 
additives, stationary phase, ionisation modes)
•Sample preparation: specificity, reproducibility, robustness, cost and ease for routine 
analysis and applicable to a wide range of matrices
Validation
•Check overall performance  requirements; accuracy, precision, reproducibility, linearity, 
limits of detection and limits of quantitation
•Check method optimisation and robustness; determine the experimental factors that have 
significant impact on the method
•Validate the method in accordance with ICH guidelines and EU directives 
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3.5  Analytical Method Validation 
The process of validating an analytical method is to demonstrate that the method is suitable for 
its intended purpose, i.e. to confirm through systematic evaluation that a method will consistently 
produce accurate results when applied in different situations.  To consistently produce accurate 
results, an analytical method must be specific, linear, precise, sensitive, robust and possess good 
recovery.  It is common practice to associate accuracy with recovery only; indicating the 
deviation between the mean value and the true value.  Typically accuracy is tested through 
spiking at 80%, 100% and 120% of a determined level, i.e. an MRL. 
 
Percentage recovery (%) = calculated concentration of analyte   x   100 
                                           theoretical concentration of analyte 
 
 
Throughout this research accuracy was determined for all PA and PANO analytes by spiked 
controls (spiking reference compounds into the relevant blank matrix).   
 
The precision of the analytical method is a measure of its reproducibility from sample 
preparation through to detection (European Commission, 2002).  Precision is expressed as the 
relative standard deviation (RSD): 
 
RSD (%) = standard deviation   x  100 
                             mean 
 
 
Precision can be investigated at three levels; (i) repeatability within a sequence, (ii) intermediate 
precision by using a different analyst or instrument and (iii) reproducibility by conducting 
analysis in a different laboratory.  All three levels of precision were used during this research 
work.  Intra and interday variability was recorded, two mass analysers were utilised and 
confirmatory analysis conducted by our collaborators at Teasgac Ashtown Food Research Centre. 
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Linearity is determined by calculating the regression line by least mean squares method versus 
the analyte concentration.  The correlation coefficient is used as a measure of linear association 
between the two variables, for LC this is peak area versus the analyte concentration.  For all PA 
and PANO calibration curves the regression line was not forced through the origin and a zero 
analyte concentration point was not part of the data set.  The correlation coefficient (R), slope of 
the line, Y intercept and residual sum of squares were calculated and reported for each plot.  The 
correlation coefficient (R) acceptance criterion was set to > 0.99.   
 
The range of the method is demonstrated as the range, upper and lower, of the analyte(s) that 
has/have been determined by acceptable accuracy, precision and linearity (European 
Commission, 2002).  The range for the LC-MS analysis of ten PAs and four PANOs was 5.7 to 
357.1 µg kg-1. 
 
The limit of detection (LOD) is the lowest concentration or amount of analyte in a sample that 
can be detected but not necessarily accurately or precisely quantified under the method 
conditions.  The limit of quantification (LOQ) is the lowest concentration or amount of analyte in 
a sample that can be determined with acceptable precision and accuracy under the method 
conditions (European Commission, 2002).  LOD and LOQ were determined experimentally for 
all PAs and PANOs as 3 times and 10 times the signal to noise (S/N) ratio, respectively. 
Robustness was investigated and built into the method on development.  Robustness illustrates 
the reliability of an analysis with respect to deliberate variations in method parameters.  A control 
sample (a blank sample extract which was spiked with all PA and PANO analytes at a known 
concentration) was analysed on each variation to ensure that the validity of the analytical 
procedure was maintained.  The following variations were investigated; 
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 Sample and standard solution stability at room temperature over a period of 3 days.  All 
standards in methanol were stable over this period when protected from light, heat and stored 
in a sealed container.  Honey, tea and herbal samples were stable over 24 hours whilst dairy 
samples of milk and cheese were maintained at 4oC. 
 Changes to the pH of mobile phase aqueous content (0.05% formic acid in water) was 
investigated over a range ±0.2 units with no variations detected in results obtained. 
 Changes to the organic content of mobile phase composition (A) when prepared as 95:5 v/v 
0.05% formic acid in water/acetonitrile.  No variations were detected over a range of ±10% 
for both formic acid of 0.045 to 0.055% and organic content of 45 to 55 mL acetonitrile per 
litre. 
 Changes to column lots; this was investigated for the analytical column Phenomenex Kinetex 
PFP, 150 × 2.1 mm (2.6 μm particle size), with no variations detected. 
 Changes to column temperature; the column compartment was maintained at 35oC ±1oC. 
 Changes to flow rate; the flow rate was maintained at 0.2 mL min-1 for MS detection. 
 
A system suitability check was not run as part of this method validation and as such resolution, 
tailing or capacity factor were not measured.  However, the use of control and retention 
check/marker solutions prepared from PA and PANO reference standards were incorporated into 
the validated methods. 
 
Selectivity, the ability to measure accurately the analyte in the presence of sample matrix, was 
determined by individual matrix-matched calibration curves for all PAs and PANOs.  Specificity, 
ensuring the signal measured relates to the analyte(s) of interest without interference from 
impurities (European Commission, 2002), was upheld by direct comparison to individual 
reference standards analysed during the same chromatographic sequence.  
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It is recognised that the highest level of uncertainty in LC-MS methods come from sample matrix 
interferences.  Infusion experiments were conducted which involved the continuous introduction 
of PA and PANO standard solution by means of a syringe pump connected to the eluent flow 
from the analytical column.  After injecting a blank sample extract into the LC system the MS 
baseline is monitored for suppression or enhancement in ionisation of the analytes due to the 
presence of matrix interferences. 
 
Figure 3.19: Post-column infusion study set-up to investigate possible ion suppression or 
enhancement effects.  
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Chapter 4 
Analysis of PAs in honey via LC-MS 
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4.0 Analysis of PAs in Honey via LC-MS  
This chapter is comprised of four separate but complimentary analytical investigations into the 
detection, persistence and profiling of PAs and PANOs in honeys.  These investigations are listed 
below and are presented as published articles in peer-reviewed scientific journals (# 1, 2 and 4) 
or prepared journal articles under review by co-authors (# 3).  
1) Griffin CT, Danaher M, Elliott CT, Kennedy DG, and Furey A. (2013). Detection of 
Pyrrolizidine Alkaloids in Commercial Honey using Liquid Chromatography-Ion Trap Mass 
Spectrometry, Food Chemistry, 136 (3-4); 1577-83. 
2) Griffin CT, O’Mahony J, Danaher M, and Furey A. (2014b).  Liquid Chromatography 
Tandem Mass Spectrometry Detection of Targeted Pyrrolizidine Alkaloids in Honeys 
purchased within Ireland, Food Analytical Methods, 8 (1); 18-31, doi 10.1007/s12161-014-
9855-1. 
3) Griffin CT, Conroy ER, O’Mahony J, Gibney M, Danaher M, and Furey A. (2015). Dietary 
exposure assessment of pyrrolizidine alkaloids in honey purchased in Ireland over a three 
year period (under review by co-authors). 
4) Griffin CT, Mitrovic S, Danaher M, and Furey A. (2015). Development of a fast isocratic 
LC-MS/MS method for the high-throughput analysis of pyrrolizidine alkaloids in Australian 
honey, Food Additives and Contaminants, Part A, doi 10.1080/ 19440049.2014.996789. 
4.1 Aims and Objectives  
The aim of this work was to; 
- develop a sensitive and robust analytical method for the detection of PAs and PANOs in 
retail honeys (at the point of consumption, thereby having a direct impact upon the 
consumer), 
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- provide a comprehensive validated method for all of the PAs and PANOs reference standards 
commercially available at the time of analysis, 
- assess the risk of PA exposure to the Irish population (adults, teenagers and children) from 
the consumption of honeys.   
 
4.2 Background 
When this work began in late 2008, previous retail studies on PAs in honey were limited in (i) 
the number of studies available (n < 10), (ii) selection of only one type of honey, e.g. floral from 
Echium genus (Betteridge et al., 2005) and (iii) the number of retail samples tested (maximum 
216 by Kempf et al., 2008).  The European Food Safety Authority (EFSA, 2007) released a 
report on PA contamination of animal feed in 2007.  In this report one of their final conclusions 
was that more data was required to quantify PA-containing honey and to assess PA exposure to 
humans.  Therefore this was the starting point for the experimental work developed and 
presented herein.  The research lab did not have any in-house testing methods for these 
compounds or matrices.  The challenge was to develop a simple yet robust method which could 
be applied not only to a difficult matrix such as honey but to other foodstuffs.  The analytical 
instrumentation available was LC coupled to either ion trap MS or QqQ-MS.   
 
4.2.1 Initial Experimental Work (Griffin et al., 2013) 
Method development and optimisation for this work is detailed in Chapter 3 (sample preparation 
as per section 3.2.1, column selection in section 3.3.1, instrument operating parameters in section 
3.3.2.2 and development of a spectral library given in 3.3.5).  In brief, a simple acidic extraction 
of honey samples (4 g) with sulphuric acid (0.05M) followed by clean-up on SCX-SPE 
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(Phenomenex Strata-X-CTM 60 mg) was developed.  LC-MS was conducted on an Agilent 1100 
LC coupled to a 6340 series ion trap MS with analyte detection and separation performed by 
using a C18 polar endcapped analytical column (Thermo ScientificTM Hypersil GOLDTM aQ) and 
acidic mobile phase (pH 3.0).  The full experimental details are given in the attached publication 
(Griffin et al., 2013) under section 2 “Materials and methods”.  The method was difficult to 
optimise and previous publications utilising LC-MS provided little assistance in the way of 
chromatographic details.  Many publications were outdated (Deinzer et al., 1977; Culvenor et al., 
1981), did not present chromatograms and full experimental workings (Kempf et al., 2010b) or 
quantify results against individual PA reference standards (Kempf et al., 2008).  So, it was 
important to develop a method which would include the most comprehensive suite of reference 
PA compounds to date (11 teritary PAs).  It was also uncertain if any PA-positive retail honeys 
could be identified and found on sale within Ireland.   
 
An ion trap mass spectrometer was employed for detection and to determine common mass 
fragments or characteristic mass fragments for PA analytes (see section 1.7.4.4 and Figure 1.16).  
Utilising the instrument software (Bruker Daltonik GmbH) PAs were tuned using the 
“SmartFrag” tool where the collision-induced dissociation (CID) voltage is ramped over a range 
of energies (30–200% of the amplitude) to ensure the precursor ion is fragmented with minimal 
ion loss from the trap.  This negated the need for manual tuning which can be very time-
consuming (as outlined in Chapter 3, section 3.3.2.2).  For accurate quantitative analysis a 
spectral library was developed which allowed for fast identification and detection of PA-positive 
honeys.  This was performed by analysing all 11 PAs spiked in blank honey extract and 
importing the MS2 and MS3 spectra to the LibraryEditor™ software.  A peak width of m/z 0.5 
and isolation width of m/z 1.0 was applied for all analytes.  On analysis the sample spectra was 
matched to the library spectra using a NIST algorithm (as outlined in Chapter 3, section 3.3.5 and 
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Figure 3.17).  This allowed for fast and unequivocal identification of positive samples by 
generating a match and purity factor.   
 
From the study (n = 50) a number of PA-positive samples (n = 8; 16%) were detected.  The PA-
concentration range of positive samples was wide; 182 to 4078 µg kg-1.  From the 8 positive 
samples 6 originated from outside the EU and 2 were blends of EU and non-EU honeys.  Positive 
samples from outside the EU had PA concentrations ranging from 190 to 4078 µg kg-1 whilst 
samples labelled as blends of both EU and non-EU honeys had a relatively lower PA 
concentration range of 182–634 µg kg-1.  These concentration ranges correlate with the earlier 
work of Betteridge et al. (2005).  Strikingly, the honey with the highest PA-concentration (4078 
µg kg-1) detected here when compared with the honey found to have the highest PA-
concentration (2850 µg kg-1) by Betteridge et al. (2005) was sourced from the same supplier (of 
Australian origin).  As a result of this work a larger retail survey was warranted to provide a 
comprehensive profile for all retail honeys sold and consumed within Ireland. 
 
4.2.2 Expanded Retail Study (Griffin et al., 2014b) 
An expanded retail honey study (n = 150) was justified based upon PA levels previously detected 
(as per study 1 above).  The aim of this work was to provide further data on the prevalence of 
PAs within honey.  Detection using targeted LC-MS/MS in MRM mode was used to obtain 
information on both the concentration range and PA-profile for retail honeys on sale in the Irish 
marketplace.  In comparison with previously published LC-MS methods, this validated method 
quantified each target analyte by matching it to its own certified reference standard.  This 
provided more accuracy over previously published work where quantitation was determined by 
using retronecine equivalents (Kempf et al., 2008; Kempf et al., 2010; Dübecke et al., 2011).  
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  Using equivalents can underestimate the concentration of PAs as otonecine-type results are not 
accounted for (see Chapter 1, Figure 1.1 for structural PA types).  Sample preparation was by a 
simple acidic extraction followed by SCX-SPE clean-up.  This protocol is a modified and 
improved method from those previously reported (Betteridge et al., 2005; Boppré et al., 2005) 
with regards to time and cost.  This method was the same as that employed within the initial 
study (Griffin et al., 2013).  However, the samples were not run in duplicate nor was the PA 
crotaline used as an internal standard.  Instead an external calibration approach was used and 
detection was verified by ion ratios (± 20%) of two transitions.  The LC-MS/MS was performed 
on an Agilent Infinity 1290 LC coupled to a 6460 QqQ-MS.  The software used dynamic MRM 
(dMRM) which permits greater sensitivity and selectivity thus improving quantitation over 
traditional time segments (such as that used with the LC-IT-MS method).   
 
The results showed that out of 150 honeys 23% (n = 34) were positive for PAs and/or PANOs.  
Table 5 of the enclosed publication (Griffin et al., 2014b) lists all 34 PA-positive honeys 
detected.  The PA-positive samples had a concentration range of 3 to 546 µg kg-1.  The current 
recommendations of EFSA (2011), the Committee on Toxicity (COT, 2008) and the German 
Federal Institute of Risk Assessment (BfR, 2011) are for a person to not exceed an intake of 
0.007 μg kg-1 bw day-1 of 1,2-unsaturated PAs.  For an average adult of 70.8 kg (Walpole et al., 
2012), this equates to a maximum daily intake of 0.4956 μg PA/day.  Using the findings 
presented in Table 5 of the publication, a consumption of 1 tablespoon (equivalent to 10 g of 
honey) of samples 1 to 10 (68–546 μg kg−1) would exceed the maximum daily intake.  Similiar to 
the results in the initial study (Griffin et al., 2013) 80 % of PA-positives originated from 
Australia/New Zealand. 
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4.2.3 Retail Honeys Survey and Risk Assessment 
A complete retail study (n = 369) was used to assess the dietary intake of PAs in the Irish 
population from the consumption of honey.  This work involved testing all 369 retail honeys (all 
purchased within Ireland during the years 2009 to 2012) using the developed acidic extraction 
and SCX-SPE clean-up protocol described in Chapter 3 of this thesis and outlined in Figure 3.3.  
Analysis was conducted by LC-MS/MS in SRM mode using a Thermo Scientific TSQ Quantum 
Discovery Max QqQ-MS (outlined in Chapter 3, section 3.3.2.1).  Collaboration was initiated 
with colleagues within the Safe and Healthy Foods research programme in University College 
Dublin (UCD).  A risk assessment was compiled using the PA-data from retail honeys (n = 369) 
and dietary intake data from the Irish Universities Nutrition Alliance (IUNA) and analysed using 
Creme modelling software.   
 
From the total survey (n = 369) it was found that 24% of honeys on sale in Ireland contained PA 
toxins above the LOD for the analytical methods employed (mean LOD 1.1 µg kg-1).  Figure 4.0 
illustrates the origin of the honeys tested from information obtained from the suppliers’ labels.   
 
Figure 4.0: The origin of honeys tested (n = 369) from information obtained from the suppliers’ 
labels (blue indicates EU countries whilst orange the rest of the world).  
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The mean PA concentration in positive honey was 81 µg kg-1.  A PA profile was acquired from 
these PA-positive samples.  Lycopsamine (m/z 300) and echimidine (m/z 398) were the most 
predominant PAs occurring in 92% and 44% of positive samples, respectively.  This observation 
was consistent over the four years of sampling.  Figure 4.1 provides a breakdown in the PA 
profile of positive honeys detected across the four years (2008 to 2012) of investigation.  PANOs 
were found to a far lesser concentration.  This correlates with an observation by Betteridge et al. 
(2005) that honey has “an innate capacity to naturally reduce N-oxides to their parent tertiary 
bases”.  The authors observed this finding when PA-free honey was fortified with PANOs 
(reference standards used) and the subsequent levels of parent PAs were between 5 and 14 %.  
Another group (Colegate et al., 2005) spiked a blank honey extract (one with no detectable levels 
of PAs or PANOs) with an extract of Echium plantagineum which was determined to contain 
95% PANOs and found a respective increase in the parent or tertiary PA. 
 
 
Figure 4.1: Breakdown of the PA profile for positive honeys detected over the four years (2008 
to 2012) of this study. 
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A margin of error (MOE) approach was chosen by EFSA (2011) when estimating exposure of 
PAs to humans and for PAs this equates to a maximum dose of 0.007 µg kg-1 bw day-1.  This is 
based upon toxicity studies in rodents where the PA lasiocarpine induced carcinogenic effects at 
a concentration of 70 µg kg-1 of body mass.  The internationally excepted MOE of 10,000 for 
genotoxic and carcinogenic compounds was applied.  The dietary intake of PAs and PANOs 
investigated during this study was calculated by using both a probabilistic and deterministic 
approach.  The deterministic or point-estimate approach is traditionally present in exposure 
assessments.  The risk from a substance is estimated to a value that ensures protection for most of 
the population but in most cases can overestimate the actual exposure.  Probabilistic approaches 
take into consideration variability in the data and employ mathematical tools, such as the Monte 
Carlo simulations (BfR, 2014), to ascertain probability distributions.  Probabilistic models 
encompass a wider distribution, with intakes among groups of individuals within a population, 
consideration for variability within the food consumed and consumption patterns, and the 
occurrence of PAs in foods containing honey.  The exposure assessment accounts for every 
variable and weights the outcomes by the probability of its occurrence.  The consumption intakes 
were obtained from the Irish Universities Nutrition Alliance (IUNA) who possess an extensive 
collection of national nutritional surveys.  Thus, using a modelling software package such as 
Creme (operated by our research collaborators at UCD), large scale consumption data sets, 
chemical concentration data (as compiled within this study), recipe and detailed food group data 
are combined.  This allows the user to conduct an accurate risk exposure assessment for any 
given population.   
 
Table 4.0 summarises the probabilistic estimated daily intakes of the sum of PAs for adults, 
teenagers and children in Ireland who consume honey (or foods with honey listed as an 
ingredient) contaminated with the PA-levels detected in the survey.  
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  Daily exposure to PAs and PANOs (µg kg-1 bw day-1) 
Population 
Mean P95 
LB UB LB UB 
Adults 0.0023 0.0046 0.0127 0.0196 
Teenagers 0.0022 0.0046 0.0117 0.0213 
Children 0.0054 0.0037 0.0264 0.0157 
Abbreviations: P95 = 95th Percentile, LB = lower bound, UB = upper bound. 
 
Table 4.0: Summary of the estimated daily intakes of the sum of PAs (µg kg-1 bw day-1) for 
adults, teenagers and children in Ireland who consume honey (or foods with honey as an 
ingredient from IUNA dietary surveys). 
 
 
The calculated PA exposure for the 95th percentile (top 5% consumption-wise) for adults, 
teenagers and children all exceed the recommended maximum intake limit of 0.007 µg kg-1 bw 
day-1.  Figure 4.2 displays the total sum concentration (µg) of PAs per 20 g of the honeys 
determined as positive (n = 90) in relation to the maximum intake limit (0.007 µg kg-1 bw day-1).   
 
Figure 4.2: The total sum concentration (µg) of PAs and PANOs per 20 g of positive honey (n = 
90) in relation to the maximum intake limit (0.007 µg kg-1 bw day-1) proposed by EFSA (2011).  
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The results of the upper bound (UB) scenario (Table 4.0) give the worst case PA exposure for the 
Irish population based upon the PA analyses in honey marketed in Ireland over the period 2008–
2012 and food consumption data derived from the Irish Universities Nutrition Alliance (IUNA, 
2012).  It should be noted however, that both the LB and UB scenarios for the mean data could 
also exceed the recommended maximum intake levels as these calculations are based solely on 
the consumption of honey and products which contain honey as listed in the food group data 
from the IUNA dietary surveys.  The estimations do not include other possible PA-containing 
foods such as herbal teas and herbal products as discussed in chapter 5 of this thesis.  Further 
data on PA-containing foods could be added to this model to facilitate a more thorough risk 
assessment for PAs in the food-chain within Ireland. 
 
4.2.4 Isocratic Method for PAs 
This experimental work developed the first isocratic method for PAs and PANOs.  It was applied 
to Australian retail honeys.  The aims of this work were two-fold; firstly to develop a reliable and 
rapid detection method for PAs and PANOs and secondly to profile Australian honeys.  The 
isocratic method presented in Griffin et al. (2015) is comparable to the gradient elution method 
presented within this chapter.  The method utilised the same MS conditions as those detailed in 
Griffin et al. (2014a) and LC conditions were modified only in the mobile phase percentage 
composition.  There was no loss of sensitivity or reduction in chromatographic peak shape 
observed.  The significance of isocratic elution is that it allows for shorter analysis times 
facilitating a high-throughput which is particularly advantageous for regulatory testing 
laboratories.  In excess of 200 injections per 24 hours are possible displaying a >50% 
improvement on all previously published methodologies.   
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From the previous survey of retail honeys (n = 369) it was observed that 20% of honeys on sale 
in Ireland originate from Australia and New Zealand.  The honeys tested from this region had 
above average concentrations for PA toxins in comparison to the rest of the world (145 µg kg-1 vs  
81 µg kg-1, total sum of PAs in positive honeys).  Thus, consumption of these honeys could 
negatively impact on the health of an Irish consumer based upon the risk assessment findings.  
Figure 4.3 summarises the positive results (from the survey of 369 honeys) in terms of the 
average PA and PANOs concentration (µg kg-1) versus the percentage of samples positive.  The 
origin of the samples is also displayed.  As can be seen from the overall results, honeys 
originating from Australia contained the highest PA concentration.  The most predominant PAs, 
in both frequency and concentration, were lycopsamine and echimidine detected in 92% and 44% 
of positive honeys, respectively.   
 
 
Figure 4.3: Summary of positive honeys in terms of the average PA and PANOs concentration 
(µg kg-1) versus the percentage of samples positive labelled by country of origin. 
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It was therefore decided to source Australian and New Zealand honeys (n = 59) which were on 
sale in Australian supermarkets to determine if the results for PA-concentration and PA-profile 
were comparable.  A licence for importation was acquired (see Appendix B) from the 
Department of Agriculture, Food and the Marine.  Forty-one samples were positive for PA toxins 
with only 7 of these below the maximum intake limit of 0.007 µg kg-1 bw day-1 based upon an 
adult consuming two tablespoons of honey.  The analysis showed lycopsamine and echimidine 
were predominant, correlating to an earlier finding, and found in 76% and 88% of samples 
respectively.   
 
4.3  Conclusions 
PAs are an emerging risk to the food chain, particularly for high consumers of honey and 
children.  The work contained within this chapter, and over 4 publications, provides quantitative 
data on the occurrence of PAs at the point of consumption within Ireland.  It also determined that 
imported honey from Australia and New Zealand (accounting for approximately 20% of the 
honey market in Ireland) contained high PA concentrations in comparison with honey purchased 
in Ireland originating from other regions of the world.  The number of indigenous honeys on sale 
in Ireland is low but of those tested (n = 19) no PA toxins were detected.  Analytical methods, 
such as those outlined herein, can ensure early detection of potential PA-related risks to the food 
chain and consumer population.  The gradient elution LC-QqQ-MS method is one of the most 
comprehensive methods published on PAs to date.  However, the isocratic method could prove to 
be the method of choice in the future as it provides comparable sensitivity and selectivity to the 
gradient elution method in half the analysis time.  Consequently, this method allows for fast and 
accurate detection of PA toxins in foods. 
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Chapter 5 
Analysis of PAs in Teas and Herbal Products via LC-MS 
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5.0 Analysis of PAs in Teas and Herbal Products via LC-MS  
This chapter contains the publication Griffin CT, Gosetto F, Danaher M, Sabatini S, Furey A. 
(2014). Investigation of targeted pyrrolizidine alkaloids in traditional Chinese medicines and 
selected herbal teas sourced in Ireland using LC-ESI-MS/MS. Food Additives and Contaminants: 
Part A, 31(5); 940-961. 
 
5.1 Aims and Objectives 
The aim of this work was to; 
- develop a sensitive and robust analytical method for the detection of PAs and PANOs in 
herbal products such as teas and traditional Chinese medicines (TCMs), 
- provide a comprehensive validated method including all of the PAs and PANOs reference 
standards commercially available at the time of analysis, 
- apply the method, for the first time, to commercial herbal products sold within Ireland. 
 
5.2 Background  
Hepatotoxicity of herbal products is extensively acknowledged and there is a wealth of reviews 
(Teschke, Frenzel, Schulze and Eickhoff, 2013; Bunchorntavakul and Reddy, 2013; Bent, 2008; 
Stickel et al., 2005) published on the topic.  There has been a significant increase in the use of 
herbal products over the past two decades even though there still exists a lack of scientific 
evidence to establish the safety and efficacy of some herbal products (Bent, 2008; Stickel et al., 
2005).  From an extensive literature review it was noted that there was a dearth of analytical and 
quantitative research of PAs within commercial herbal products.  This ranged from inadequate 
method validation, quantitation of results, and presentation of chromatograms to the testing of a 
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limited number of commercial products.  Thus, the aim of this work was to bridge this analytical 
gap by providing a fully validated and comprehensive method for the testing of PAs and PANOs 
in herbal products and applying the method to herbal teas and TCMs commercially available 
within Ireland.   
 
Within this chapter’s published journal article (Griffin et al., 2014a) Table 1 provides a summary 
of the previous literature on the analysis of commercial tea/herbal products.  Herbal teas have 
been shown to contain PAs (Huxtable, 1980) including traditional “bush” teas (Stuart and Bras, 
1955; Fragoso-Serrano et al., 2012), TCMs (Fu et al., 2002; Zhou et al., 2013) and dietary 
supplements (Ridker et al., 1985; Betz et al., 1994) and in certain reports PA toxicity resulted in 
acute poisonings (Roulet et al., 1988; Bach et al., 1989).  The majority of previous investigations 
focused on the raw plant species contained within a herbal product rather than analysing the 
commercial goods themselves (Li et al., 2008; Zhang et al., 2008; Qi et al., 2009; Tang et al., 
2012; Windono et al., 2012).  There have been only a limited number of commercial products 
tested for PAs; some quantitatively (Gray et al., 2004; Oberlies et al., 2004) and others for PA 
identification only (Wuilloud et al., 2004; Ruan et al., 2012; Bosi et al., 2013).  As with other 
experimental work presented within this research it was important to test commercially available 
herbal products at the point of consumption for PAs, to determine the quantity of PAs reaching 
the consumer.   
 
5.3 Discussion 
5.3.1 Herbal Teas 
Teas were chosen based upon the likelihood of containing PAs and/or PANOs.  For example, 
‘Camomile & Honey’ as it has been demonstrated that PA contamination of honey, when used as 
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an ingredient, can infiltrate and persist in products further along the food chain (Kempf et al., 
2011a).  The authors demonstrated that mead and candy contained PAs, up to 0.5 and 0.04 µg g-1 
respectively, from the honey ingredient used to produce these products even though they have 
undergone treatments such as dilution, fermentation and heating.  Another tea was marketed as a 
“slimming aid” and due to previous publications on comfrey (Symphytum officinale), a PA-
containing plant, being used as a digestive and slimming remedy this tea was selected.  In total 
18 herbal teas were purchased from supermarkets, health and Asian food stores. 
 
Figure 5.0 provides a flow diagram for the sample preparation method.  This extraction and 
clean-up protocol was developed using knowledge acquired in processing honey samples.  The 
SPE protocol is identical to that used for honeys except for a slightly stronger eluting solvent (5% 
ammoniated methanol versus 3% for honeys as per Figure 3.3).  This was purely to ensure full 
recovery of potential PA analytes as the aqueous wash step appeared to eliminate the majority of 
matrix interferences.  The acid extraction was optimised to provide the correct ratio between 
sample mass and acidic solvent volume.  The average mass of the contents of one herbal tea bag 
was approximately 1.5 g (± 0.1 g) and so this mass was chosen for the extraction protocol.  Trial 
extractions were conducted using a representative sample to prove that the mass and 
homogenisation times were adequate for the protocol.  Previous publications tend to use Soxhlet 
extraction with long extraction times (generally 2 hours) or liquid-liquid extraction involving the 
use of harmful chemicals (halogenated or ozone depletors).  The use of a simple acidic extraction 
followed by SCX-SPE clean-up provides a quicker, safer, cheaper and more sensitive method of 
determining PAs and PANOs in herbal teas.   
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Figure 5.0: Flow diagram for the sample preparation of herbal teas and TCMs (extraction 
followed by SCX-SPE). 
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The results were enlightening, in that nine of the 18 teas tested positive (50%) for one or more 
PAs/PANOs included within the targeted study.  The PA-content ranged from 10 to 1733 µg kg-1 
(dry weight).  Table 4 in the enclosed publication provides a full listing for all 18 herbal teas 
tested.  Tea #11 was marketed by the manufacturer as a “digestive aid” to help “alleviate 
intestinal problems” but no ingredients were given on the packaging.  This tea had the highest 
PA-content and was positive for six of the 14 PAs and PANOs tested for.  In drinking one cup of 
this tea the consumer could potentially ingest 2.16 µg of toxic PAs which is over 4 times the 
recommended maximum intake limit suggested by EFSA (2011).  Figure 4 (of the publication) 
displays the total sum of PAs and PANOs from this study in each sample based on a 3-cup intake 
per day with respect to the daily maximum intake limit suggested by EFSA (2011).   
 
Tea #3 had a PA-content of 29 µg kg-1 containing lycopsamine and senecionine.  The tea was 
classified by the manufacturer as an expectorant with black cohosh and elecampane listed among 
its ingredients.  Elecampane (Inula helenium) is a member of the Asteraceae plant family, a 
family which contains many PA-containing plants although elecampane has not been analysed 
for the presence of PAs.  Therefore, the PAs detected in this tea could potentially have come 
from Elecampane (Inula helenium).  Black cohosh, in particular the rhizomes of Cimicifuga 
racemosa or Actaea racemosa, has been used by herbalists to treat symptoms of menopause but 
has been linked with herbal hepatotoxicity.  In a publication by Borrelli and Ernst (2008) the 
authors describe how an extensive systematic literature search was conducted in order to 
investigate a potential link between black cohosh and hepatotoxicity.  The authors concluded that 
clinical studies suggested that black cohosh was safe but causal attribution was problematic.  
Since black cohosh has been associated with hepatotoxicity further investigation of this herb is 
required.  Similar to black cohosh, chronic toxicity from PAs is difficult to definitively prove as 
there is usually a time lapse in patient diagnosis.  There can also be a failure to investigate and 
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identify herbal products consumed by the patient, insufficient ingredient listing on the herbal 
product(s) consumed, co-medication with synthetic or dietary herbal supplements and deficient 
documentation and/or reporting of such cases.  Therefore, a consumer of tea #3 which contains 
toxic PAs (lycopsamine and senecionine) may also be consuming other potentially hepatotoxic 
herbs in black cohosh. 
 
Tea #13 was branded as ‘Camomile & Spearmint’ which are not known to contain PAs (no 
previous literature on possible PA-content) and had no other ingredients listed on the packaging 
yet this tea was positive for seven of the 14 PAs and PANOs tested for within this study.  By 
using identification points (IPs), as explained in the publication herein, to monitor a parent ion 
and two daughter ions per target analyte they can ensure accurate detection of PAs using 
relatively lower resolution MS instruments such as a QqQ (as opposed to QTOF or Orbitrap).  
Figure 5.1: illustrates the match for both retention time and 3 daughter ion transitions for the PA 
senecionine detected in tea #13 to the relevant reference standard.  Given that the method has 
proven accuracy it can only be assumed that either (i) quality control was seriously lacking and 
significant contamination with PA-containing plants occurred, (ii) a PA-containing plant was also 
used in the production of this tea but the plant was not listed as an ingredient, or (iii) Camomile 
or Spearmint contain PAs.  There is no published literature to demonstrate that either plant 
contains PAs but Camomile is a member of the Asteraceae family which harbours other plants 
that contain PAs.  Tea #6 branded as ‘Rooibos’ or “Red Bush” is produced from Aspalathus 
linearis, a member of the Fabaceae family, and was found to contain six of the fourteen PAs and 
PANOs tested for within this study.  The Fabaceae family contains the tribe Crotalarieae and are 
known to contain PAs.  Tea #10 was marketed as a “slimmer’s aid” and had the main ingredients 
listed as senna leaf, frangula bark, hibiscus flowers and goldenrod herb. 
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Figure 5.1: Comparison of tea #13 containing the PA senecionine to the calibration standard 
illustrating the match for both retention time and SRM transitions of 3 daughter ions with 
identical ion ratios. 
 
 
 
Figure 5.2: Visual similarities between the flowers of European goldenrod (Solidago virgaurea) 
and ragwort (Senecio jacobaea).  There is a notable difference in their leaf structure (photographs 
contain copyright information).  
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Interestingly, goldenrod herb (Solidago virgaurea L.) from the Asteraceae family has very 
similar flowers to that of ragwort (Senecio jacobaea) whose tribe Senecioneae is also a member 
of the Asteraceae family (Figure 5.3).  However, the PAs detected in this tea originate from the 
Crotalarieae genus of the Fabaceae family which would indicate poor quality control or 
agricultural practices.  Quality control and standardisation practices play a pivotal role in 
guaranteeing the quality of herbal preparations and Good Agricultural Practices (GAP) are 
integral to this (Folashade et al., 2012). 
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5.3.2 TCMs 
Fifty-four TCMs were tested within this study, all of which were readily available from retail 
outlets trading solely in TCMs.  A total listing of all TCMs is provided in Table 5 of the enclosed 
publication.  The majority of TCMs tested (89%) were in tablet form consisting of hard coated 
pellets, as those depicted in Figure 5.3.   
 
Figure 5.3: Typical TCM pills investigated during this study (photographs obtained from 
http:\\www.acupunctureaz.us, 2013). 
 
The recommended daily dose on the majority of TCM products tested was 8 pellets or pills which 
equated to 0.5 g (± 0.05 g).  Sample preparation involved the same protocol as that used for teas 
(section 5.3.1).  Trial extractions were conducted using a representative sample of TCM pellets to 
prove that the mass of 0.5 g (equivalent to a daily dose) and homogenisation times were adequate 
for the protocol.  From the 54 samples tested 78% (n = 42) were positive for one or more of the 
PAs and/or PANOs included in this targeted study.  In the positive samples the total PA-content 
ranged from 13 to 3668 µg kg-1 (dry weight).  Similar to the data provided for herbal teas, Table 
5 and Figure 6 of the enclosed publication displays the listing for all 54 TCMs and a graph 
illustrating those positive samples which exceeded the maximum daily intake limit proposed by 
EFSA (2011).   
 
From the results of the study there were notable variations between both brands and batches.  For 
example, Ba Zhen Wan (samples #19 and #51) used for gynecopathy and anaemia were different 
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brands and varied in concentration from 644 to 16 μg kg-1, respectively, while samples #4 and 
#38 were from the same manufacturer but varied in detected concentrations of 0 (< LOD) and 65 
μg kg-1, respectively.  Among the listed ingredients for this product was Bai Zhu, the rhizomes of 
Atractylodes lancea, belonging to the Asteraceae family of which many members contain PAs.  
However, from a literature search there were no publications detailing investigations of this 
particular plant (Atractylodes lancea) for PAs.  Samples #12 and #16 named ‘Long Dan Xie Gan 
Wan’ were sourced from different suppliers but had concentrations of 0 (< LOD) and 1918 μg 
kg-1, respectively.  Figure 5.4 displays (a) the TIC obtained for TCM sample #12 in which four 
PAs are visible and (b) an overlay for the individual SRM chromatograms.   
 
Qing Re An Cang Wan, Xie Gan Wan and Long Dan Xie Gan Wan samples were tested by the 
Medicines and Healthcare products Regulatory Agency (MHRA) in 2007 and seized due to the 
presence of aristolochia.  This plant species contains acids which are known carcinogens and are 
responsible for renal failure yet Aristolochia was not listed among the ingredients information 
(MHRA, 2007).  The Health Products Regulatory Authority (HPRA), formerly the Irish 
Medicines Board (IMB), have also issued advisory warnings on TCMs containing undeclared 
prescription Active Pharmaceutical Ingredients (APIs) and heavy metals (HPRA, 2005; HPRA, 
2007).  The HPRA were notified by the New Zealand Medicines Agency that two named Chinese 
herbal products (Nasutra and Dai Hua Jiao Nang) may contain undeclared prescription APIs; 
sildenafil citrate (approximate content 35 mg) which is commonly known as Viagra and 
sibutramine, a diet aid (approximate content 15mg).  Similarly, the HPRA were contacted by the 
MHRA in the U.K. due to an unannounced inspection and testing of products from a traditional 
Chinese medicines supplier.  The product (Fufang Lu Hui Jiaonang) contained extremely high 
mercury levels, in fact 117,000 times more than is allowable in food substances in the U.K. 
(MHRA, 2006).    
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Thus consumers may be at risk of more than PAs and associated toxicity resulting from the 
ingestion of these products may have had any PA-content masked by other health damaging 
compounds. 
 
 
 
Figure 5.4: (a) LC-MS/MS TIC chromatogram of TCM sample #12, and (b) LC-MS/MS SRM 
displaying the detected PAs; (1; Rt 3.12 min) lycopsamine 31 µg kg-1, (2; Rt 5.65 min) heliotrine 
107 µg kg-1, (3; Rt 8.36 min) senecionine 43 µg kg-1, (4; Rt 9.36 min) senkirkine 1737 µg kg-1. 
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5.4  Conclusion 
The safety and efficacy of some herbal products have yet to be proven.  The term ‘Natural’ does 
not necessarily indicate that the product is safe.  The herbal teas and TCMs listed as positive for 
PAs and/or PANOs in this study could potentially contain other hepatotoxic and carcinogenic 
compounds, which are not included in this targeted study, and would lead to an increase in their 
overall toxicity. 
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pyrrolizidine alkaloids in traditional Chinese medicines and selected herbal teas sourced in 
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Chapter 6 
Analysis of PAs in milk and cheese via LC-MS 
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6.0 Analysis of PAs in Milk and Cheese via LC-MS 
6.1 Aims and Objectives  
The aims of this work were to; 
- apply the previously developed extraction, SPE clean-up and LC-MS/MS method to milk and 
cheese samples for the detection of PAs and PANOs, 
- determine if PAs are present in commercial milk and cheese samples as previous research 
groups have conducted dose feeding studies only (no previous publications of the analysis of 
PAs in commercial milk or cheese samples), 
- develop a QuEChERS method for the detection of PAs and PANOs in milk and cheese 
samples (based upon the use of this technique in determining veterinary residues, such as 
anthelmintics or flukicides, in milk and cheese).  This represents a new application of 
QuEChERS as the technique had yet to be applied to PAs. 
 
6.2 Introduction 
Pyrrolizidine alkaloids (PAs) can be transferred into the milk of livestock who consume or graze 
inadvertently on PA-containing plants.  Excretion of PAs into milk by lactating cattle is 
considered to be negligible (having low PA concentrations, possibly 0.1% carryover from PA-
contaminated feed to milk) but the risk to human health should not be overlooked (Panter and 
James, 1990; Hoogenboom et al., 2011), particularly since the lactating animal may not show 
signs of alkaloidosis.  Studies have been conducted on the transfer of PAs into milk.  Deinzer et 
al. (1982) analysed milk from goats fed Senecio jacobaea (ragwort) flowering tops at a dosage 
level of 1% of their body weight per day.  The alkaloids were extracted through reflux, with 
clean-up by C18 column, followed by analysis via GC-MS.  The PA content was deemed to range 
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between 0.33 to 0.81 mg L-1 resulting in 0.1% of PAs which were ingested being carried over 
into milk.  Dickinson et al. (1976), in a similar study, detected PAs from 0.094 to 0.167 mg L-1 in 
milk from cows who had ingested ragwort at a dosage of 10 g kg-1 bw day-1 for a duration of 2 
weeks.  However, the percentage recovery for the method (a colourimetric test developed by 
Mattocks, 1967) was quoted at 20% and thus the authors stated that values should be multiplied 
by a factor of 5 to adjust for actual content.  Taking this percentage recovery into consideration 
the concentration of PAs detected range from 0.47 to 0.84 mg L-1, correlating to those reported 
by Deinzer et al. (1982).  Candrian et al. (1991) monitored the PA transfer into milk from a 
single dose of [3H] seneciphylline given at 1 mg kg bw-1 to dairy cows.  It was determined that 
0.16% of the dose was excreted into milk, comparable to 0.1% reported by Deinzer et al. (1982). 
 
Ingestion of PA-containing plants resulting in acute toxicity is relatively infrequent.  In general, 
PA toxicosis is of a chronic nature and delayed manifestation of the toxicosis is common 
(Molyneux et al., 1988).  Lactating animals ingesting PAs over a period of time can transfer them 
into milk without any overt signs of toxicity in the animal (Panter and James, 1990).  The chronic 
lethal dose of ragwort to cattle was estimated to be 2.5 mg kg-1 bw day-1 for 18 to 20 days 
(Johnson, 1976).  In another study (Goeger et al., 1982) this estimation ranged from 50 to 200 g 
kg-1 bw for cattle and horses which are more susceptible than goats at 1.25 to 4.04 kg kg-1 bw.  
Cattle and horses can be 14 times more sensitive than sheep and goats to PA toxicity, whereas 
pigs are 200 times more sensitive than sheep and goats (Hooper, 1978). 
 
Investigations have been conducted into the stability of PAs in hay, silage and animal feed.  PAs 
are bitter tasting and would normally be avoided by cattle.  However, when cut and dried, PA-
containing plants such as Senecio jacobaea, can become more palatable and hence dangerous in 
fodder.  PAs of Senecio alpines were the cause of alkaloidosis in Swiss livestock with 
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seneciphylline detected as the major PA constituent (Lüthy et al., 1981).  Candrian et al. (1984) 
measured the decomposition of PAs from Senecio alpines using GC-FID and GC-MS and 
quantified using the PA seneciphylline.  The authors reported that the PA content of hay 
remained constant over the 2 month testing period whilst in silage PAs decomposed significantly 
but the degradation was less complete at lower concentration ranges.  The authors concluded that 
decomposition of PAs in silage was not significant enough to render it safe for fodder (silage 
contaminated with 3.5 to 23% of Senecio alpines still contained 20 mg kg-1, wet weight).  In a 
later study (Crews et al., 2009) the decomposition of Senecio jacobaea (ragwort) and its PA 
levels were analysed using LC-TOF-MS.  Plants were composted in black bin liners in direct 
sunlight using thermal and microbiological breakdown.  Every 2 weeks for 14 weeks a plant 
sample was removed, freeze dried, Soxhlet extraction with methanol performed overnight before 
direct injection onto the LC-MS.  The authors’ findings indicated that free tertiary PAs were not 
as quick to decompose as PANOs and that over an 8 week period the total sum of PAs decreased 
from 340 to 6 mg kg-1.  Hough et al. (2010) also looked at the degradation of PAs, along with 
yew and rhododendron which are toxic to livestock.  It was observed that jacobine and its N-
oxide showed degradation whilst seneciphylline and senecionine were more persistent.  This 
study also determined that as the free tertiary PAs degraded the PANOs did not increase, 
indicating that decomposition is not via oxidation.  Thus, depending upon the PA-plant present 
and the time given for decomposition results can vary.   
 
In a Dutch National Monitoring Program for animal feeds (Mulder et al., 2009) 147 samples 
underwent screening for 40 PAs using LC-MS/MS.  Samples were classified as either silage, hay, 
grass (dried) or alfalfa.  For both grass and hay results the risk of contamination with PAs was 
deemed small as the samples had trace levels below 10 and 15 µg kg-1, respectively, and thus not 
likely to present a risk to animals or humans through milk consumption.  Only one hay sample 
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had a significant amount of PAs, 549 µg kg-1, produced from a nature reserve area.  The authors 
state that nature reserve areas may be more prone to contamination with ragwort species than 
plots that are in regular use for agriculture (due to pasture management).  In contrast, the average 
PA concentration in alfalfa samples (Lucerne, a livestock fodder) was 455 μg kg-1, approximately 
30-fold higher than the average for grass and hay.  Most of these samples had the same PA 
profile originating from Senecio vulgaris (groundsel).  Alfalfa (Medicago sativa) belongs to the 
Fabaceae family and is an important agricultural crop.  The authors recommended that the 
production of alfalfa, in particular commercial products, should be monitored more carefully.  
The authors also stated that the Council Directive 2002/32/EC (2002) on undesirable substances 
in animal feed focuses mainly on toxic seeds of alkaloid containing plants, without specifically 
mentioning Senecio species (Mulder et al., 2009). 
 
The objective of this research was to determine if PAs and their PANOs could be detected in 
milk and cheese from retail products.  Previous experimental feeding studies where animals are 
purposely fed PA containing plants have proven that PAs and PANOs can be transferred to the 
animals’ milk.  However, there are no previous studies on commercial milk or cheese in 
published literature and hence it has not been determined if the population is exposed to PAs 
through these foods.  A previously developed extraction, SPE clean-up and LC-MS/MS method 
for honey was applied to milk and cheese samples.  Also, a new QuEChERS method was 
developed based upon the AOAC 2007.01 method for pesticide residues in foods.  QuEChERS 
has been applied by regulatory labs for determining veterinary residues in milk and cheese 
(Kinsella et al., 2009; Whelan et al., 2010) and thus could be adapted to the detection of PAs and 
PANOs. 
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6.3 Experimental 
6.3.1. Chemicals and reagents 
Methanol, acetonitrile and water, all of HPLC grade, were obtained from Fisher Scientific 
(Dublin, Ireland).  Formic acid (99–100% purity) was purchased from Reagecon Ltd. (Co. Clare, 
Shannon, Ireland).  Sulphuric acid (98%) and ammonium hydroxide (33% NH3 in H2O) were 
acquired from Sigma Aldrich (Wicklow, Ireland).  Polymeric SPE cartridges, StrataTM-X-C 33 
µm (60 mg, 3 mL), were purchased from Phenomenex Inc. (Macclesfield, Cheshire, UK), 0.22 
μm PTFE Chromacol syringe filters and centrifuge tubes (50 mL) from Lab Unlimited (Dublin, 
Ireland).  Enviro-clean® sachets (mylar pouch) of magnesium sulphate (6 g) and sodium acetate 
(1.5 g) were obtained from UCT (Bristol, Pennsylvania, U.S.) and dSPE tubes (15 mL) 
containing PSA, carbon and magnesium sulphate from Agilent Technologies (Cork, Ireland). 
 
Pyrrolizidine alkaloids and pyrrolizidine alkaloid N-oxides were purchased from Sigma Aldrich, 
Ireland (crotaline, retrorsine and senecionine); Carl Roth, Germany (seneciphylline and 
senkirkine); PhytoLab, Germany (echimidine, lycopsamine, otosenine, crotaline N-oxide, 
retrorsine N-oxide, seneciphylline N-oxide and senecionine N-oxide) and Latoxan, France 
(heliotrine and trichodesmine). 
6.3.2 Samples 
Commercial goats milk samples (n = 12) were purchased from supermarkets (n = 9; 75%) and 
health food stores (n = 3; 25%).  Goat milk samples (n = 36) were supplied from a goat farm in 
Northern Ireland via Dr. Steven Crooks (Agri-Food and Biosciences Institute, Veterinary 
Sciences Division, Stormont, Belfast).  Commercial cheese samples (n = 72) were purchased 
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from supermarkets (n = 36; 50%), health food stores (n = 33; 46%), local farmers markets (n = 2; 
3%) and greengrocers (n = 1; 1%). 
6.3.3 Preparation of reference standards and controls 
All PA and PANO reference standard solutions were prepared at a concentration of 1 mg mL-1 
from dilution of suppliers vials using HPLC grade methanol.  These solutions were dried under 
nitrogen (>98% purity) and stored at -20oC.  From these, weekly working standards were 
prepared by serial dilution and stored between 2 and 4°C in solution (HPLC grade MeOH). 
 
A milk sample that did not contain detectable levels of PAs or PANOs was used as a negative 
control. This sample was extracted and subjected to both SCX-SPE and QuEChERS using the 
procedures outlined in Section 6.3.5.  The extract was fortified with PAs and PANOs at two 
known concentration levels, 35.7 and 71.4 µg L-1 , to act as controls.  A seven-point calibration 
curve was prepared in methanol ranging from 7.1 to 357.1 µg L-1. All samples were quantified 
against the individual PA or PANO calibration plots produced from the reference standards. 
6.3.4 Instrumental Analysis 
An Accela LC system consisting of a quaternary pump, thermostat autosampler, degasser and 
column heater was hyphenated to a triple quadrupole (QqQ) TSQ Quantum Discovery Max mass 
spectrometer (Thermo Scientific, Hemel Hempstead, UK). The instrument was controlled by 
Thermo Scientific Xcalibur 2.0 software.  Chromatographic analysis was performed using a 
Kinetex PFP core-shell column (150 × 2.1 mm, 2.6 μm particle size) protected with a 
KrudKatcherTM in-line filter (Phenomenex Inc.). The column was maintained at 35°C (± 1°C) and 
the autosampler at 4oC (± 1°C). The mobile phase was (A) 0.05% formic acid in water with 5% 
acetonitrile and (B) 100% acetonitrile, at a flow rate of 0.2 ml min-1. A gradient elution was used: 
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0–2 min 10% B; 2–8 min linear increase in B from 10 to 25%; 8.5–10.5 min 80% B maintained 
before returning to 10% B which allowed for column equilibration over 10 void volumes prior to 
the next injection (18 minutes at 0.2 mL min-1).  The autosampler needle and loop were washed 
between injections with 80:20 v/v methanol/water in order to remove any possible carryover.  
Both standard and sample injection volumes were 10 µL.  The mass spectrometer was fitted with 
a heated electrospray (HESI) source and operated in positive mode.  The MS acquisition 
parameters for the EZ method in SRM mode (spray voltage, vaporising temperature, gas flow, 
capillary temperature, tube lens voltage, collision energies and SRM transitions) were optimised.  
Optimised parameters are reported in the publication Griffin et al., 2014, Chapter 5. 
6.3.5 Sample Preparation 
Test samples of goat’s milk were selected as Molyneux and James (1990) and Panter and James 
(1990) reported that browsing animal’s milk may contain higher PAs.  All test samples, milk and 
cheese, were stored at -20oC from the day of purchase.  Prior to testing the sample was allowed to 
completely thaw at room temperature.  Two methods of extraction and clean-up were performed; 
acidic extraction followed by SPE sample clean-up and a modified QuEChERS technique as 
described in Chapter 3.  Note that in this instance “modified” refers to the fact that the developed 
QuEChERS method is based upon the AOAC 2007.01 method for pesticide residues in foods 
using acetonitrile for extraction and magnesium sulphate for partitioning. 
6.3.5.1 Extraction followed by SPE 
For milk samples 4.0 mL (± 0.1 mL) was transferred to a 15 mL centrifuge tube with 6.0 mL of 
0.05 M sulphuric acid.  This was based on previous honey sample analysis.  For cheese samples 
2.0 g (± 0.1 g) was weighed into a 15 mL centrifuge tube and 8.0 mL of 0.05 M sulphuric acid 
was added.  Half the quantity, 2.0 g as opposed to 4.0g, was used as the resulting mixture was 
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viscous.  Cheese samples were placed in a water bath at 40oC for 10 minutes in order to 
homogenise the sample.  All tubes were capped, vortexed for 30 seconds and centrifuged at 6,000 
rpm (3,421 g) for 10 min.  The resulting supernatant was transferred to a volumetric flask (10 
mL), adjusting to the mark if necessary with sulphuric acid (0.05 M).  Use of a volumetric flask, 
a method which is not adopted by other publications, ensures that all extracts are of equal volume 
prior to loading onto the SPE cartridge providing more accurate quantification.  A 2.5 mL aliquot 
was applied to a conditioned Strata-X-CTM cartridge.  Potential PAs and/or PANOs were eluted 
with ammoniated methanol (3%; 9 mL) and dried in a turbovap at 45oC under a nitrogen gas 
flow.  Dried extracts were reconstituted in HPLC grade methanol (1.0 mL) and filtered using a 
syringe filter (0.22 µm) directly into a LC amber vial (2 mL).  Figure 6.0 provides a flow 
diagram for the sample preparation method followed by SPE clean-up. 
6.3.5.2 Extraction followed by QuEChERS 
Milk samples (10.0 mL ±0.1 mL) were transferred to 50 mL polypropylene centrifuge tubes (Lab 
Unlimited, Dublin, Ireland).  Cheese samples (4.0 g ± 0.1 g) were weighed into 50 mL 
polypropylene centrifuge tubes and water was added (6.0 mL ±0.1 mL).  Cheese samples were 
warmed in a water bath at 40oC for 10 minutes in order to homogenise and liquefy.  To each 
sample tube 10.0 mL of 1% acetic acid in acetonitrile (v/v) was added and the sample mixture 
vortexed for 30 seconds.  Phase separation was induced by adding the contents of the sample 
tube to a 50 mL tube containing a mixture of 1.5 g sodium acetate, 6 mg of anhydrous 
magnesium sulphate (Enviro-clean® from UCT) and 3.0 mL of 1% acetic acid in acetonitrile.  
Samples were immediately shaken for 1 minute and centrifuged (6000 rpm; 3421 g) for 10 
minutes.  The entire supernatant, approximately 8.0 mL, was poured into a 15 mL centrifuge tube 
containing 150 mg PSA (Primary and Secondary Amine exchange material), 15 mg carbon and 
900 mg of anhydrous magnesium sulphate (dSPE from Agilent Technologies, Cork, Ireland).  
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The samples were vortexed for 30 seconds and centrifuged (6000 rpm; 3421 g) for 10 minutes.  
Two different protocols were employed for the purified supernatant; (A) an aliquot of the 
purified supernatant (1.0 mL) was transferred to a 5.0 mL glass test tube, evaporated under 
nitrogen at 45oC using a turbovap and the dried extract reconstituted in methanol (HPLC grade), 
and (B) a 1.0 mL aliquot of the purified supernatant was taken for direct injection to LC-MS.  In 
both cases, extracts were filtered through a 0.22 µm PTFE 13 mm syringe filter (Chromacol) into 
an amber LC vial.  Figure 6.1 provides a flow diagram for the modified QuEChERS procedure.   
 
To test the recovery of the QuEChERS protocol a blank milk sample, one which was determined 
negative for PAs and PANOs by direct injection into the MS, was fortified with a 100 µg mL-1 
reference PA and PANO mixture at four levels; (i) 500 µL to give 5 µg/10 mL, (ii) 100 µL to 
give 1 µg/10 mL, (iii) 50 µL to give 0.5 µg/10 mL, and (iv) 10 µl to give 0.1 µg/10 mL. 
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 Figure 6.0: Flow diagram for the sample preparation of milk and cheese (extraction followed by 
SCX-SPE).  
Sample Preparation/Extraction
Solid Phase Extraction/Clean-up
Load: 
2.5 mL of sample
Wash (1): 
2 mL 0.1% aq. formic acid
Wash (2): 
2 mL methanol
Elute: 
9mL 3% ammoniated methanol
Centrifuge 6,000 rpm (3,421 g) 10 min
Transfer 10 mL volumetric flask 
(adjust to mark with 0.05M sulphuric 
acid, if necessary)
Strata-X-CTM
60 mg/3 mL cartridge
Condition:
2 mL methanol
Equilibrate:
2 mL deionised water
Dry under N2 in Turbovap (45oC)
Reconstitute in 1.0 mL and 
syringe filter (0.22 µm) to LC vial 
Milk: 4 mL (± 0.1 mL)
+ 6.0 mL 0.05M 
sulphuric acid in 15 mL 
centrifuge tube 
Cheese: 2.0 g (± 0.1 g)
+ 8.0 mL 0.05M 
sulphuric acid in 15 mL 
centrifuge tube 
Vortex 30 sec
Water bath (40oC) 
10 min to allow for 
homogenisation
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 Figure 6.1: Flow diagram for the sample preparation of milk and cheese by modified 
QuEChERS. 
Add 10.0 mL of 1% acetic 
acid in acetonitrile
Vortex 30 sec Add test sample
Shake vigorously 1 min
Shake vigorously 1 min
Centrifuge 6,000 rpm (3,421 g) 10 min
Decant supernatant (~ 8 mL) 
to dSPE clean-up tube
dSPE 15 mL tube; 150 mg PSA 
+ 15 mg C + 900 mg MgSO4
Vortex 30 sec
Centrifuge 6,000 rpm (3,421 g) 10 min
Add to 50 mL tube 1.5 g sodium 
acetate + 6 mg MgSO4 + 3 mL of 
1% acetic acid in acetonitrile
Transfer 10.0 mL 
milk to 50 mL 
centrifuge tube
Transfer 4.0 g of cheese 
+ 6.0 mL water in a 50 
mL centrifuge tube
Water bath (40oC) 
10 min to allow for 
homogenisation
From supernatant (~ 7 mL)
1.0 mL transferred to test tube, dried in 
Turbovap under N2 @ 45oC, and 
reconstituted in 1.0 mL MeOH
Syringe filter (0.22 µm) to LC vial 
A B
Sample Preparation/Extraction
Modified QuEChERS & dSPE
1.0 mL
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Table 6.0: Methods of detection for PAs (and PANOs) in milk and in animal feeds. 
Sample matrix Sample preparation Detection methods PA analytes 
detected 
Comments Reference 
PA feeding study in cows 
(with S.jacobaea) 
LLE, reduction and 
SPE 
LC-MS/MS Jacoline, jacobine, 
jaconine, senkirkine, 
otosenine, 
florosenine 
0.1% of initial dose detected 
in milk except for jacobine 
yielding a result of 4% 
Hoogenboom et al., 
2011 
PAs in animal forage Freeze-dried, SPE, and 
LLE for reduction of 
PAs to PANOs 
LC-MS/MS Various PA and 
PANO profiles 
(15 PAs and their N-
oxides) 
0 – 5.4 mg/kg (hay or silage, 
identification of some PAs 
and PANOs as equivalents) 
Mulder et al., 2009 
Orally administered [3H] 
seneciphylline in cows 
milk 
LLE, prep. column 
chromatography 
TLC and HPLC Seneciphylline 0.16% of initial dose 
detected in milk samples 
Candrian et al., 1991 
Senecio alpines in hay 
and silage 
LLE and reduction TLC, GC with FID and 
MS 
15 PAs  
(including isomers) 
13 - 4000 mg/kg detected in 
spiked hay and silage 
samples 
Candrian et al., 1984 
Goats milk spiked with 
tansy ragwort 
Reflux followed by 
ion-exchange and C18 
RP prep. column 
chromatography 
GC with  
63Ni-ECD 
Jacobine 0.33 - 0.81mg/L (milk) Deinzer et al., 1982 
Senecio alpines in hay 
and silage 
Soxhlet, LLE and 
reduction 
GC-MS Seneciphylline, 
senecionine, 
integerrimine, 
jacozine, jacobine, 
jaconine, jaconine 
0.5 mg/L detected in urine, 
milk not tested 
(identification based upon 
MS in literature)   
Lüthy et al., 1981 
PA feeding study in cows N.R. N.R. Jacoline detected  
in milk 
Chromatographic methods 
not described 
Dickinson et al., 
1976 
N.R. = Not Reported 
 
 
6.4 Results and Discussion  
Table 6.0 provides a summary of known publications to date on the investigation of PAs (and 
their N-oxides) in milk and animal feeds.  As can be seen, there have been no previous 
investigations into commercial milk or cheese samples.  Therefore, it was important to determine 
if PAs could be detected in such samples.  All research relates to spiked feeding studies or the 
contamination of animal feed or fodder.  It has been estimated that 0.1 to 0.16% of PAs in 
contaminated feed have been carried over into milk (Hoogenboom et al., 2011; Candrian et al., 
1991).  Using data from the animal feeds study by Mulder et al. (2009) this would equate to 0.2 
µg L-1 (or 0.04 µg per glass of milk, 200 mL).  This figure is obtained by taking the mass of an 
average dairy cow as 450 kg, a feeding rate of 1% of their body mass being 4.5 kg, considering 
the detection result of 455 µg of PAs per kg (giving approximately 2000 µg) and a carryover of 
0.1% (2000 µg x 0.1% = 0.2 µg L-1).  This result is far less than those reported by Dickinson et 
al. (1976) and Deinzer et al. (1982) of up to 0.167 mg L-1 and 0.81 mg L-1, respectively. 
 
All previous sample preparation utilised the traditional PA extraction methods of liquid-liquid 
extraction (LLE) or Soxhlet followed by reduction over zinc for N-oxide determination.  
Detection methods generally employed LC-MS or GC-MS for PA analytes from the Senecio 
genus. 
6.4.1 Method development 
LC-MS/MS conditions 
The LC-MS/MS method development and optimisation has been previously discussed in Griffin 
et al., 2014a and Chapter 5.  The samples were identified based on equivalence to the individual 
reference standards (with matrix-matched calibration curves) by (i) retention times of ± 0.2 
minutes and (ii) mass spectra of target ion ratios for the quantifier and qualifier ions being ± 
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20%.  Identification relies upon the correct selection of diagnostic ions.  This was achieved using 
the Thermo Scientific TSQ Quantum Discovery MAX software which captures the [M+H]+ ion 
while altering the collision energy to produce product ions.  The optimisation software was set to 
average the results of 5 plots.  A representative plot illustrating the fragment ions and collision 
energy is shown in Figure 6.2 for the PA seneciphylline.  This was obtained by post-column 
infusion as explained in Chapter 3; QqQ-MS Tuning (Appendix A contains plots for all PAs and 
PANOs).  Using a tighter tolerance of ± 20% for MS/MS ion ratios than that proposed by the 
European Commission for safety in the food chain (2013) of 30% reduces the likelihood of false 
positive results.  Figure 6.3 illustrates how both parameters had to be met before a test sample 
would be recorded as positive for PAs and/or PANOs. 
 
 
 
Figure 6.2: Plot for seneciphylline (m/z 334) illustrating the optimised fragment ions and 
collision energies. 
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Sample preparation  
The extraction and SCX-SPE clean-up procedure employed for milk and cheese, as per Figure 
6.0, was similar to that applied to honeys and discussed in Chapters 3 and 4.  An identical SPE 
protocol was used.  The only difference between the methods is the ratio of sample mass to 
solvent volume during the acidic extraction step.  For example, 4 g of cheese to 6 mL of acid 
produced too viscous an extract (4 g used for honeys). Therefore the mass was halved.  
QuEChERS application was first published by Anastassiades and Lehotay et al. (2003) for the 
application of pesticide detection in food and since then it has become a popular extraction and 
clean-up methodology.  It is primarily used for pesticide residues in fruits and vegetables.  
However, our research collaborators found that QuEChERS could be applied to other matrices 
such as milk, liver and muscle tissues for the detection of veterinary residues (Kinsella et al., 
2009; Whelan et al., 2010).  The advantage of QuEChERS is that it combines several steps, 
reduces reagent and solvent costs and usage, and it requires little instrumentation and bench 
space.  The method, as per Figure 6.1, was optimised in order to avoid excessive protein crash 
out/precipitation from the dairy produce in acetonitrile and minimise the affinity polar 
compounds (analytes in this case) have for the aqueous phase by reducing the salt levels.  The 
method used here is one of many possible variations based upon the AOAC 2007.01 method for 
pesticide residues in foods using acetonitrile for extraction and magnesium sulphate for 
partitioning.  The use of 1% acetic acid in acetonitrile and sodium acetate buffer is to protect 
alkaline compounds from degradation.  
6.4.2 Method Performance 
Linearity 
Calibration curves for all 10 free tertiary PAs and 4 PANOs ranged in concentration from 3.57 to 
357.14 µg L-1 over 7-points and were prepared in (i) methanol and (ii) blank milk extract.  Each 
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concentration level was injected in triplicate in one day and for three consecutive days ensuring 
repeatability for all analytes.  The average correlation coefficient (R) for curves prepared in 
methanol was 0.9982 and for curves in blank milk extract was 0.9951. 
 
Precision and trueness 
Method precision and trueness were established by using a blank milk extract (from SPE clean-
up) spiked with all reference standards, PAs and PANOs, at two concentration levels, 35.7 and 
71.4 µg L-1. 
 
Precision was determined as intra-day variability of three injections (non-consecutive) at both 
concentration levels analysed in one day and inter-day variability was performed using the higher 
concentration level for six injections (non-consecutive) over 2 days.  Both intra- and inter-day are 
expressed as %RSD.  Blank milk extract from SPE clean-up only was used as there was no 
difference found following post-column infusion studies on LC-MS/MS for the analysis of milk 
versus cheese extracts, or from SPE versus QuEChERS extracts.  Figures 6.6 (a) and (b) display 
results obtained from matrix interference assessments. 
 
Limits of detection (LOD) and quantification (LOQ) 
The average LOD and LOQ determined were in line with those reported in Chapter 5 (Table 3 of 
the publication Griffin et al., 2014b) of 1.1 and 3.5 µg kg-1, respectively. 
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The recoveries (%; n= 3) determined at both concentration levels ranged from 65 to 125% for 
concentration level 35.7 µg L-1 and 73 to 122% for concentration level 71.4 µg L-1.  This 
information is detailed in Table 6.1 and found to be acceptable given the recommended criteria 
from the European Commission (2013) of ≤20% RSD and within a recovery range of 70-120%.  
Recoveries for the fortified QuEChERS samples (PAs spiked into milk and cheese samples prior 
to extraction) at four concentration levels are given in Table 6.2 (a) samples which were dried 
and reconstituted in methanol and (b) samples in which the supernatant from the final clean-up 
were directly filtered into LC vials. 
Compound % Recovery (n = 3) Intra-day (n = 3) %RSD Intra-day (n = 3) 
%RSD 
 
 35.7 
µg L-1 
71.4 
µg L-1 
35.7 
µg L-1 
71.4 
µg L-1 
71.4 
µg L-1 
Crotaline 65 74 6 5 7 
Crotaline N-oxide 77 85 5 7 11 
Echimidine 87 86 12 10 6 
Heliotrine 65 79 9 10 9 
Lycopsamine 79 118 2 5 8 
Otosenine 68 73 11 13 10 
Retrorsine 105 97 8 4 8 
Retrorsine N-oxide 92 91 7 6 12 
Seneciphylline 97 106 4 6 10 
Seneciphylline N-oxide 125 122 9 6 12 
Senecionine  87 82 6 6 8 
Senecionine N-oxide 113 114 9 9 8 
Senkirkine 82 89 8 9 9 
Trichodesmine 99 101 8 10 10 
 
Table 6.1: LC-MS/MS (SRM) validation data for PAs and PANOs in milk (extract via SPE). 
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PA/PANO 
Concentration 
5 µg/10 mL 
(%) 
1 µg/10 mL 
(%) 
0.5 µg/10 mL 
(%) 
0.1 µg/10 mL 
(%) 
Mean  
(%) 
Crotaline 27 22 20 N.D. 23 
Crotaline N-oxide 15 12 13 29 17 
Echimidine 74 70 79 65 72 
Heliotrine 54 52 55 46 52 
Lycopsamine 43 28 23 N.D. 31 
Otosenine 51 51 56 35 48 
Retrorsine 42 40 44 43 42 
Retrorsine N-oxide 26 15 15 26 21 
Seneciphylline 43 39 33 N.D. 38 
Seneciphylline N-oxide 47 34 28 N.D. 36 
Senecionine 49 45 45 N.D. 46 
Senecionine N-oxide 48 34 27 N.D. 36 
Senkirkine 73 74 80 64 73 
Trichodesmine 46 50 45 15 39 
Overall Average 41 
Table 6.2 (a): Recoveries for the fortified QuEChERS samples, at four concentration levels, 
from extracts which were dried and reconstituted in methanol before LC-MS/MS (A from Figure 
6.1). 
 
PA/PANO 
Concentration 
5 µg/10 mL 
(%) 
1 µg/10 mL 
(%) 
0.5 µg/10 mL 
(%) 
0.1 µg/10 mL 
(%) 
Mean  
(%) 
Crotaline 29 25 17 N.D. 24 
Crotaline N-oxide 18 13 12 29 18 
Echimidine 73 76 79 67 74 
Heliotrine 45 46 46 38 44 
Lycopsamine 30 15 N.D. N.D. 23 
Otosenine 51 57 55 33 49 
Retrorsine 37 42 40 43 41 
Retrorsine N-oxide 24 13 13 26 19 
Seneciphylline 38 37 31 N.D. 35 
Seneciphylline N-oxide 46 33 27 N.D. 35 
Senecionine 44 44 41 N.D. 43 
Senecionine N-oxide 43 32 25 N.D. 33 
Senkirkine 65 70 78 66 70 
Trichodesmine 54 57 57 28 49 
Overall Average 40 
Table 6.2 (b): Recoveries for the fortified QuEChERS samples, at four concentration levels, in 
which the supernatant from the final clean-up stage was directly filtered into LC vials for LC-
MS/MS (B from Figure 6.1). 
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Selectivity 
Selectivity was assessed by possible effects of the matrix, both milk and cheese, on the ionisation 
of analytes.  Any change in the mass spectrometry response of an analyte due to component(s) of 
the sample matrix was monitored.  Figure 6.4 displays the (a) chromatogram for the reference 
standards mixture of PAs and PANOs (71.4 µg L-1) prepared in methanol matched to (b) the 
chromatogram obtained for the reference standards of the same concentration spiked into a blank 
milk extract.  As previously discussed in other experimental chapters (3, 4 and 5) ion suppression 
affects the reliability of the analytical result and thus the integrity of the analytical method.  
Matrix-matched calibration curves and post-column infusion studies were performed.  In matrix-
matched calibrations the difference between the slopes of the two linear curves is observed by 
overlaying the reference standard curve prepared in methanol with the standard curve prepared in 
blank extract, as shown in Figure 6.5 for two representative PAs; seneciphylline (m/z 334) and 
senecionine (m/z 336).  This was performed for all PAs and PANOs with no obvious differences. 
 
In performing a post-column infusion study a blank extract (no PAs or PANOs detected) for both 
milk and cheese was monitored for matrix effects.  The PA and PANO reference mixture (71.4 
µg L-1) is introduced via a syringe pump (10 µL min-1) to be ionised concurrently as the matrix 
elutes from the analytical/LC column.  The matrix is injected from the autosampler (10 µL) under 
the normal gradient conditions of the developed method.  Figure 6.6 (a) displays the post-column 
infusion result of a milk extract and Figure 6.6 (b) a cheese extract.  The produced TICs for both 
clearly overlay illustrating that no ion suppression or enhancement was detected. 
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Figure 6.4: (a) LC-MS/MS TIC for the reference standard mixture (71.4 µg L-1); (1; Rt 2.74 
min) crotaline, (2; Rt 3.07 min) lycopsamine, (3; Rt 3.30 min) crotaline N-oxide, (4; Rt 5.10 min) 
retrorsine, (5; Rt 5.67 min) retrorsine N-oxide, (6; Rt 5.86 min) heliotrine, (7; Rt 6.24 min) 
trichodesmine, (8; Rt 6.84 min) otosenine, (9; Rt 6.96 min) seneciphylline, (10; Rt 7.76 min) 
seneciphylline N-oxide, (11; Rt 8.42 min) senecionine, (12; Rt 9.19) senecionine N-oxide, (13; 
Rt 9.30 min) senkirkine, (14; Rt 9.41 min) echimidine, and (b) matched to a negative milk extract 
(post SPE) spiked with the same reference standards (71.4 µg L-1). 
 
 
 
Figure 6.5: Matrix-matched calibration curves for two representative PAs; seneciphylline and 
senecionine. 
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Figure 6.6: (a) Sample matrix ion-suppression (enhancement) assessment; milk extract injection 
(blue TIC), post-column infusion of PA and PANO reference mixture (71.4 µg L-1) while 
simultaneously injecting a blank milk extract (red TIC), and an overlay of a reference mixture of 
PA and PANOs to illustrate the region of elution. 
 
 
Figure 6.6: (b) Sample matrix ion-suppression (enhancement) assessment; cheese extract 
injection (blue TIC) and post-column infusion of PA and PANO reference mixture (71.4 µg L-1) 
while simultaneously injecting a blank cheese extract (red TIC).  
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6.4.3 Screening of Samples 
No positive sample was detected, i.e. one showing the presence of one or more PAs and PANOs 
included in this study above the LOD, among the 48 milk and 72 cheese products.  As previously 
illustrated a 0.1% carryover of PAs into milk may only equate to 0.2 µg L-1.  At this level results 
would be below the LOD for this method (1.1 µg L-1).  It should be noted that previously 
published results (0.167 mg L-1 and 0.81 mg L-1 as presented in Table 6.0) were obtained from 
spiked feeding studies and thus the PA-content in milk would be greater than milk from animals 
under normal grazing conditions.  There are other considerations for commercial samples such as 
batch blending and pasteurisation.  These variables could possibly dilute or decrease the PA-
content in milk and cheese samples.  Also, PA-negative results may be as a result of good pasture 
management and Good Agriculture Practice (GAP) which is adopted in the farming community 
in Ireland.  However, much work is still needed on the investigation of PAs in dairy produce 
(including sheep and goats produce), on the metabolism of PAs ingested by dairy animals and if 
PA-metabolites can accumulate in muscle.  It has been suggested that up to 90% of PA 
metabolites are excreted within 24 hours through the kidneys (Stewart and Steenkamp, 2001).  
This could provide further reasoning for the PA-negative results obtained herein.  The possibility 
of PAs binding to proteins within milk and cheese samples should also be investigated as these 
complexes could be eluted during the wash step of SPE clean-up, retained on the SPE cartridge 
or trapped in the aqueous phase of QuEChERS and thus not detected by the methods reported in 
this investigation. 
 
Test samples of goats’ milk were selected as it had previously been reported that browsing 
animals’ milk may contain higher PAs (Molyneux and James, 1990; Panter and James, 1990).  
The extraction followed by SPE clean-up provided excellent recoveries (91% ± 16% SD) for the 
desired analytes in the milk and cheese matrices.  The SPE cartridge did not experience any 
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blockages although low vacuum was applied to the manifold (< 10 in Hg or 5 psi), particularly 
for cheese samples. 
 
The new application of QuEChERS for PAs and/or PANOs detection would need further 
optimisation as the mean recoveries from the fortified extracts were 41% for those samples 
subjected to drying and reconstitution in methanol prior to analysis (Figure 6.1, route A) and 
40% for those which were directly injected (Figure 6.1, route B).  Modifications can be made by 
adjusting solvents, pH, salts, volumes, water content and clean-up sorbents in the dispersive SPE 
(dSPE) step.  Both sets of recoveries were very similar for all PAs and PANOs included in this 
study.  Therefore, taking the supernatant after dSPE direct to LC-MS/MS analysis would 
eliminate the need for additional work (drying and reconstituting in solvent/methanol).  It was 
also determined that no difference existed between blank milk or cheese extracts obtained via 
SPE clean-up or through QuEChERS (%RSDs were equivalent; 6% determined for QuEChERS 
as opposed to 7% for SPE at the concentration level of 35.7 µg L-1 and 7% versus 8%, 
respectively, for the concentration level of 71.4 µg L-1).  
 
Since the completion of this research work a study on PAs in animal feed using a modified 
QuEChERS procedure has been published (Bolechova et al., 2015).  The authors did not perform 
a dSPE clean-up on the extracts and achieved an average recovery of 72 to 94% at a 5 µg kg-1 
spiking level for five PAs (monocrotaline, retrorsine, seneciphylline, senecionine and 
senkirkine).  Eliminating the dSPE clean-up from the protocol detailed herein could improve the 
percentage recoveries obtained.  Also, the authors did not find the use of sodium chloride 
detrimental to the basic PAs during salting out. 
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6.5  Conclusions 
There were no detectable levels of the ten PAs and four PANOs included in this study in retail 
milk (n = 48) and cheese (n = 72).  This indicates that even if some of the produce originated 
from an animal that had grazed on PA containing plants, the transfer into the retail produce tested 
here was significantly low (below the LOD for this method, 1.1 µg L-1).  Other rationales are also 
presented in section 6.4.3 of this chapter.  However, this is a targeted study and does not contain 
all known PAs and PANOs.  The results were obtained via extraction with SPE clean-up which 
has proven extremely effective in previous studies of honeys (Griffin et al., 2013 and 2014b) and 
herbal products (Griffin et al., 2014a).  A new application of QuEChERS was also investigated 
by applying a modified method to these dairy samples.  Although the mean recoveries of fortified 
extracts (40 to 41%) are not within the acceptable range of 70-120%, the method could be 
modified further to allow for greater recoveries and thus be used as part of a multi-residue testing 
regime in conjunction with veterinary residues.  “The biggest difficulty with QuEChERS arises 
from its greatest strength; it is extremely flexible and rugged” and thus different modifications 
will give rise to different results (Lehotay et al., 2010).  
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Conclusions 
Pyrrolizidine alkaloids (PAs) are a large group of natural toxins produced by plants, several of 
which are known to be highly hepatotoxic and also have been shown to be carcinogenic.  PAs 
have been associated with a number of livestock diseases and cases of human poisoning 
following contamination of staple foods, generally grain crops, or upon consumption of some 
herbal remedies.  Other possible food sources of exposure include honey, milk, offal and eggs, 
which have all been found to contain PAs in some instances although cases of human poisoning 
resulting from exposure through these sources have not been reported. It is unknown whether PA 
residues are present in meat but the potential for exposure is thought to be slight due to the fast 
metabolism and elimination of PAs from the bodies of animals.  Veno-occlusive disease is the 
most prominent hepatic lesion resulting from PA poisoning. Classical symptoms and signs are 
abdominal pain and rapidly developing ascites. The effects of PAs can take time to develop and 
might result from long term low level exposure.  Cases of poisoning in humans and livestock, 
combined with the results of studies in experimental animals indicate that there is variation 
between species in susceptibility to PAs.  Also, the metabolic pathways of PAs and PANOs are 
yet to be fully elucidated. 
 
The principal objective of this research was to investigate the presence of, and quantify, PAs and 
PANOs in food using liquid chromatography-mass spectrometry.  A range of food produce, 
including honey, herbal teas, TCMs, milk and cheese, were investigated for PA-contamination.   
 
Chapter 3 outlines the experimental approaches taken to achieve the research aims and illustrates 
the improvements made upon previously published methods.  A simple acidic extraction was 
optimised for a range of food matrices (sample mass to acid volume ratio) before the extract was 
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applied to a SCX polymeric SPE cartridge for clean-up.  SCX-SPE provided superior clean-up of 
both PA and PANO analytes.  PAs interacted via a cation exchange mechanism whilst PANOs by 
polar interactions with the active sites of the sorbent, thus mixed-mode.  A study was conducted 
of LC analytical columns in an effort to improve chromatographic performance and provide 
superior elution of a range of PAs and PANOs over previously published methods.  Both ion trap 
MS and QqQ-MS analysers were used.  Each method has its own benefits.  The IT-MS method 
allowed for accurate detection of PAs/PANOs via a spectral library, identification of 
characteristic fragments and quantitation through established processing methods.  The QqQ-MS 
methods used both MRM and SRM modes for data acquisition.  These methods are targeted but 
allow for accurate detection of PAs and PANOs with high sensitivity and selectivity. 
 
The experimental work contained within Chapter 4 provides quantitative data on the occurrence 
of PAs at the point of consumption in Ireland for honeys.  It was determined from a large scale 
survey (369 honeys) that approximately 24% of honeys contain one or more PAs and/or PANOs.  
The mean concentration for the total survey was 20 µg kg-1 (or 81 µg kg-1 based upon the 
positives detected).  All quantitation was performed using certified reference standards rather 
than retronecine-type PA equivalents which have been used by some research groups.  Using 
equivalents will generally underestimate the PA-content as otonecine-type PAs are not accounted 
for.  It was also determined that imported honey from Australia and New Zealand, accounting for 
approximately 20% of the honeys sold in the Irish market, contained higher concentrations (145 
µg kg-1) of PA toxins in comparison with honeys originating from other regions of the world or 
with indigenous honeys (no PAs/PANOs detected).  It was for this reason a subsequent survey 
was conducted on 59 Australian and New Zealand honeys which were purchased from Australian 
supermarkets.  In analysing these samples the first isocratic method for PAs and PANOs was 
developed.  The method was comparable to the previously developed method which employed a 
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gradient elution.  The isocratic method, while giving the same selectivity and sensitivity as the 
validated gradient method, allows for fast identification of PA-positives.  Isocratic elution is 
particularly useful for quality testing laboratories or regulatory control agencies.  This chapter 
also includes findings from a risk exposure assessment which was conducted using data on PA-
concentrations from the 369 honeys and dietary intake information from surveys conducted by 
the IUNA (2012).  Research colleagues at UCD utilised a modelling software package (Creme 
software) to conduct both deterministic and probabilistic risk assessments.  This highlighted that 
PAs are an emerging risk to the food chain.  From both assessments high consumers of honey 
(and foods which contain honey as an ingredient), that is the 95th percentile, all exceed the 
maximum recommended intake limit of 0.007 µg kg-1 bw day-1 as proposed by EFSA (2011).  
Troublingly, the average or mean consumer of honey, particularly children, while not exceeding 
the limit are extremely close to it (0.004 µg kg-1 bw day-1).  It should be noted that these figures 
are based solely on the consumption of honeys (or food where honey is listed as an ingredient).  
If other foods which tested PA-positive, such as herbal teas reported in Chapter 5, were to be 
incorporated into the risk assessment then this would increase the exposure of PAs to the section 
of the Irish population who consumed same.   
 
Chapter 5 contains the experimental work conducted on herbal teas and traditional Chinese 
medicines (TCMs).  The analytical methods developed, validated and described in Chapter 3, and 
applied to the testing of honeys in Chapter 4, were used to test 18 herbal teas and 54 TCMs for 
PAs (and their N-oxides).  All samples were sourced within Ireland.  The results were surprising 
in that 50% of herbal teas and 78% of TCMs tested positive for one or more PAs and/or PANOs.  
With regards to herbal products the term ‘Natural’ does not necessarily indicate that the product 
is safe.  The herbal teas and TCMs tested herein could potentially contain other hepatotoxic and 
carcinogenic compounds, or other PAs and PANOs, which were not included in this targeted 
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study and hence increase their toxicity further.  Since this work was completed and published 
further research has been conducted by other groups highlighting the presence of PAs in herbal 
teas and products sourced within Germany and Switzerland.  Similar findings were reported.  
This has prompted the Food and Environmental Research Agency (FERA) in the UK to conduct 
a large scale survey (> 250 samples) of herbal teas (2014). 
 
Chapter 6 represents the initial experimental work conducted on commercial milk and cheese 
samples.  To date there are no publications on research of commercial milk products.  Until now 
research has focused on the carryover of PAs in milk from experimental feeding studies using 
spiked/contaminated feed and fodder.  There was no detectable level of PAs and PANOs in retail 
milk (n = 48) or cheese (n = 72) products.  The results were obtained via acidic extraction 
followed by SPE clean-up which has proven extremely effective in previous studies of honeys 
and herbal products.  This indicates that even if some of the produce originated from an animal 
that had grazed on PA containing plants the transfer into the retail produce tested here was 
significantly low (below the LOD for the LC-MS/MS method).  However, it may also show that 
Good Agricultural Practices have been adopted within Ireland leading to effective pasture 
management.  Chapter 6 also investigated the new application of QuEChERS by applying this 
technique to milk and cheese samples for the detection of PAs and PANOs.  Although the mean 
recoveries (41%) of fortified extracts were not within the acceptable range of 70-120%, the 
method could be optimised to allow for greater recoveries and therefore be used as part of a 
multi-residue testing regime in conjunction with veterinary residues.  Since the completion of this 
research a publication on PAs in animal feed utilised a similar modified QuEChERS technique 
(Bolechova et al., 2015).  The authors did not subject the sample extracts to dispersive SPE 
(dSPE) clean-up, which is the second and final step of the QuEChERS technique.  They reported 
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mean recoveries of 88% for five retronecine-type PAs in animal feed.  Thus, if the dSPE clean-up 
was eliminated from the protocol detailed herein, it may improve recoveries. 
 
Although measures exist within the food supply chain to improve both food safety and 
traceability, there is still a distinct lack of same with regards to PA toxins and exposure.  In 
response, this research work is a significant contribution to the area of PA analysis, detection of 
PAs within the food chain and the profiling of PAs. 
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Recommendations / Future Work 
o Further research needed to fully elucidate biosynthesis of PAs and the metabolism of PAs in 
both humans and livestock. 
o Investigations need to be conducted on the variation between species in susceptibility to PAs. 
o Make additions to the work of Smith and Culvenor (1981), by identifying more PA-plants. 
o Extend our knowledge on the PA-content of various plant species, between aerial parts and 
roots and the environmental conditions which lend to differences in PA-concentration. 
o Develop methods (such as preparative HPLC) to isolate and purify PAs (and their N-oxides) 
as there is a significant dearth of commercially available reference standards. 
o Develop other techniques such as colourimetric field tests, ELISA and NIR spectroscopy, the 
latter being used as an in-process quality control measure (non-destructive technique). 
o Apply the developed sample preparation and SCX-SPE protocol to a range of other food 
matrices.  It has proven effective for complex matrices such as honey, milk and cheese. 
o Develop the QuEChERS protocol further, optimise the analyte recoveries, and investigate the 
potential of using this technique for multi-analyte analysis. 
o Consider the economic consequences for the presence of PAs within the food chain.  For 
example, honey blending is essential at EU level to meet consumer demands.  The EU 
currently imports over half of the honey it consumes (EFSA, 2011).  Testing bulk honeys for 
the presence of PAs before blending occurs would eliminate or significantly reduce PA-
contamination (through dilution). 
o Expand the survey of herbal teas, herbal products and dairy produce.   
o Investigate if PA toxins accumulate in muscle tissues, offal and meat.  During this work the 
possibility of PAs binding or forming complexes with protein should be considered. 
o Develop the spectral library further; include other PA reference standards which have become 
available since the completion of this research and develop a multi-analyte platform..   
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Appendix B 
Copy of importers licence for honey samples received from Australia issued by the Department 
of Agriculture, Food and the Marine. 
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